~~0001038509 us-gaap:ReinsuranceRecoverableMember 2020-06-30~~FALSE2020Q3PRUCO LIFE INSURANCE OF NEW JERSEY000103850912/311,599,2641,437,79617,71814,2215,0655,13944816529,12224,72655400,000400,000400,000400,000400,000400,0000001038509cik1038509:PGIMMembersrt:AffiliatedEntityMember2019-01-012019-09-30

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q



☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~June~~September 30, 2020



☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from to

Commission File Number 333-18053

____________________________________________________________

Pruco Life Insurance Company of New Jersey

(Exact Name of Registrant as Specified in its Charter)



New Jersey						22-2426091
(State or Other Jurisdiction of Incorporation or Organization)						(I.R.S. Employer Identification Number)

213 Washington Street

Newark,, NJ07102

(~~973~~) (973) 802-6000

(Address and Telephone Number of Registrant’s Principal Executive Offices)

SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:



Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Not Applicable	Not Applicable	Not Applicable

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of the Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer", "accelerated filer", "smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.



Large Accelerated Filer	☐	Accelerated Filer	☐
Non-accelerated Filer	☒	Smaller Reporting Company	☐
		Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~August~~November 12, 2020, 400,000 shares of the registrant’s Common Stock (par value $5) were outstanding. As of such date, Pruco Life Insurance Company, an Arizona corporation, owned all of the registrant’s Common Stock.

Pruco Life Insurance Company of New Jersey meets the conditions set

forth in General Instruction (H) (1) (a) and (b) on Form 10-Q and

is therefore filing this Form 10-Q in the reduced disclosure format.

Table of Contents

TABLE OF CONTENTS


					Page Number
PART I—FINANCIAL INFORMATION

			Item 1.	~~Page~~Financial Statements: ~~Number~~
~~PART I—FINANCIAL INFORMATION~~

~~Item 1.~~	~~Financial Statements:~~

	Unaudited Interim Statements of Financial Position as of ~~June~~September 30, 2020 and December 31, 2019	4

			Unaudited Interim Statements of Operations and Comprehensive Income (Loss) for the three and ~~six~~nine months ended ~~June~~September 30, 2020 and 2019		5

			Unaudited Interim Statements of Equity for the three and ~~six~~nine months ended ~~June~~September 30, 2020 and 2019		6

			Unaudited Interim Statements of Cash Flows for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019		78

			Notes to Unaudited Interim Financial Statements		9

			1. Business and Basis of Presentation		9

			2. Significant Accounting Policies and Pronouncements		10

			3. Investments		15

			4. Derivative Instruments		24

			5. Fair Value of Assets and Liabilities		3029

			6. Reinsurance		4039

			7. Income Taxes		4443

			8. Equity		4544

			9. Related Party Transactions		4745

			10. Commitments and Contingent Liabilities		5049

			11. Revision to Prior Year Information		51

Item 2.			Management’s Discussion and Analysis of Financial Condition and Results of Operations		5352

Item 3.			Quantitative and Qualitative Disclosures About Market Risk		62

Item 4.			Controls and Procedures		6263

PART II—OTHER INFORMATION					6364

Item 1.			Legal Proceedings		6364

Item 1A.			Risk Factors		6364

Item 6.			Exhibits		6566

SIGNATURES					6667

Table of Contents

FORWARD-LOOKING STATEMENTS

Certain of the statements included in this Quarterly Report on Form 10-Q, constitute forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Words such as “expects,” “believes,” “anticipates,” “includes,” “plans,” “assumes,” “estimates,” “projects,” “intends,” “should,” “will,” “shall” or variations of such words are generally part of forward-looking statements. Forward-looking statements are made based on management’s current expectations and beliefs concerning future developments and their potential effects upon Pruco Life Insurance Company of New Jersey and its subsidiary. There can be no assurance that future developments affecting Pruco Life Insurance Company of New Jersey and its subsidiary will be those anticipated by management. These forward-looking statements are not a guarantee of future performance and involve risks and uncertainties, and there are certain important factors that could cause actual results to differ, possibly materially, from expectations or estimates reflected in such forward-looking statements, including, among others: (1) the ongoing impact of the COVID-19 pandemic on the global economy, financial markets and our business, (2) losses on investments or financial contracts due to deterioration in credit quality or value, or counterparty default; (3) losses on insurance products due to mortality experience or policyholder behavior experience that differs significantly from our expectations when we price our products; (4) changes in interest rates and equity prices that may (a) adversely impact the profitability of our products, the value of separate accounts supporting these products or the value of assets we manage, (b) result in losses on derivatives we use to hedge risk or increase collateral posting requirements and (c) limit opportunities to invest at appropriate returns; (5) guarantees within certain of our products which are market sensitive and may decrease our earnings or increase the volatility of our results of operations or financial position; (6) liquidity needs resulting from (a) derivative collateral market exposure, (b) asset/liability mismatches, (c) the lack of available funding in the financial markets or (d) unexpected cash demands due to severe mortality calamity or lapse events; (7) financial or customer losses, or regulatory and legal actions, due to inadequate or failed processes or systems, external events and human error or misconduct such as (a) disruption of our systems and data, (b) an information security breach, (c) a failure to protect the privacy of sensitive data (d) reliance on third parties or (e) labor and employment matters; (8) changes in the regulatory landscape, including related to (a) financial sector regulatory reform, (b) changes in tax laws, (c) fiduciary rules and other standards of care, (d) state insurance laws and developments regarding group-wide supervision, capital and reserves, and (e) privacy and cybersecurity regulation; (9) technological changes which may adversely impact companies in our investment portfolio or cause insurance experience to deviate from our assumptions; (10) ratings downgrades; (11) market conditions that may adversely affect the sales or persistency of our products; (12) competition; and (13) reputational damage. Pruco Life Insurance Company of New Jersey does not intend, and is under no obligation, to update any particular forward-looking statement included in this document. See “Risk Factors” included in this Quarterly Report on Form 10-Q for the quarter ended ~~June~~September 30, 2020 and the Annual Report on Form 10-K for the year ended December 31, 2019 for discussion of certain risks relating to our business and investment in our securities.

Table of Contents

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY

Unaudited Interim Statements of Financial Position

~~June~~September 30, 2020 and December 31, 2019 (in thousands, except share amounts)


	September 30, 2020		December 31, 2019
ASSETS
Fixed maturities available for sale, at fair value (amortized cost: 2020 - $1,599,264; 2019–$1,437,796)	$	1,808,546	$	1,550,096
Fixed maturities, trading, at fair value (amortized cost: 2020 - $17,718; 2019–$14,221)	17,857		13,700
Equity securities, at fair value (cost: 2020 - $5,065; 2019–$5,139)	8,438		7,512

Policy loans	212,519		211,986

Commercial mortgage and other loans (net of $448 and $165 allowance for credit losses at September 30, 2020 and December 31, 2019, respectively) (1)	136,705		143,098
Other invested assets (includes $29,122 and $24,726 of assets measured at fair value at September 30, 2020 and December 31, 2019, respectively)	103,429		89,536
Total investments	2,287,494		2,015,928
Cash and cash equivalents	68,360		55,924
Deferred policy acquisition costs	213,072		178,813
Accrued investment income	21,027		19,539
Reinsurance recoverables	4,116,435		3,200,642
Receivables from parent and affiliates	32,775		32,820

Income taxes receivable	0		6,268
Other assets	20,042		21,203
Separate account assets	15,887,732		15,904,208
TOTAL ASSETS	$	22,646,937	$	21,435,345
LIABILITIES AND EQUITY
LIABILITIES
Future policy benefits	$	3,235,868	$	2,302,959
Policyholders’ account balances	2,508,775		2,424,120
Cash collateral for loaned securities	2,731		2,481

Income taxes payable(1)	2,528		0
Short-term debt to affiliates	0		89

Payables to parent and affiliates	13,661		24,958
Other liabilities(1)	163,252		140,628
Separate account liabilities	15,887,732		15,904,208
Total liabilities	21,814,547		20,799,443
COMMITMENTS AND CONTINGENT LIABILITIES (See Note 10)
EQUITY
Common stock ($5 par value; 400,000 shares authorized, issued and outstanding)	2,000		2,000
Additional paid-in capital	348,735		268,021
Retained earnings	323,986		280,246
Accumulated other comprehensive income (loss)	157,669		85,635
Total equity	832,390		635,902
TOTAL LIABILITIES AND EQUITY	$	22,646,937	$	21,435,345

June 30, 2020 December 31, 2019
ASSETS
Fixed maturities available for sale, at fair value (amortized cost: 2020 - $1,587,004; 2019–$1,437,796) $ 1,771,553
$ 1,550,096
Fixed maturities, trading, at fair value (amortized cost: 2020 - $14,221; 2019–$14,221) 12,727
13,700
Equity securities, at fair value (cost: 2020 - $5,065; 2019–$5,139) 7,311
7,512
Policy loans 213,467
211,986
Commercial mortgage and other loans (net of $457 and $165 allowance for credit losses at June 30, 2020 and December 31, 2019, respectively)(1) 137,914
143,098
Other invested assets (includes $37,189 and $24,726 of assets measured at fair value at June 30, 2020 and December 31, 2019, respectively) 107,524
89,536
Total investments 2,250,496
2,015,928
Cash and cash equivalents 41,120
55,924
Deferred policy acquisition costs 203,125
178,813
Accrued investment income 20,984
19,539
Reinsurance recoverables 4,310,574
3,200,642
Receivables from parent and affiliates 39,848
32,820
Income taxes receivable(1) 1,827
6,268
Other assets 22,948
21,203
Separate account assets 15,290,949
15,904,208
TOTAL ASSETS $ 22,181,871
$ 21,435,345
LIABILITIES AND EQUITY
LIABILITIES
Future policy benefits $ 3,425,560
$ 2,302,959
Policyholders’ account balances 2,477,893
2,424,120
Cash collateral for loaned securities 2,700
2,481
Short-term debt to affiliates 0
89
Payables to parent and affiliates 26,632
24,958
Other liabilities(1) 156,347
140,628
Separate account liabilities 15,290,949
15,904,208
Total liabilities 21,380,081
20,799,443
COMMITMENTS AND CONTINGENT LIABILITIES (See Note 10)

EQUITY
Common stock ($5 par value; 400,000 shares authorized, issued and outstanding) 2,000
2,000
Additional paid-in capital 348,735
268,021
Retained earnings 304,986
280,246
Accumulated other comprehensive income (loss) 146,069
85,635
Total equity 801,790
635,902
TOTAL LIABILITIES AND EQUITY $ 22,181,871
$ 21,435,345
(1)September 30, 2020 amounts include the impacts of the January 1, 2020 adoption of ASU 2016-13. See Note 2 for details.


~~(1)~~	~~June 30, 2020 amounts include the impacts of the January 1, 2020 adoption of ASU 2016-13. See Note 2 for details.~~

See Notes to Unaudited Interim Financial Statements

Table of Contents

PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY

Unaudited Interim Statements of Operations and Comprehensive Income (Loss)

Three and ~~Six~~Nine Months Ended ~~June~~September 30, 2020 and 2019 (in thousands)


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
REVENUES
Premiums	$	5,586	$	3,099	$	15,909	$	9,718
Policy charges and fee income	14,623		10,344		56,835		52,798
Net investment income	23,260		18,059		60,908		56,272
Asset administration fees	1,756		1,500		4,867		4,292
Other income	3,371		452		3,062		3,095




Realized investment gains (losses), net	2,535		2,719		8,088		(8,447)
TOTAL REVENUES	51,131		36,173		149,669		117,728
BENEFITS AND EXPENSES
Policyholders’ benefits	1,227		2,397		31,356		22,725
Interest credited to policyholders’ account balances	10,836		13,759		33,014		32,817
Amortization of deferred policy acquisition costs	6,297		3,519		13,576		10,918
General, administrative and other expenses	12,488		7,885		33,257		21,841
TOTAL BENEFITS AND EXPENSES	30,848		27,560		111,203		88,301
INCOME (LOSS) FROM OPERATIONS BEFORE INCOME TAXES	20,283		8,613		38,466		29,427
Income tax expense (benefit)	1,283		247		(5,441)		19
NET INCOME (LOSS)	$	19,000	$	8,366	$	43,907	$	29,408
Other comprehensive income (loss), before tax:
Foreign currency translation adjustments	92		(64)		133		(60)
Net unrealized investment gains (losses)	14,591		40,681		91,050		133,542
Total	14,683		40,617		91,183		133,482
Less: Income tax expense (benefit) related to other comprehensive income (loss)	3,083		8,530		19,149		28,031
Other comprehensive income (loss), net of taxes	11,600		32,087		72,034		105,451
Comprehensive income (loss)	$	30,600	$	40,453	$	115,941	$	134,859

Three Months Ended June 30, Six Months Ended
June 30,
2020 2019 2020 2019
REVENUES
Premiums $ 5,129
$ 3,281
$ 10,323
$ 6,619
Policy charges and fee income 18,243
22,605
42,212
42,454
Net investment income 20,683
19,472
37,648
38,213
Asset administration fees 1,546
1,449
3,111
2,792
Other income 1,640
1,329
(309 ) 2,643
Realized investment gains (losses), net (7,512 ) (5,056 ) 5,553
(11,166 )
TOTAL REVENUES 39,729
43,080
98,538
81,555
BENEFITS AND EXPENSES
Policyholders’ benefits 13,443
10,351
30,129
20,328
Interest credited to policyholders’ account balances 11,987
10,005
22,178
19,058
Amortization of deferred policy acquisition costs 1,967
6,174
7,279
7,399
General, administrative and other expenses 10,395
6,858
20,769
13,956
TOTAL BENEFITS AND EXPENSES 37,792
33,388
80,355
60,741
INCOME (LOSS) FROM OPERATIONS BEFORE INCOME TAXES 1,937
9,692
18,183
20,814
Income tax expense (benefit) (8,425 ) (805 ) (6,724 ) (228 )
NET INCOME (LOSS) $ 10,362
$ 10,497
$ 24,907
$ 21,042
Other comprehensive income (loss), before tax:
Foreign currency translation adjustments 42
4
41
4
Net unrealized investment gains (losses) 97,427
46,263
76,459
92,861
Total 97,469
46,267
76,500
92,865
Less: Income tax expense (benefit) related to other comprehensive income (loss) 20,470
9,715
16,066
19,501
Other comprehensive income (loss), net of taxes 76,999
36,552
60,434
73,364
Comprehensive income (loss) $ 87,361
$ 47,049
$ 85,341
$ 94,406

See Notes to Unaudited Interim Financial Statements

Table of Contents

PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY

Unaudited Interim Statements of Equity

Three and ~~Six~~Nine Months Ended ~~June~~September 30, 2020 and 2019 (in thousands)

Common Stock Additional Paid-in Capital Retained Earnings Accumulated Other Comprehensive Income (Loss) Total Equity
Balance, December 31, 2019 $ 2,000
$ 268,021
$ 280,246
$ 85,635
$ 635,902
Cumulative effect of adoption of accounting changes(1) (167 ) (167 )
Contributed capital 85,112
85,112
Contributed (distributed) capital - parent/child asset transfers (4,268 ) (4,268 )
Comprehensive income (loss):
        Net income (loss) 14,545
14,545
Other comprehensive income (loss), net of tax (16,565 ) (16,565 )
Total comprehensive income (loss) (2,020 )
Balance, March 31, 2020 $ 2,000
$ 348,865
$ 294,624
$ 69,070
$ 714,559
Contributed capital 0
0
Contributed (distributed) capital-parent/child asset transfers (130 ) (130 )
Comprehensive income (loss):
Net income (loss) 10,362
10,362
        Other comprehensive income (loss), net of taxes 76,999
76,999
Total comprehensive income (loss) 87,361
Balance, June 30, 2020 $ 2,000
$ 348,735
$ 304,986
$ 146,069
$ 801,790


	Common Stock		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total Equity
Balance, December 31, 2019	$	2,000	$	268,021	$	280,246	$	85,635	$	635,902
Cumulative effect of adoption of accounting changes(1)					(167)				(167)
Contributed capital			85,112						85,112

Contributed (distributed) capital - parent/child asset transfers			(4,268)						(4,268)
Comprehensive income (loss):
Net income (loss)					14,545				14,545
Other comprehensive income (loss), net of tax							(16,565)		(16,565)
Total comprehensive income (loss)									(2,020)
Balance, March 31, 2020	$	2,000	$	348,865	$	294,624	$	69,070	$	714,559

Contributed capital			0						0

Contributed (distributed) capital-parent/child asset transfers			(130)						(130)
Comprehensive income (loss):
Net income (loss)					10,362				10,362
Other comprehensive income (loss), net of taxes							76,999		76,999
Total comprehensive income (loss)									87,361
Balance, June 30, 2020	$	2,000	$	348,735	$	304,986	$	146,069	$	801,790

Contributed capital			0						0

Contributed (distributed) capital-parent/child asset transfers			0						0
Comprehensive income (loss):
Net income (loss)					19,000				19,000
Other comprehensive income (loss), net of taxes							11,600		11,600
Total comprehensive income (loss)									30,600
Balance, September 30, 2020	$	2,000	$	348,735	$	323,986	$	157,669	$	832,390

Common Stock Additional Paid-in Capital Retained Earnings Accumulated Other Comprehensive Income (Loss) Total Equity
Balance, December 31, 2018 $ 2,000
$ 213,261
$ 243,827
$ (14,367 ) $ 444,721
Cumulative effect of adoption of accounting changes(2) (336 ) (336 )
Contributed capital 0
0
Contributed (distributed) capital-parent/child asset transfers 0
0
Comprehensive income (loss):
Net income (loss) 10,545
10,545
Other comprehensive income (loss), net of tax 36,812
36,812
Total comprehensive income (loss) 47,357
Balance, March 31, 2019 $ 2,000
$ 213,261
$ 254,036
$ 22,445
$ 491,742
Contributed capital 0
0
Contributed (distributed) capital-parent/child asset transfers 0
0
Comprehensive income (loss):
Net income (loss) 10,497
10,497
Other comprehensive income (loss), net of tax 36,552
36,552
Total comprehensive income (loss) 47,049
Balance, June 30, 2019 $ 2,000
$ 213,261
$ 264,533
$ 58,997
$ 538,791

Table of Contents


~~(1)~~			~~Includes the impact from the adoption of ASU 2016-13. See Note 2.~~


~~(2)~~			Includes the impact from the adoption of ASU 2017-08 and 2017-12. See Note 2 to the Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 for additional information.


	Common Stock		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total Equity
Balance, December 31, 2018	$	2,000	$	213,261	$	243,827	$	(14,367)	$	444,721
Cumulative effect of adoption of accounting changes(2)					(336)				(336)
Contributed capital			0						0

Contributed (distributed) capital-parent/child asset transfers			0						0
Comprehensive income (loss):
Net income (loss)					10,545				10,545
Other comprehensive income (loss), net of tax							36,812		36,812
Total comprehensive income (loss)									47,357
Balance, March 31, 2019	$	2,000	$	213,261	$	254,036	$	22,445	$	491,742

Contributed capital			0						0

Contributed (distributed) capital-parent/child asset transfers			0						0
Comprehensive income (loss):
Net income (loss)					10,497				10,497
Other comprehensive income (loss), net of tax							36,552		36,552
Total comprehensive income (loss)									47,049
Balance, June 30, 2019	$	2,000	$	213,261	$	264,533	$	58,997	$	538,791

Contributed capital			0						0

Contributed (distributed) capital-parent/child asset transfers			0						0
Comprehensive income (loss):
Net income (loss)					8,366				8,366
Other comprehensive income (loss), net of tax							32,087		32,087
Total comprehensive income (loss)									40,453
Balance, September 30, 2019	$	2,000	$	213,261	$	272,899	$	91,084	$	579,244

(1)Includes the impact from the adoption of ASU 2016-13. See Note 2.

(2)Includes the impact from the adoption of ASU 2017-08 and 2017-12. See Note 2 to the Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 for additional information.

See Notes to Unaudited Interim Financial Statements

Table of Contents

PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY

Unaudited Interim Statements of Cash Flows

~~Six~~Nine Months Ended ~~June~~September 30, 2020 and 2019 (in thousands)

2020 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss) $ 24,907
$ 21,042
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Policy charges and fee income (1) (11,802 ) (9,068 )
Interest credited to policyholders’ account balances 22,178
19,058
Realized investment (gains) losses, net (5,553 ) 11,166
Amortization and other non-cash items 2,238
(7,220 )
Change in:
Future policy benefits 161,149
148,113
Reinsurance recoverables (143,500 ) (133,304 )
Accrued investment income (1,445 ) (1,046 )
Net payables to/receivables from parent and affiliates (5,474 ) (1,306 )
Deferred policy acquisition costs (30,587 ) (7,803 )
Income taxes (10,410 ) (8,684 )
Derivatives, net (292 ) (1,378 )
Other, net (1,756 ) (16,605 )
Cash flows from (used in) operating activities (347 ) 12,965
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from the sale/maturity/prepayment of:
Fixed maturities, available-for-sale 19,910
33,123
Equity securities 84
3,298
Policy loans 13,902
12,885
Ceded policy loans (693 ) (713 )
Commercial mortgage and other loans 6,794
6,576
Other invested assets 1,391
1,161
Payments for the purchase/origination of:
Fixed maturities, available-for-sale (90,832 ) (111,939 )
Fixed maturities, trading 0
(3,045 )
Equity securities 0
(50 )
Policy loans (13,334 ) (12,010 )
Ceded policy loans 3,077
1,036
Commercial mortgage and other loans (2,552 ) (10,557 )
Other invested assets (6,758 ) (8,939 )
Notes receivable from parent and affiliates, net 145
6,127
Derivatives, net (1,252 ) 25
Other, net 98
(139 )
Cash flows from (used in) investing activities (70,020 ) (83,161 )
CASH FLOWS FROM FINANCING ACTIVITIES:
Policyholders’ account deposits 272,218
284,528
Ceded policyholders’ account deposits (179,733 ) (172,340 )
Policyholders’ account withdrawals (1) (166,760 ) (173,074 )
Ceded policyholders’ account withdrawals 125,471
113,527
Net change in securities sold under agreement to repurchase and cash collateral for loaned securities 219
(256 )
Contributed (distributed) capital - parent/child asset transfers (5,567 ) 0
Net change in all other financing arrangements (maturities 90 days or less) (89 ) 0
Drafts outstanding 4,456
(2,054 )
Other, net (1) 5,348
(4,935 )
Cash flows from (used in) financing activities 55,563
45,396
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (14,804 ) (24,800 )
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 55,924
70,441
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 41,120
$ 45,641


	2020		2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$	43,907	$	29,408
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Policy charges and fee income (1)	(19,045)		(13,874)
Interest credited to policyholders’ account balances	33,014		32,817
Realized investment (gains) losses, net	(8,088)		8,447
Amortization and other non-cash items	(4,695)		(9,565)
Change in:
Future policy benefits	208,507		209,451
Reinsurance recoverables	(187,085)		(197,372)
Accrued investment income	(1,488)		(588)
Net payables to/receivables from parent and affiliates	(12,876)		(1,497)
Deferred policy acquisition costs	(42,715)		(16,068)
Income taxes	(9,139)		(9,256)

Derivatives, net	1,605		(1,548)
Other, net	882		(13,181)
Cash flows from (used in) operating activities	2,784		17,174
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from the sale/maturity/prepayment of:
Fixed maturities, available-for-sale	35,035		45,863

Equity securities	84		3,298
Policy loans	20,129		19,997
Ceded policy loans	(1,185)		(967)

Commercial mortgage and other loans	9,737		9,163
Other invested assets	1,542		1,451

Payments for the purchase/origination of:
Fixed maturities, available-for-sale	(117,524)		(139,109)
Fixed maturities, trading	(3,497)		(6,776)
Equity securities	0		(50)
Policy loans	(16,249)		(17,942)
Ceded policy loans	3,381		1,749

Commercial mortgage and other loans	(3,616)		(25,088)
Other invested assets	(7,923)		(11,821)

Notes receivable from parent and affiliates, net	1,398		6,254
Derivatives, net	315		(173)
Other, net	93		(246)
Cash flows from (used in) investing activities	(78,280)		(114,397)
CASH FLOWS FROM FINANCING ACTIVITIES:
Policyholders’ account deposits	403,557		425,091
Ceded policyholders’ account deposits	(265,304)		(259,621)
Policyholders’ account withdrawals (1)	(247,216)		(263,941)
Ceded policyholders’ account withdrawals	189,038		169,411
Net change in securities sold under agreement to repurchase and cash collateral for loaned securities	250		(174)


Contributed (distributed) capital - parent/child asset transfers	(5,567)		0
Net change in all other financing arrangements (maturities 90 days or less)	(89)		0


Drafts outstanding	6,046		(5,652)
Other, net (1)	7,217		(7,606)
Cash flows from (used in) financing activities	87,932		57,508
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	12,436		(39,715)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	55,924		70,441
CASH AND CASH EQUIVALENTS, END OF PERIOD	$	68,360	$	30,726

(1) Prior period amounts have been revised to correct an error. See Note 11 for details.

~~Table of Contents~~

Significant Non-Cash Transactions

For the ~~six~~nine months ended ~~June~~September 30, 2020, the Company received $85 million of non-cash assets from its parent, Pruco Life Insurance Company. There were 0 significant non-cash transactions for the ~~six~~nine months ended ~~June~~September 30, 2019. See Note 9 for additional information.

See Notes to Unaudited Interim Financial Statements

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial ~~Statements~~Statements—(Continued)

1. BUSINESS AND BASIS OF PRESENTATION

Pruco Life Insurance Company of New Jersey ("PLNJ") is a wholly-owned subsidiary of Pruco Life Insurance Company (“Pruco Life”), which in turn is a wholly-owned subsidiary of The Prudential Insurance Company of America (“Prudential Insurance”). Prudential Insurance is a direct wholly-owned subsidiary of Prudential Financial, Inc. (“Prudential Financial”). PLNJ is a stock life insurance company organized in 1982 under the laws of the State of New Jersey. It is licensed to sell life insurance and annuities in New Jersey and New York only, and sells such products primarily through affiliated and unaffiliated distributors.

Basis of Presentation

The Unaudited Interim Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) on a basis consistent with reporting interim financial information in accordance with instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Intercompany balances and transactions have been eliminated.

In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company’s Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

The most significant estimates include those used in determining deferred policy acquisition costs ("DAC") and related amortization; policyholders' account balances related to the fair value of embedded derivative instruments associated with the index-linked features of certain universal life products; valuation of investments including derivatives, measurement of allowance for credit losses, and recognition of other-than-temporary impairments (“OTTI”); future policy benefits including guarantees; reinsurance recoverables; provision for income taxes and valuation of deferred tax assets; and accruals for contingent liabilities, including estimates for losses in connection with unresolved legal and regulatory matters.

COVID-19

Beginning in the first quarter of 2020, the outbreak of the novel coronavirus (“COVID-19”) has resulted in extreme stress and disruption in the global economy and financial markets, and has adversely impacted, and may continue to adversely impact, our results of operations, financial condition and cash flows. Due to the highly uncertain nature of these conditions, it is not possible to estimate the ultimate impacts at this time. The risks may have manifested, and may continue to manifest, in our financial statements in the areas of, among others, i) investments: increased risk of loss on our investments due to default or deterioration in credit quality or value; and ii) insurance liabilities and related balances: potential changes to assumptions regarding investment returns, mortality ~~morbidity~~ and policyholder behavior which are reflected in our insurance liabilities and certain related balances (e.g., DAC, etc.). We cannot predict what impact the COVID-19 pandemic will ultimately have on the global economy, markets or our businesses.

Revision to Prior Period Financial Statements

The Company identified an error in the presentation of certain cash flow activity related to policyholders' account balances that impacted several line items within previously issued Statements of Cash Flows. Prior period amounts have been revised in the financial statements to correct this error. Management evaluated these adjustments and concluded they were not material to any previously reported quarterly or annual financial statements. See Note 11 for a more detailed description of the revision and for comparisons of amounts previously reported to the revised amounts.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Reclassifications

Certain amounts in prior periods have been reclassified to conform to the current period presentation.

2. SIGNIFICANT ACCOUNTING POLICIES AND PRONOUNCEMENTS

Recent Accounting Pronouncements

Changes to U.S. GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of Accounting Standards Updates ("ASUs") to the FASB Accounting Standards Codification ("ASC"). The Company considers the applicability and impact of all ASUs. ASUs listed below include those that have been adopted during the current fiscal year and/or those that have been issued but not yet adopted as of ~~June~~September 30, 2020, and as of the date of this filing. ASUs not listed below were assessed and determined to be either not applicable or not material.

Adoption of ASU 2016-13

The Company adopted ASU 2016-13, and related ASUs, effective January 1, 2020 using the modified retrospective method for certain financial assets carried at amortized cost and certain off-balance sheet exposures. The modified retrospective method results in a cumulative effect adjustment to opening retained earnings. The Company adopted the guidance related to fixed maturities, available-for-sale on a prospective basis.

This ASU requires the use of a new current expected credit loss (“CECL”) model to account for expected credit losses on certain financial assets reported at amortized cost (e.g., loans held for investment, reinsurance receivables, etc.) and certain off-balance sheet credit exposures (e.g., indemnification of serviced mortgage loans and certain loan commitments). The guidance requires an entity to estimate lifetime credit losses related to such financial assets and credit exposures based on relevant information about past events, current conditions, and reasonable and supportable forecasts that may affect the collectability of the reported amounts. The standard also modifies the OTTI guidance for fixed maturities, available-for-sale requiring the use of an allowance rather than a direct write-down of the investment.

The impacts of this ASU on the Company’s Financial Statements primarily include (1) A Cumulative Effect Adjustment Upon Adoption; (2) Changes to the Presentation of the Statements of Financial Position and Statements of Operations; and (3) Changes to Accounting Policies. Each of these impacts is described below. This section is meant to serve as an update to, and should be read in conjunction with, Note 2 to the Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

(1) Cumulative Effect Adjustment Upon Adoption

Adoption of the standard resulted in a cumulative effect adjustment to opening retained earnings in the amount of $0.2 million, primarily related to commercial mortgage and other loans. The impact of adoption is not material to the following financial statement line items: income taxes ~~receivable~~payable and other liabilities. The prospective adoption of the portions of the standard related to fixed maturities, available-for-sale resulted in no impact to opening retained earnings.

(2) Changes to the Presentation of the Statements of Financial Position and Statements of Operations

The allowance for credit losses is presented parenthetically on relevant line items in the Statements of Financial Position. In the Statements of Operations, realized investment gains (losses), net are presented on one line item and will no longer reflect the breakout of OTTI on fixed maturity securities; OTTI on fixed maturity securities transferred to other comprehensive income (“OCI”); and other realized investment gains (losses), net. The presentation of this detail in prior periods is immaterial.

(3) Changes to Accounting Policies

This section has been updated to include the following changes in our accounting policies resulting from the adoption of ASU 2016-13.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Fixed maturities, available-for-sale

Fixed maturities, available-for-sale (“AFS debt securities”) are reported at fair value in the Statements of Financial Position. Interest income, and amortization of premium and accretion of discount are included in “Net investment income” under the effective yield method. For mortgage-backed and asset-backed securities, the effective yield is based on estimated cash flows, including interest rate and prepayment assumptions based on data from widely accepted third-party data sources or internal estimates. In addition to interest rate and prepayment assumptions, cash flow estimates also vary based on other assumptions relating to the underlying collateral, including default rates and changes in value. These assumptions can significantly impact income recognition and the amount of impairments recognized in earnings and OCI. For mortgage-backed and asset-backed securities rated below AA, the effective yield is adjusted prospectively for any changes in the estimated timing and amount of cash flows unless the investment is impaired or purchased with credit deterioration. For impaired mortgage-backed and asset-backed securities rated below AA, the effective yield is adjusted prospectively only if subsequent favorable or adverse changes in expected cash flows are not reflected in the allowance for credit losses. Prior to the adoption of this standard, the effective yield was adjusted prospectively regardless of whether the investment was impaired or not.

AFS debt securities with unrealized losses are reviewed quarterly to determine whether the amortized cost basis of the security is recoverable. In evaluating whether the amortized cost basis is recoverable, the Company considers several factors including, but not limited to the extent of the decline and the reasons for the decline in value (credit events, currency or interest-rate related, including general credit spread widening), and the financial condition of the issuer.

When an AFS debt security is in an unrealized loss position and (1) the Company has the intent to sell the AFS debt security, or (2) it is more likely than not the Company will be required to sell the AFS debt security before its anticipated recovery, or (3) the Company has deemed the AFS debt security to be uncollectable, the amortized cost basis of the AFS debt security is written down to fair value and any previously recognized allowance is reversed. The impairment is reported in “Realized investment gains (losses), net.” The new cost basis is not adjusted for subsequent increases in estimated fair value.

For an AFS debt security in an unrealized loss position that does not meet these conditions, the Company analyzes its ability to recover the amortized cost by comparing the net present value of projected future cash flows (the “net present value”) with the amortized cost of the security. The net present value is calculated by discounting the Company’s best estimate of projected future cash flows at the effective interest rate implicit in the AFS debt security at the date of acquisition. The Company may use the estimated fair value of collateral, if any, as a proxy for the net present value if it believes that the security is dependent on the liquidation of collateral for recovery of its investment. If the net present value is less than the amortized cost of the investment, an allowance for losses is recognized in earnings for the difference between amortized cost and the net present value and is limited to the difference between amortized cost and fair value of the AFS debt security. Any difference between the fair value and the net present value of the debt security at the impairment measurement date remains in “Other comprehensive income (loss).” Changes in the allowance for losses are reported in “Realized investment gains (losses), net.”

Prior to the adoption of this standard, any impairments on AFS debt securities were reported as an adjustment to the amortized cost basis of the security. Subsequent to the impairment, the AFS debt security was treated as if it were newly acquired at the date of impairment, and any increases in cash flows expected to be collected were accreted into net investment income over the life of the investment.

Commercial mortgage and other loans

Commercial mortgage and other loans are reported in the Statements of Financial Position at amortized cost net of the CECL allowance. Additionally, certain off-balance sheet credit exposures (e.g., indemnification of serviced mortgage loans, and certain unfunded mortgage loan commitments where the Company cannot unconditionally cancel the commitment) are also subject to a CECL allowance.

The CECL allowance represents the Company’s best estimate of expected credit losses over the remaining life of the assets or off-balance sheet credit exposures. The determination of the allowance considers historical credit loss experience, current conditions, and reasonable and supportable forecasts. The allowance is calculated separately for commercial mortgage loans, agricultural mortgage loans, and other collateralized and uncollateralized loans.

For commercial mortgage and agricultural mortgage loans (and related unfunded commitments where the Company cannot unconditionally cancel the commitment), the allowance is calculated using an internally developed CECL model.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Key inputs to the CECL model include unpaid principal balances, internal credit ratings, annual expected loss factors, average lives of the loans adjusted for prepayment considerations, current and historical interest rate assumptions, and other factors influencing the Company’s view of the current stage of the economic cycle and future economic conditions. Subjective considerations include a review of whether historical loss experience is representative of current market conditions and the Company’s view of the credit cycle. Model assumptions and factors are reviewed and updated as appropriate. Information about certain key inputs is detailed below.

Key factors in determining the internal credit ratings for commercial mortgage and agricultural mortgage loans include loan-to-value and debt-service-coverage ratios. Other factors include amortization, loan term, and estimated market value growth rate and volatility for the property type and region. The loan-to-value ratio compares the carrying amount of the loan to the fair value of the underlying property or properties collateralizing the loan and is commonly expressed as a percentage. Loan-to-value ratios greater than 100% indicate that the carrying amount of the loan exceeds the collateral value. A loan-to-value ratio less than 100% indicates an excess of collateral value over the carrying amount of the loan. The debt-service-coverage ratio is a property’s net operating income as a percentage of its debt service payments. Debt-service-coverage ratios less than 1.0 times indicate that a property’s operations do not generate enough income to cover the loan’s current debt payments. A debt-service-coverage ratio greater than 1.0 times indicates an excess of net operating income over the debt service payments. The values utilized in calculating these ratios are developed as part of the Company’s periodic review of the commercial mortgage and agricultural mortgage loan portfolios, which includes an internal appraisal of the underlying collateral value. The Company’s periodic review also includes a credit re-rating process, whereby the internal credit rating originally assigned at underwriting is updated based on current loan, property and market information using a proprietary credit quality rating system. See Note 3 for additional information related to the loan-to-value ratios and debt-service-coverage ratios related to the Company’s commercial mortgage and agricultural mortgage loan portfolios. Generally, every loan is re-rated at least annually.

Annual expected loss rates are based on historical default and loss experience factors. Using average lives, the annual expected loss rates are converted into life-of-loan loss expectations.

When individual loans no longer have the credit risk characteristics of the commercial or agricultural mortgage loan pools, they are removed from the pools and are evaluated individually for an allowance. The allowance is determined based on the outstanding loan balance less the present value of expected future cash flows discounted at the loan’s effective interest rate or the fair value of the collateral if the loan is collateral dependent.

The CECL allowance on commercial mortgage and other loans can increase or decrease from period to period based on the factors noted above. The change in allowance is reported in “Realized investment gains (losses), net.” As it relates to unfunded commitments that are in scope of this guidance, the CECL allowance is reported in “Other liabilities”, and the change in the allowance is reported in “Realized investment gains (losses), net.”

When a commercial mortgage or other loan is deemed to be uncollectible, any allowance is reversed and a direct write-down of the carrying amount of the loan is recorded through "Realized investment gains (losses), net." The carrying amount of the loan is not adjusted for subsequent recoveries in value.

The CECL allowance for other collateralized and uncollateralized loans carried at amortized cost is determined based on probability of default and loss given default assumptions by sector, credit quality and average lives of the loans. Additions to or releases of the allowance are reported in “Realized investment gains (losses), net.”

Prior to the adoption of this standard, the impairments on commercial mortgage and other loans were collectively reviewed at a portfolio level for impairment based on probable incurred but not specifically identified losses with any such losses reflected in an allowance for credit losses. When a loan was individually identified to be impaired, the loan was individually evaluated for an allowance. Changes in these allowances were reported in “Realized investment gains (losses), net.” Additionally, an allowance for credit losses was not required on unfunded loan commitments.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Reinsurance Recoverables

Reinsurance recoverables are reported on the Statements of Financial Position net of the CECL allowance. The CECL allowance considers the credit quality of the reinsurance counterparty and is generally determined based on the probability of default and loss given default assumptions, after considering any applicable collateral arrangements. The CECL allowance does not apply to reinsurance recoverables with affiliated counterparties under common control. Additions to or releases of the allowance are reported in “Policyholders’ benefits.”

Prior to the adoption of this standard, an allowance for credit losses for reinsurance recoverables was established only when it was deemed probable that a reinsurer may fail to make payments to us in a timely manner.

Other ASUs adopted during the ~~six~~nine months ended ~~June~~September 30, 2020.

Standard

Description

Effective date and method of adoption

Effect on the financial statements or other significant matters

ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation

of the Effects of Reference Rate Reform on Financial Reporting

This ASU provides optional relief for certain contracts impacted by reference rate reform. The standard permits an entity to consider contract modification due to reference rate reform to be an event that does not require contract remeasurement at the modification date or reassessment of a previous accounting determination. The ASU also temporarily (until December 31, 2022) allows hedge relationships to continue without de-designation upon changes due to reference rate reform.

March 12, 2020 to December 31, 2022 using the prospective method.

This ASU did not have a significant impact on the Company’s Financial Statements and Notes to the Financial Statements.

The Company made the election under ASU 2020-04 for all applicable contracts as they converted from the current reference rate to the new reference rate.

ASU issued but not yet adopted as of ~~June~~September 30, 2020 — ASU 2018-12

ASU 2018-12, Financial Services - Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts, was issued by the FASB on August 15, 2018 and is expected to have a significant impact on the Company’s Financial Statements and Notes to the Financial Statements. In October 2019, the FASB issued ASU 2019-09, Financial Services - Insurance (Topic 944): Effective Date to affirm its decision to defer the effective date of ASU 2018-12 to January 1, 2022 (with early adoption permitted), representing a one year extension from the original effective date of January 1, 2021. As a result of the COVID-19 pandemic, in November 2020 the FASB ~~voted in June 2020~~issued ASU 2020-11, Financial Services-Insurance (Topic 944): Effective Date and Early Application to ~~tentatively~~ defer for an additional one year the ~~current~~ effective date of ASU 2018-12 from January 1, 2022 to January 1, 2023, and to provide transition relief to facilitate the early adoption of the ASU. Subsequently in July 2020, the FASB issued a proposed ASU with comment deadline of August 24, 2020 to obtain additional feedback on the tentative decisions, which are expected to be finalized during the third quarter of 2020. The transition relief would allow large calendar-year public companies that early adopt ASU 2018-12 to apply the guidance either as of January 1, 2020 or January 1, 2021 (and record transition adjustments as of January 1, ~~2021)~~2020 or January 1, 2021, respectively) in the 2022 financial statements. Companies that do not early adopt ASU 2018-12 would ~~also~~ apply the guidance as of January 1, 2021 (and record transition adjustments as of January 1, 2021) in the 2023 financial statements. ASU 2018-12 will impact, at least to some extent, the accounting and disclosure requirements for all long-duration insurance and investment contracts issued by the Company. Outlined below are four key areas of change, although there are other changes not noted below. In addition to the impacts to the balance sheet upon adoption, the Company also expects an impact to how earnings emerge thereafter.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

ASU 2018-12 Amended Topic

Description

Method of adoption

Effect on the financial statements or other significant matters

Cash flow assumptions used to measure the liability for future policy benefits for non-participating traditional and limited-pay insurance products

Requires an entity to review, and if necessary, update the cash flow assumptions used to measure the liability for future policy benefits, for both changes in future assumptions and actual experience, at least annually using a retrospective update method with a cumulative catch-up adjustment recorded in a separate line item in the Statements of Operations.

An entity may choose one of two adoption methods for the liability for future policy benefits: (1) a modified retrospective transition method whereby the entity ~~will~~may choose to apply the amendments to contracts in force as of the beginning of the prior year (if early adoption is elected) or as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in Accumulated ~~Other Comprehensive Income~~other comprehensive income (loss) ("AOCI") or (2) a full retrospective transition method.

The options for method of adoption and the impacts of such methods are under assessment.

Discount rate assumption used to measure the liability for future policy benefits for non-participating traditional and limited-pay insurance products

Requires discount rate assumptions to be based on an upper-medium grade fixed income instrument yield, ~~and~~which will ~~be required to~~ be updated each quarter with the impact recorded through OCI. An entity shall maximize the use of relevant observable information and minimize the use of unobservable information in determining the discount rate assumptions.

As noted above, an entity may choose either a modified retrospective transition method or full retrospective transition method for the liability for future policy benefits. Under either method, for balance sheet remeasurement purposes, the liability for future policy benefits will be remeasured using current discount rates as of either the beginning of the prior year (if early adoption is elected) or the beginning of the earliest period presented with the impact recorded as a cumulative effect adjustment to AOCI.

Upon adoption, under either transition method, there will be an adjustment to AOCI as a result of remeasuring in force contract liabilities using current upper-medium grade fixed income instrument yields. The adjustment upon adoption will largely reflect the difference between ~~the~~ discount ~~rate~~rates locked-in at contract inception versus current discount rates at transition. The magnitude of such adjustment is currently being assessed.

Amortization of DAC and other balances

Requires DAC and other balances, such as unearned revenue reserves and deferred sales inducements ("DSI"), to be amortized on a constant level basis over the expected term of the related contract, independent of expected profitability.

An entity may apply one of two adoption methods: (1) a modified retrospective transition method whereby the entity ~~will~~may choose to apply the amendments to contracts in force as of the beginning of the prior year (if early adoption is elected) or as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or (2) if an entity chooses a full retrospective transition method for its liability for future policy benefits, as described above, it is required to also use a full retrospective transition method for DAC and other balances.

The options for method of adoption and the impacts of such methods are under assessment. Under the modified retrospective transition method, the Company would not expect a significant impact to the balance sheet, other than the impact of the removal of any related amounts in AOCI.

Market Risk Benefits (MRB)

Requires an entity to measure all market risk benefits (e.g., living benefit and death benefit guarantees associated with variable annuities) at fair value, and record ~~market risk benefit~~MRB assets and liabilities separately on the Statements of Financial Position. Changes in fair value of market risk benefits are recorded in net income, except for the portion of the change ~~that is~~in MRB liabilities attributable to changes in an entity’s non-performance risk ("NPR"), which is recognized in OCI.

An entity shall adopt the guidance for market risk benefits using the retrospective transition method which includes a cumulative-effect adjustment on the balance sheet as of either the beginning of prior year (if early adoption is elected) or the beginning of the earliest period presented. An entity shall maximize the use of relevant observable information and minimize the use of unobservable information in determining the balance of the market risk benefits upon adoption.

Upon adoption, the Company expects an impact to retained earnings for the difference between the fair value and carrying value of benefits not currently measured at fair value (e.g., guaranteed minimum death benefits on variable annuities) and an impact from reclassifying the cumulative effect of changes in NPR from retained earnings to AOCI. The magnitude of such adjustments is currently being assessed.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

3. INVESTMENTS

Fixed Maturity Securities

The following tables set forth the composition of fixed maturity securities (excluding investments classified as trading), as of the dates indicated:


	September 30, 2020
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Allowance for Credit Losses		Fair Value
	(in thousands)
Fixed maturities, available-for-sale:
U.S. Treasury securities and obligations of U.S. government authorities and agencies	$	10,694	$	1,144	$	0	$	0	$	11,838
Obligations of U.S. states and their political subdivisions	162,327		18,590		0		0		180,917
Foreign government bonds	75,345		11,069		98		0		86,316

U.S. public corporate securities	743,982		132,179		1,045		0		875,116
U.S. private corporate securities	223,616		19,538		560		0		242,594
Foreign public corporate securities	61,164		8,119		624		0		68,659
Foreign private corporate securities	157,423		9,466		2,502		0		164,387
Asset-backed securities(1)	18,027		632		47		0		18,612
Commercial mortgage-backed securities	143,234		12,821		0		0		156,055
Residential mortgage-backed securities(2)	3,452		600		0		0		4,052
Total fixed maturities, available-for-sale	$	1,599,264	$	214,158	$	4,876	$	0	$	1,808,546

June 30, 2020

Amortized
Cost

Gross
Unrealized
Gains

Gross
Unrealized
Losses
Allowance for Credit Losses
Fair
Value
(in thousands)
Fixed maturities, available-for-sale:
U.S. Treasury securities and obligations of U.S. government authorities and agencies $ 14,775
$ 1,277
$ 0
$ 0
$ 16,052
Obligations of U.S. states and their political subdivisions 162,428
17,662
0
0
180,090
Foreign government bonds 69,664
9,164
34
0
78,794
U.S. public corporate securities 734,382
123,756
1,687
0
856,451
U.S. private corporate securities 225,446
16,527
1,367
0
240,606
Foreign public corporate securities 52,922
6,584
326
0
59,180
Foreign private corporate securities 162,044
5,135
4,892
0
162,287
Asset-backed securities(1) 18,020
545
128
0
18,437
Commercial mortgage-backed securities 143,676
11,698
0
0
155,374
Residential mortgage-backed securities(2) 3,647
635
0
0
4,282
Total fixed maturities, available-for-sale $ 1,587,004
$ 192,983
$ 8,434
$ 0
$ 1,771,553


~~(1)~~	~~Includes credit-tranched securities collateralized by loan obligations and education loans.~~


~~(2)~~	~~Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.~~

(1)Includes credit-tranched securities collateralized by loan obligations and education loans.

(2)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.


	December 31, 2019													December 31, 2019
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		OTTI in AOCI(3)				Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value		OTTI in AOCI(3)
	(in thousands)													(in thousands)
Fixed maturities, available-for-sale:													Fixed maturities, available-for-sale:
U.S. Treasury securities and obligations of U.S. government authorities and agencies	$	14,983	$	1,032	$	0		$	16,015	$	0		U.S. Treasury securities and obligations of U.S. government authorities and agencies	$	14,983	$	1,032	$	0	$	16,015	$	0
Obligations of U.S. states and their political subdivisions	123,505		10,172		0		��	133,677		0			Obligations of U.S. states and their political subdivisions	123,505		10,172		0		133,677		0
Foreign government bonds	70,287		6,993		0			77,280		0			Foreign government bonds	70,287		6,993		0		77,280		0

U.S. public corporate securities	627,880		70,167		527			697,520		0			U.S. public corporate securities	627,880		70,167		527		697,520		0
U.S. private corporate securities	222,952		10,416		153			233,215		0			U.S. private corporate securities	222,952		10,416		153		233,215		0
Foreign public corporate securities	53,115		4,958		80			57,993		0			Foreign public corporate securities	53,115		4,958		80		57,993		0
Foreign private corporate securities	161,597		4,505		2,210			163,892		0			Foreign private corporate securities	161,597		4,505		2,210		163,892		0
Asset-backed securities(1)	17,816		753		27			18,542		0			Asset-backed securities(1)	17,816		753		27		18,542		0
Commercial mortgage-backed securities	141,593		5,796		0			147,389		0			Commercial mortgage-backed securities	141,593		5,796		0		147,389		0
Residential mortgage-backed securities(2)	4,068		509		4			4,573		(50		)	Residential mortgage-backed securities(2)	4,068		509		4		4,573		(50)
Total fixed maturities, available-for-sale	$	1,437,796	$	115,301	$	3,001		$	1,550,096	$	(50	)	Total fixed maturities, available-for-sale	$	1,437,796	$	115,301	$	3,001	$	1,550,096	$	(50)


~~(1)~~	~~Includes credit-tranched securities collateralized by loan obligations, sub-prime mortgages, and education loans.~~


~~(2)~~	~~Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.~~

(1)Includes credit-tranched securities collateralized by loan obligations, sub-prime mortgages, and education loans.

(2)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

(3)Represents the amount of unrealized losses remaining in AOCI, from the impairment measurement date. Amount excludes $0.1 million of net unrealized gains on impaired available-for-sale securities relating to changes in the value of such securities subsequent to the impairment measurement date.


~~(3)~~	Represents the amount of unrealized losses remaining in AOCI, from the impairment measurement date. Amount excludes $0.1 million of net unrealized gains on impaired available-for-sale securities relating to changes in the value of such securities subsequent to the impairment measurement date.

The following table sets forth the fair value and gross unrealized losses on available-for-sale fixed maturity securities without an allowance for credit losses aggregated by investment category and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of the date indicated:


	September 30, 2020
	Less Than Twelve Months				Twelve Months or More				Total
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
	(in thousands)
Fixed maturities, available-for-sale:


Foreign government bonds	$	5,707	$	98	$	0	$	0	$	5,707	$	98
U.S. public corporate securities	28,363		1,045		0		0		28,363		1,045
U.S. private corporate securities	10,349		560		0		0		10,349		560
Foreign public corporate securities	12,339		624		0		0		12,339		624
Foreign private corporate securities	5,819		149		35,064		2,353		40,883		2,502
Asset-backed securities	2,490		10		3,917		37		6,407		47

Residential mortgage-backed securities	0		0		0		0		0		0
Total fixed maturities, available-for-sale	$	65,067	$	2,486	$	38,981	$	2,390	$	104,048	$	4,876

June 30, 2020
Less Than Twelve Months Twelve Months or More Total
Fair Value
Gross
Unrealized
Losses
Fair Value
Gross
Unrealized
Losses
Fair Value
Gross
Unrealized
Losses
(in thousands)
Fixed maturities, available-for-sale:
Foreign government bonds $ 1,977
$ 34
$ 0
$ 0
$ 1,977
$ 34
U.S. public corporate securities 34,409
1,687
0
0
34,409
1,687
U.S. private corporate securities 24,994
1,367
0
0
24,994
1,367
Foreign public corporate securities 4,989
326
0
0
4,989
326
Foreign private corporate securities 19,719
728
33,253
4,164
52,972
4,892
Asset-backed securities 2,955
42
3,407
86
6,362
128
Residential mortgage-backed securities 0
0
0
0
0
0
Total fixed maturities, available-for-sale $ 89,043
$ 4,184
$ 36,660
$ 4,250
$ 125,703
$ 8,434

The following table sets forth the fair value and gross unrealized losses on fixed maturity securities aggregated by investment category and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of the date indicated:


	December 31, 2019
	Less Than Twelve Months				Twelve Months or More				Total
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
	(in thousands)
Fixed maturities, available-for-sale:


Foreign government bonds	$	0	$	0	$	400	$	0	$	400	$	0
U.S. public corporate securities	16,892		190		1,073		337		17,965		527
U.S. private corporate securities	7,350		140		4,757		13		12,107		153
Foreign public corporate securities	2,054		23		2,427		57		4,481		80
Foreign private corporate securities	10,659		281		27,048		1,929		37,707		2,210
Asset-backed securities	1,488		12		2,985		15		4,473		27

Residential mortgage-backed securities	91		4		0		0		91		4
Total fixed maturities, available-for-sale	$	38,534	$	650	$	38,690	$	2,351	$	77,224	$	3,001

December 31, 2019
Less Than Twelve Months Twelve Months or More Total
Fair Value   Gross
Unrealized
Losses Fair Value   Gross
Unrealized
Losses Fair Value   Gross
Unrealized
Losses
(in thousands)
Fixed maturities, available-for-sale:
Foreign government bonds $ 0
$ 0
$ 400
$ 0
$ 400
$ 0
U.S. public corporate securities 16,892
190
1,073
337
17,965
527
U.S. private corporate securities 7,350
140
4,757
13
12,107
153
Foreign public corporate securities 2,054
23
2,427
57
4,481
80
Foreign private corporate securities 10,659
281
27,048
1,929
37,707
2,210
Asset-backed securities 1,488
12
2,985
15
4,473
27
Residential mortgage-backed securities 91
4
0
0
91
4
Total fixed maturities, available-for-sale $ 38,534
$ 650
$ 38,690
$ 2,351
$ 77,224
$ 3,001

As of ~~June~~September 30, 2020, the gross unrealized losses on fixed maturity available-for-sale securities without an allowance were composed of ~~$6.2~~$3.8 million related to “1” highest quality or “2” high quality securities based on the National Association of Insurance Commissioners (“NAIC”) or equivalent rating and ~~$2.2~~$1.1 million related to other than high or highest quality securities based on NAIC or equivalent rating. As of ~~June~~September 30, 2020, the ~~$4.3~~$2.4 million of gross unrealized losses of twelve months or more were concentrated in the Company’s corporate securities within the finance,, consumer non-cyclical,, and transportation sectors.

~~transportation~~ ~~sectors.~~

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

As of December 31, 2019, the gross unrealized losses on fixed maturity securities were composed of $2.4 million related to “1” highest quality or “2” high quality securities based on the NAIC or equivalent rating and $0.6 million related to other than high or highest quality securities based on NAIC or equivalent rating. As of December 31, 2019, the $2.4 million of gross unrealized losses of twelve months or more were concentrated in the Company’s corporate securities within the finance,, consumer ~~on-cyclical~~non-cyclical and energy sectors.

In accordance with its policy described in Note 2, the Company concluded that an adjustment to earnings for credit losses related to these fixed maturity securities was not warranted at ~~June~~September 30, 2020. These conclusions were based on a detailed analysis of the underlying credit and cash flows on each security. Gross unrealized losses are primarily attributable to general credit spread widening, increases in interest rates, foreign currency exchange rate movements and the financial condition or near-term prospects of the issuer. As of ~~June~~September 30, 2020, the Company did not intend to sell these securities, and it was not more likely than not that the Company would be required to sell these securities before the anticipated recovery of the remaining amortized cost basis.

The following table sets forth the amortized cost and fair value of fixed maturities by contractual maturities, as of the date indicated:


	September 30, 2020
	Amortized Cost		Fair Value
	(in thousands)
Fixed maturities, available-for-sale:
Due in one year or less	$	38,528	$	38,910
Due after one year through five years	203,196		213,078
Due after five years through ten years	206,436		221,643
Due after ten years	986,391		1,156,196
Asset-backed securities	18,027		18,612
Commercial mortgage-backed securities	143,234		156,055
Residential mortgage-backed securities	3,452		4,052
Total fixed maturities, available-for-sale	$	1,599,264	$	1,808,546

June 30, 2020
Amortized Cost Fair Value
(in thousands)
Fixed maturities, available-for-sale:
Due in one year or less $ 48,076
$ 48,656
Due after one year through five years 206,128
213,023
Due after five years through ten years 207,481
216,827
Due after ten years 959,976
1,114,954
Asset-backed securities 18,020
18,437
Commercial mortgage-backed securities 143,676
155,374
Residential mortgage-backed securities 3,647
4,282
Total fixed maturities, available-for-sale $ 1,587,004
$ 1,771,553

Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. Asset-backed, commercial mortgage-backed and residential mortgage-backed securities are shown separately in the table above, as they do not have a single maturity date.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

The following table sets forth the sources of fixed maturity proceeds and related investment gains (losses), as well as losses on write-downs, impairments and the allowance for credit losses of fixed maturities, for the periods indicated:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
	(in thousands)
Fixed maturities, available-for-sale:
Proceeds from sales(1)	$	810	$	482	$	3,105	$	12,121
Proceeds from maturities/prepayments	14,331		11,536		31,946		33,742
Gross investment gains from sales and maturities	136		7		162		150
Gross investment losses from sales and maturities	1		(2)		(43)		(461)
OTTI recognized in earnings(2)	N/A		(2,295)		N/A		(5,458)
Write-downs recognized in earnings(3)	0		N/A		(625)		N/A
(Addition to) release of allowance for credit losses(4)	0		N/A		0		N/A

Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
(in thousands)
Fixed maturities, available-for-sale:
Proceeds from sales(1) $ 885
$ 8,383
$ 2,295
$ 11,639
Proceeds from maturities/prepayments 5,361
19,043
17,615
22,206
Gross investment gains from sales and maturities 2
40
26
143
Gross investment losses from sales and maturities (44 ) (424 ) (44 ) (459 )
OTTI recognized in earnings(2) N/A
0
N/A
(3,163 )
Write-downs recognized in earnings(3) 0
N/A
(625 ) N/A
(Addition to) release of allowance for credit losses(4) 0
N/A
0
N/A

(1)Includes $0.0 million and $0.0 million of non-cash related proceeds due to the timing of trade settlements for the nine months ended September 30, 2020 and 2019, respectively.

(2)For the three and nine months ended September 30, 2019, amounts exclude the portion of OTTI amounts remaining in OCI, representing any difference between the fair value of the impaired debt security and the net present value of its projected future cash flows at the time of impairment.

(3)For the three and nine months ended September 30, 2020, amounts represent write-downs on securities approaching maturity related to foreign exchange movements and securities actively marketed for sale.

(4)Effective January 1, 2020, credit losses on available-for-sale fixed maturity securities are recorded within the "allowance for credit losses."


~~(1)~~	~~Includes $0.0 million and $0.7 million of non-cash related proceeds due to the timing of trade settlements for the six months ended June 30, 2020 and 2019, respectively.~~


~~(2)~~	For the three and six months ended June 30, 2019, amounts exclude the portion of OTTI amounts remaining in OCI, representing any difference between the fair value of the impaired debt security and the net present value of its projected future cash flows at the time of impairment.


~~(3)~~	~~For the three and six months ended June 30, 2020, amounts represent write-downs on securities approaching maturity related to foreign exchange movements and securities actively marketed for sale.~~


~~(4)~~	~~Effective January 1, 2020, credit losses on available-for-sale fixed maturity securities are recorded within the "allowance for credit losses."~~

For both the three and nine months ended September 30, 2020, there was 0 activity in the allowance for credit losses for fixed maturity securities.

See Note 2 for additional information about the Company's methodology for developing our allowance and expected losses.

The Company did ~~not~~0t have any fixed maturity securities purchased with credit deterioration, as of ~~June~~September 30, 2020.

Equity Securities

The net change in unrealized gains (losses) from equity securities still held at period end, recorded within “Other income,” was ~~$0.4~~$1.1 million and ~~$0.3~~$0.0 million during the three months ended ~~June~~September 30, 2020 and 2019, respectively, and ~~$(0.1)~~$1.0 million and $0.5 million during the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Commercial Mortgage and Other Loans

The following table sets forth the composition of “Commercial mortgage and other loans,” as of the dates indicated:


	September 30, 2020				December 31, 2019
	Amount (in thousands)		% of Total		Amount (in thousands)		% of Total
Commercial mortgage and agricultural property loans by property type:
Apartments/Multi-Family	$	46,969	34.2	%	$	47,568	33.2	%
Hospitality	14,160		10.3		14,266		10.0
Industrial	17,656		12.9		18,907		13.2
Office	23,143		16.9		24,035		16.7
Other	16,845		12.3		18,853		13.2
Retail	15,945		11.6		16,174		11.3
Total commercial mortgage loans	134,718		98.2		139,803		97.6
Agricultural property loans	2,435		1.8		3,460		2.4
Total commercial mortgage and agricultural property loans	137,153		100.0	%	143,263		100.0	%
Allowance for credit losses	(448)				(165)





Total net commercial mortgage and other loans	$	136,705			$	143,098

June 30, 2020 December 31, 2019

Amount
(in thousands)
% of Total
Amount
(in thousands)
% of Total
Commercial mortgage and agricultural property loans by property type:
Apartments/Multi-Family $ 47,170
34.1 % $ 47,568
33.2 %
Hospitality 14,160
10.2
14,266
10.0
Industrial 16,479
11.9
18,907
13.2
Office 23,290
16.8
24,035
16.7
Other 18,775
13.6
18,853
13.2
Retail 16,025
11.6
16,174
11.3
Total commercial mortgage loans 135,899
98.2
139,803
97.6
Agricultural property loans 2,472
1.8
3,460
2.4
Total commercial mortgage and agricultural property loans by property type 138,371
100.0 % 143,263
100.0 %
Allowance for credit losses (457 ) (165 )
Total commercial mortgage and other loans $ 137,914
$ 143,098

As of ~~June~~September 30, 2020, the commercial mortgage and agricultural property loans were secured by properties geographically dispersed throughout the United States ~~(with~~with the largest concentrations in New York (13%), Texas (11%) and ~~Florida~~ ~~(10%)~~Illinois (9%) and included loans secured by properties in Europe (10%).

The following ~~table sets~~tables set forth the activity in the allowance for credit losses for commercial mortgage and other loans, as of the dates indicated:

Commercial Mortgage Loans Agricultural Property Loans Total
(in thousands)
Balance at December 31, 2018 $ 150
$ 1
$ 151
Addition to (release of) allowance for credit losses 14
0
14
Balance at December 31, 2019 164
1
165
Cumulative effect of adoption of ASU 2016-13 204
0
204
Addition to (release of) allowance for expected losses 89
(1 ) 88
Balance at June 30, 2020 $ 457
$ 0
$ 457


	Three Months Ended September 30, 2020
	Commercial Mortgage Loans		Agricultural Property Loans		Total
	(in thousands)



Balance, beginning of period	$	457	$	0	$	457

Addition to (release of) allowance for expected losses	(9)		0		(9)




Balance, end of period	$	448	$	0	$	448


	Nine Months Ended September 30, 2020
	Commercial Mortgage Loans		Agricultural Property Loans		Total
	(in thousands)



Balance at December 31, 2019	$	164	$	1	$	165
Cumulative effect of adoption of ASU 2016-13	204		0		204
Addition to (release of) allowance for expected losses	80		(1)		79




Balance at September 30, 2020	$	448	$	0	$	448

~~Table of Contents~~

~~PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY~~

~~Notes to Unaudited Interim Financial Statements—(Continued)~~

See Note 2 for additional information about the Company's methodology for developing our allowance and expected losses.

~~As of June~~For the nine months ended September 30, 2020, the increase in the allowance for credit losses on commercial mortgage and other loans was primarily related to the cumulative effect of adoption of ASU 2016-13.

Table of Contents


PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

The following tables set forth key credit quality indicators based upon the recorded investment gross of allowance for credit losses, as of the date indicated:


	September 30, 2020
	Amortized Cost by Origination Year
	2020		2019		2018		2017		2016		Prior		Revolving Loans		Total
	(in thousands)
Commercial Mortgage Loans
Loan-to-Value Ratio:
0%-59.99%	$	0	$	10,359	$	0	$	8,440	$	9,751	$	58,431	$	0	$	86,981
60%-69.99%	2,198		20,944		1,488		4,005		3,192		11,798		0		43,625
70%-79.99%	0		4,112		0		0		0		0		0		4,112
80% or greater	0		0		0		0		0		0		0		0
Total	$	2,198	$	35,415	$	1,488	$	12,445	$	12,943	$	70,229	$	0	$	134,718
Debt Service Coverage Ratio:
Greater or Equal to 1.2x	$	2,198	$	32,042	$	0	$	12,445	$	11,872	$	68,406	$	0	$	126,963
1.0 - 1.2x	0		3,373		1,488		0		1,071		1,823		0		7,755
Less than 1.0x	0		0		0		0		0		0		0		0
Total	$	2,198	$	35,415	$	1,488	$	12,445	$	12,943	$	70,229	$	0	$	134,718
Agricultural Property Loans
Loan-to-Value Ratio:
0%-59.99%	$	0	$	0	$	0	$	0	$	0	$	2,435	$	0	$	2,435
60%-69.99%	0		0		0		0		0		0		0		0
70%-79.99%	0		0		0		0		0		0		0		0
80% or greater	0		0		0		0		0		0		0		0
Total	$	0	$	0	$	0	$	0	$	0	$	2,435	$	0	$	2,435
Debt Service Coverage Ratio:
Greater or Equal to 1.2x	$	0	$	0	$	0	$	0	$	0	$	2,435	$	0	$	2,435
1.0 - 1.2x	0		0		0		0		0		0		0		0
Less than 1.0x	0		0		0		0		0		0		0		0
Total	$	0	$	0	$	0	$	0	$	0	$	2,435	$	0	$	2,435

June 30, 2020
Amortized Cost by Origination Year
2020 2019 2018 2017 2016 Prior Revolving Loans Total
(in thousands)
Loan-to-Value Ratio:
Commercial mortgage loans
0%-59.99% $ 0
$ 10,307
$ 0
$ 8,804
$ 9,771
$ 58,521
$ 0
$ 87,403
60%-69.99% 2,198
20,727
1,498
3,946
3,192
13,886
0
45,447
70%-79.99% 0
3,049
0
0
0
0
0
3,049
80% or greater 0
0
0
0
0
0
0
0
Subtotal 2,198
34,083
1,498
12,750
12,963
72,407
0
135,899
Agricultural property loans
0%-59.99% 0
0
0
0
0
2,472
0
2,472
60%-69.99% 0
0
0
0
0
0
0
0
70%-79.99% 0
0
0
0
0
0
0
0
80% or greater 0
0
0
0
0
0
0
0
Subtotal 0
0
0
0
0
2,472
0
2,472
Total commercial mortgage and agricultural property loans
0%-59.99% 0
10,307
0
8,804
9,771
60,993
0
89,875
60%-69.99% 2,198
20,727
1,498
3,946
3,192
13,886
0
45,447
70%-79.99% 0
3,049
0
0
0
0
0
3,049
80% or greater 0
0
0
0
0
0
0
0
Total commercial mortgage and agricultural property loans $ 2,198
$ 34,083
$ 1,498
$ 12,750
$ 12,963
$ 74,879
$ 0
$ 138,371


Commercial mortgage loans
	December 31, 2019
	Debt Service Coverage Ratio
	>1.2X		1.0X to <1.2X		< 1.0X		Total
	(in thousands)
Loan-to-Value Ratio:
0%-59.99%	$	89,855	$	1,131	$	0	$	90,986
60%-69.99%	42,726		1,877		0		44,603
70%-79.99%	2,695		1,519		0		4,214
80% or greater	0		0		0		0
Total commercial mortgage loans	$	135,276	$	4,527	$	0	$	139,803

June 30, 2020 December 31, 2019
Commercial Mortgage Loans Agricultural Property Loans Commercial Mortgage Loans Agricultural Property Loans
(in thousands)
Debt Service Coverage Ratio:
Greater or equal to 1.2x $ 131,469
$ 2,472
$ 135,276
$ 3,460
1.0 - 1.2x 4,430
0
4,527
0
Less than 1.0x 0
0
0
0
Total $ 135,899
$ 2,472
$ 139,803
$ 3,460

Table of Contents


PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)


Agricultural property loans
	December 31, 2019
	Debt Service Coverage Ratio
	>1.2X		1.0X to <1.2X		< 1.0X		Total
	(in thousands)
Loan-to-Value Ratio:
0%-59.99%	$	3,460	$	0	$	0	$	3,460
60%-69.99%	0		0		0		0
70%-79.99%	0		0		0		0
80% or greater	0		0		0		0
Total agricultural property loans	$	3,460	$	0	$	0	$	3,460

See Note 2 for additional information about the Company's commercial mortgage and other loans credit quality monitoring process.

~~Table of Contents~~

~~PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY~~

~~Notes to Unaudited Interim Financial Statements—(Continued)~~

The following tables set forth an aging of past due commercial mortgage and other loans based upon the recorded investment gross of allowance for credit losses, as well as the amount of commercial mortgage and other loans on non-accrual status, as of the dates indicated:


	September 30, 2020
	Current		30-59 Days Past Due		60-89 Days Past Due		90 Days or More Past Due(1)		Total Loans		Non-Accrual Status(2)
	(in thousands)
Commercial mortgage loans	$	134,718	$	0	$	0	$	0	$	134,718	$	0
Agricultural property loans	2,435		0		0		0		2,435		0

Total	$	137,153	$	0	$	0	$	0	$	137,153	$	0

June 30, 2020
Current 30-59 Days Past Due 60-89 Days Past Due 90 Days or More Past Due(1) Total Loans Non-Accrual Status(2)
(in thousands)
Commercial mortgage loans $ 135,899
$ 0
$ 0
$ 0
$ 135,899
$ 0
Agricultural property loans 2,472
0
0
0
2,472
0
Total $ 138,371
$ 0
$ 0
$ 0
$ 138,371
$ 0


~~(1)~~	~~As of June 30, 2020, there were 0 loans in this category accruing interest.~~


~~(2)~~	For additional information regarding the Company’s policies for accruing interest on loans, see Note 2 to the Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

December 31, 2019
Current 30-59 Days Past Due 60-89 Days Past Due 90 Days or More Past Due(1) Total Loans Non-Accrual Status(2)
(in thousands)
Commercial mortgage loans $ 139,803
$ 0
$ 0
$ 0
$ 139,803
$ 0
Agricultural property loans 3,460
0
0
0
3,460
0
Total $ 143,263
$ 0
$ 0
$ 0
$ 143,263
$ 0

(1)As of September 30, 2020, there were 0 loans in this category accruing interest.

(2)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2 to the Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.


	December 31, 2019
	Current		30-59 Days Past Due		60-89 Days Past Due		90 Days or More Past Due(1)		Total Loans		Non-Accrual Status(2)
	(in thousands)
Commercial mortgage loans	$	139,803	$	0	$	0	$	0	$	139,803	$	0
Agricultural property loans	3,460		0		0		0		3,460		0

Total	$	143,263	$	0	$	0	$	0	$	143,263	$	0


~~(1)~~	~~As of December 31, 2019, there were 0 loans in this category accruing interest.~~


~~(2)~~	For additional information regarding the Company’s policies for accruing interest on loans, see Note 2 to the Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

(1)As of December 31, 2019, there were 0 loans in this category accruing interest.

There were 0 loans on non-accrual status with a related allowance for credit losses which recognized interest income for both the three and ~~six~~nine months ended ~~June~~September 30, 2020.

The Company did ~~not~~0t have any commercial mortgage and other loans purchased with credit deterioration, as of ~~June~~September 30, 2020.

For both the three and ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, there were 0 commercial mortgage and other loans acquired, other than those through direct origination, and there were 0 commercial mortgage and other loans sold.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Other Invested Assets

The following table sets forth the composition of “Other invested assets,” as of the dates indicated:


	September 30, 2020		December 31, 2019
	(in thousands)
Company’s investment in separate accounts	$	3,325	$	3,418
LPs/LLCs:
Equity method:
Private equity	34,157		26,609
Hedge funds	32,375		30,629
Real estate-related	4,450		4,154
Subtotal equity method	70,982		61,392
Fair value:
Private equity	586		774
Hedge funds	69		78
Real estate-related	2,320		2,490
Subtotal fair value	2,975		3,342
Total LPs/LLCs	73,957		64,734
Derivative instruments	26,147		21,384
Total other invested assets	$	103,429	$	89,536

June 30, 2020 December 31, 2019
(in thousands)
Company’s investment in separate accounts $ 3,320
$ 3,418
LPs/LLCs:
Equity method:
Private equity 31,380
26,609
Hedge funds 31,169
30,629
Real estate-related 4,466
4,154
Subtotal equity method 67,015
61,392
Fair value:
Private equity 567
774
Hedge funds 69
78
Real estate-related 2,305
2,490
Subtotal fair value 2,941
3,342
Total LPs/LLCs 69,956
64,734
Derivative instruments 34,248
21,384
Total other invested assets $ 107,524
$ 89,536

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Accrued Investment Income

The following table sets forth the composition of “Accrued investment income,” as of the date indicated:


	September 30, 2020
	(in thousands)
Fixed maturities	$	14,807
Equity securities	92
Commercial mortgage and other loans	380
Policy loans	5,735

Short-term investments and cash equivalents	13

Total accrued investment income	$	21,027

June 30, 2020
(in thousands)
Fixed maturities $ 14,881
Equity securities 1
Commercial mortgage and other loans 384
Policy loans 5,702
Short-term investments and cash equivalents 16
Total accrued investment income $ 20,984

There were 0 write-downs on accrued investment income for both the three and ~~six~~nine months ended ~~June~~September 30, 2020.

Net Investment Income

The following table sets forth “Net investment income” by investment type, for the periods indicated:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
	(in thousands)
Fixed maturities, available-for-sale	$	15,531	$	13,858	$	45,374	$	41,664
Fixed maturities, trading	144		95		386		258
Equity securities	91		91		273		273
Commercial mortgage and other loans	1,331		1,283		4,175		3,784
Policy loans	2,899		2,967		8,660		8,547
Other invested assets	4,300		506		4,625		3,602
Short-term investments and cash equivalents	40		143		399		745
Gross investment income	24,336		18,943		63,892		58,873
Less: investment expenses	(1,076)		(884)		(2,984)		(2,601)
Net investment income	$	23,260	$	18,059	$	60,908	$	56,272

Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
(in thousands)
Fixed maturities, available-for-sale $ 15,681
$ 14,248
$ 29,843
$ 27,806
Fixed maturities, trading 121
86
242
163
Equity securities 91
91
182
182
Commercial mortgage and other loans 1,442
1,324
2,844
2,501
Policy loans 2,885
2,846
5,761
5,580
Other invested assets 1,370
1,414
325
3,096
Short-term investments and cash equivalents 56
322
359
602
Gross investment income 21,646
20,331
39,556
39,930
Less: investment expenses (963 ) (859 ) (1,908 ) (1,717 )
Net investment income $ 20,683
$ 19,472
$ 37,648
$ 38,213

Realized Investment Gains (Losses), Net

The following table sets forth “Realized investment gains (losses), net” by investment type, for the periods indicated:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
	(in thousands)
Fixed maturities(1)	$	137	$	(2,290)	$	(506)	$	(5,769)

Commercial mortgage and other loans	9		(47)		(79)		(14)
Other invested assets	4		0		(55)		11
Derivatives	2,393		5,053		8,771		(2,680)

Short term investments and cash equivalents	(8)		3		(43)		5
Realized investment gains (losses), net	$	2,535	$	2,719	$	8,088	$	(8,447)

Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
(in thousands)
Fixed maturities(1) $ (42 ) $ (384 ) $ (643 ) $ (3,479 )
Commercial mortgage and other loans (15 ) 21
(88 ) 33
Other invested assets 1
0
(59 ) 11
Derivatives (7,493 ) (4,689 ) 6,378
(7,733 )
Short term investments and cash equivalents 37
(4 ) (35 ) 2
Realized investment gains (losses), net $ (7,512 ) $ (5,056 ) $ 5,553
$ (11,166 )


~~(1)~~	~~Includes fixed maturity securities classified as available-for-sale and excludes fixed maturity securities classified as trading.~~

(1)Includes fixed maturity securities classified as available-for-sale and excludes fixed maturity securities classified as trading.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Net Unrealized Gains (Losses) on Investments within AOCI

The following table sets forth net unrealized gains (losses) on investments, as of the dates indicated:


	September 30, 2020		December 31, 2019
	(in thousands)
Fixed maturity securities, available-for-sale — with OTTI(1)	$ N/A		$	51
Fixed maturity securities, available-for-sale — all other(1)	N/A		112,249
Fixed maturity securities, available-for-sale with an allowance	0		N/A
Fixed maturity securities, available-for-sale without an allowance	209,282		N/A
Derivatives designated as cash flow hedges(2)	6,634		3,193
Affiliated notes	253		480
Other investments	52		66
Net unrealized gains (losses) on investments	$	216,221	$	116,039

June 30, 2020 December 31, 2019
(in thousands)
Fixed maturity securities, available-for-sale — with OTTI(1) $ N/A
$ 51
Fixed maturity securities, available-for-sale — all other(1) N/A
112,249
Fixed maturity securities, available-for-sale with an allowance 0
N/A
Fixed maturity securities, available-for-sale without an allowance 184,549
N/A
Derivatives designated as cash flow hedges(2) 13,596
3,193
Affiliated notes 508
480
Other investments 39
66
Net unrealized gains (losses) on investments $ 198,692
$ 116,039

(1)Effective January 1, 2020, per ASU 2016-13, fixed maturity securities, available-for-sale are no longer required to be disclosed “with OTTI” and “all other.”

(2)For more information on cash flow hedges, see Note 4.


~~(1)~~	~~Effective January 1, 2020, per ASU 2016-13, fixed maturity securities, available-for-sale are no longer required to be disclosed “with OTTI” and “all other.”~~


~~(2)~~	~~For more information on cash flow hedges, see Note 4.~~

Repurchase Agreements and Securities Lending

In the normal course of business, the Company sells securities under agreements to repurchase and enters into securities lending transactions. As of ~~June~~September 30, 2020 and December 31, 2019, the Company had 0 repurchase agreements.

The following table sets forth the composition of “Cash collateral for loaned securities,” which represents the liability to return cash collateral received for the following types of securities loaned, as of the dates indicated:


	September 30, 2020						December 31, 2019
	Remaining Contractual Maturities of the Agreements						Remaining Contractual Maturities of the Agreements
	Overnight & Continuous		Up to 30 Days		Total		Overnight & Continuous		Up to 30 Days		Total
	(in thousands)





Foreign public corporate securities	$	2,731	$	0	$	2,731	$	2,481	$	0	$	2,481





Total cash collateral for loaned securities(1)	$	2,731	$	0	$	2,731	$	2,481	$	0	$	2,481

June 30, 2020 December 31, 2019
Remaining Contractual Maturities of the Agreements Remaining Contractual Maturities of the Agreements
Overnight & Continuous Up to 30 Days Total Overnight & Continuous Up to 30 Days Total
(in thousands)
Foreign public corporate securities $ 2,700
$ 0
$ 2,700
$ 2,481
$ 0
$ 2,481
Total cash collateral for loaned securities(1) $ 2,700
$ 0
$ 2,700
$ 2,481
$ 0
$ 2,481


~~(1)~~	~~The Company did 0t have any agreements with remaining contractual maturities greater than thirty days, as of the dates indicated.~~

(1)The Company did 0t have any agreements with remaining contractual maturities greater than thirty days, as of the dates indicated.

4. DERIVATIVE INSTRUMENTS

Types of Derivative Instruments and Derivative Strategies

The Company utilizes various derivative instruments and strategies to manage its risk. Commonly used derivative instruments include, but are not necessarily limited to:

•Interest rate contracts: futures, swaps, options, caps and floors

•Equity contracts: futures, options and total return swaps

•Foreign exchange contracts: futures, options, forwards and swaps

•Credit contracts: single and index reference credit default swaps

Other types of financial contracts that the Company accounts for as derivatives include:

•Embedded derivatives

For detailed information on these contracts and the related strategies, see Note 4 to the Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Primary Risks Managed by Derivatives

The table below provides a summary of the gross notional amount and fair value of derivative contracts by the primary underlying risks, excluding embedded derivatives and associated reinsurance recoverables. Many derivative instruments contain multiple underlying risks. The fair value amounts below represent the value of derivative contracts prior to taking into account the netting effects of master netting agreements and cash collateral.


	September 30, 2020						December 31, 2019
Primary Underlying Risk/Instrument Type			Fair Value						Fair Value
	Gross Notional		Assets		Liabilities		Gross Notional		Assets		Liabilities
	(in thousands)
Derivatives Designated as Hedge Accounting Instruments:
Currency/Interest Rate
Foreign Currency Swaps	$	128,688	$	6,257	$	(469)	$	131,212	$	4,653	$	(1,504)
Total Derivatives Designated as Hedge Accounting Instruments:	$	128,688	$	6,257	$	(469)	$	131,212	$	4,653	$	(1,504)
Derivatives Not Qualifying as Hedge Accounting Instruments:
Interest Rate
Interest Rate Swaps	$	30,200	$	4,851	$	0	$	32,075	$	3,005	$	(5)
Credit
Credit Default Swaps	713		9		0		0		0		0
Currency/Interest Rate
Foreign Currency Swaps	33,224		3,626		(69)		33,224		2,691		(579)
Foreign Currency
Foreign Currency Forwards	2,690		33		(1)		1,858		0		(36)
Equity
Equity Options	429,925		27,273		(15,355)		379,350		24,064		(10,919)
Total Derivatives Not Qualifying as Hedge Accounting Instruments:	$	496,752	$	35,792	$	(15,425)	$	446,507	$	29,760	$	(11,539)
Total Derivatives(1)(2)	$	625,440	$	42,049	$	(15,894)	$	577,719	$	34,413	$	(13,043)

June 30, 2020 December 31, 2019
Primary Underlying Risk/Instrument Type Fair Value Fair Value
Gross Notional Assets Liabilities Gross Notional Assets Liabilities
(in thousands)
Derivatives Designated as Hedge Accounting Instruments:
Currency/Interest Rate
Foreign Currency Swaps $ 133,255
$ 14,212
$ 0
$ 131,212
$ 4,653
$ (1,504 )
Total Derivatives Designated as Hedge Accounting Instruments: $ 133,255
$ 14,212
$ 0
$ 131,212
$ 4,653
$ (1,504 )
Derivatives Not Qualifying as Hedge Accounting Instruments:

Interest Rate
Interest Rate Swaps $ 30,200
$ 5,177
$ 0
$ 32,075
$ 3,005
$ (5 )
Credit
Credit Default Swaps 713
9
0
0
0
0
Currency/Interest Rate
Foreign Currency Swaps 33,224
5,447
0
33,224
2,691
(579 )
Foreign Currency
Foreign Currency Forwards 2,249
1
(66 ) 1,858
0
(36 )
Equity
Equity Options 416,175
17,868
(8,391 ) 379,350
24,064
(10,919 )
Total Derivatives Not Qualifying as Hedge Accounting Instruments: $ 482,561
$ 28,502
$ (8,457 ) $ 446,507
$ 29,760
$ (11,539 )
Total Derivatives(1)(2) $ 615,816
$ 42,714
$ (8,457 ) $ 577,719
$ 34,413
$ (13,043 )

~~(1)~~

Excludes embedded derivatives and associated reinsurance recoverables which contain multiple underlying risks. The fair value of these embedded derivatives was a net liability of $1,742 million and $761 million as of June 30, 2020 and December 31, 2019, respectively included in “Future policy benefits” and $143 million and $134 million as of June 30, 2020 and December 31, 2019, respectively included in “Policyholders’ account balances". The fair value of the related reinsurance, included in "Reinsurance recoverables" or "Other liabilities" was an asset of $1,742 million and $761 million as of June 30, 2020 and December 31, 2019, respectively.


~~(2)~~	~~Recorded in "Other invested assets" and "Payables to parent and affiliates" on the Unaudited Interim Statements of Financial Position.~~

(1)Excludes embedded derivatives and associated reinsurance recoverables which contain multiple underlying risks. The fair value of these embedded derivatives was a net liability of $1,522 million and $761 million as of September 30, 2020 and December 31, 2019, respectively included in “Future policy benefits” and $145 million and $134 million as of September 30, 2020 and December 31, 2019, respectively included in “Policyholders’ account balances". The fair value of the related reinsurance, included in "Reinsurance recoverables" or "Other liabilities" was an asset of $1,522 million and $761 million as of September 30, 2020 and December 31, 2019, respectively.

(2)Recorded in "Other invested assets" and "Payables to parent and affiliates" on the Unaudited Interim Statements of Financial Position.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Offsetting Assets and Liabilities

The following table presents recognized derivative instruments (excluding embedded derivatives and associated reinsurance recoverables), and repurchase and reverse repurchase agreements that are offset in the Unaudited Interim Statements of Financial Position, and/or are subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in the Unaudited Interim Statements of Financial Position.


	September 30, 2020
	Gross Amounts of Recognized Financial Instruments		Gross Amounts Offset in the Statements of Financial Position		Net Amounts Presented in the Statements of Financial Position		Financial Instruments/ Collateral(1)		Net Amount
	(in thousands)
Offsetting of Financial Assets:
Derivatives(1)	$	42,049	$	(15,902)	$	26,147	$	(26,147)	$	0
Securities purchased under agreements to resell	0		0		0		0		0
Total Assets	$	42,049	$	(15,902)	$	26,147	$	(26,147)	$	0
Offsetting of Financial Liabilities:
Derivatives(1)	$	15,894	$	(15,894)	$	0	$	0	$	0
Securities sold under agreements to repurchase	0		0		0		0		0
Total Liabilities	$	15,894	$	(15,894)	$	0	$	0	$	0

June 30, 2020

Gross
Amounts of
Recognized
Financial
Instruments

Gross
Amounts
Offset in the
Statements of
Financial
Position

Net Amounts
Presented in
the Statements
of Financial
Position

Financial
Instruments/
Collateral(1)

Net
Amount
(in thousands)
Offsetting of Financial Assets:
Derivatives(1) $ 42,714
$ (8,466 ) $ 34,248
$ (34,232 ) $ 16
Securities purchased under agreements to resell 0
0
0
0
0
Total Assets $ 42,714
$ (8,466 ) $ 34,248
$ (34,232 ) $ 16
Offsetting of Financial Liabilities:
Derivatives(1) $ 8,457
$ (8,457 ) $ 0
$ 0
$ 0
Securities sold under agreements to repurchase 0
0
0
0
0
Total Liabilities $ 8,457
$ (8,457 ) $ 0
$ 0
$ 0


	December 31, 2019
	Gross Amounts of Recognized Financial Instruments		Gross Amounts Offset in the Statements of Financial Position		Net Amounts Presented in the Statements of Financial Position		Financial Instruments/ Collateral(1)		Net Amount
	(in thousands)
Offsetting of Financial Assets:
Derivatives(1)	$	34,413	$	(13,029)	$	21,384	$	(21,384)	$	0
Securities purchased under agreements to resell	0		0		0		0		0
Total Assets	$	34,413	$	(13,029)	$	21,384	$	(21,384)	$	0
Offsetting of Financial Liabilities:
Derivatives(1)	$	13,043	$	(13,043)	$	0	$	0	$	0
Securities sold under agreements to repurchase	0		0		0		0		0
Total Liabilities	$	13,043	$	(13,043)	$	0	$	0	$	0

December 31, 2019

Gross
Amounts of
Recognized
Financial
Instruments

Gross
Amounts
Offset in the
Statements of
Financial
Position

Net Amounts
Presented in
the Statements
of Financial
Position

Financial
Instruments/
Collateral(1)

Net
Amount
(in thousands)
Offsetting of Financial Assets:
Derivatives(1) $ 34,413
$ (13,029 ) $ 21,384
$ (21,384 ) $ 0
Securities purchased under agreements to resell 0
0
0
0
0
Total Assets $ 34,413
$ (13,029 ) $ 21,384
$ (21,384 ) $ 0
Offsetting of Financial Liabilities:
Derivatives(1) $ 13,043
$ (13,043 ) $ 0
$ 0
$ 0
Securities sold under agreements to repurchase 0
0
0
0
0
Total Liabilities $ 13,043
$ (13,043 ) $ 0
$ 0
$ 0

(1)Amounts exclude the excess of collateral received/pledged from/to the counterparty.


~~(1)~~	~~Amounts exclude the excess of collateral received/pledged from/to the counterparty.~~

For information regarding the rights of offset associated with the derivative assets and liabilities in the table above see “Credit Risk” below and Note 9. For securities purchased under agreements to resell and securities sold under agreements to repurchase, the Company monitors the value of the securities and maintains collateral, as appropriate, to protect against credit exposure. Where the Company has entered into repurchase and resale agreements with the same counterparty, in the event of default, the Company would generally be permitted to exercise rights of offset. For additional information on the Company’s accounting policy for securities repurchase and resale agreements, see Note 2 to the Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Cash Flow Hedges

The primary derivative instruments used by the Company in its cash flow hedge accounting relationships are currency swaps. These instruments are only designated for hedge accounting in instances where the appropriate criteria are met. The Company does not use futures, options, credit or equity derivatives in any of its cash flow hedge accounting relationships.

The following tables provide the financial statement classification and impact of derivatives used in qualifying and non-qualifying hedge relationships, excluding the offset of the hedged item in an effective hedge relationship.


	Three Months Ended September 30, 2020
	Realized Investment Gains (Losses)		Net Investment Income		Other Income		AOCI (1)
	(in thousands)
Derivatives Designated as Hedge Accounting Instruments:
Cash flow hedges
Currency/Interest Rate	$	(92)	$	470	$	(763)	$	(6,962)
Total cash flow hedges	(92)		470		(763)		(6,962)
Derivatives Not Qualifying as Hedge Accounting Instruments:
Interest Rate	(31)		0		0		0
Currency	(96)		0		0		0
Currency/Interest Rate	(1,733)		0		(16)		0
Credit	(1)		0		0		0
Equity	4,281		0		0		0
Embedded Derivatives	65		0		0		0
Total Derivatives Not Qualifying as Hedge Accounting Instruments:	2,485		0		(16)		0
Total	$	2,393	$	470	$	(779)	$	(6,962)

Three Months Ended June 30, 2020
Realized
Investment
Gains (Losses)
Net
Investment
Income
Other Income AOCI (1)
(in thousands)
Derivatives Designated as Hedge Accounting Instruments:
Cash flow hedges
Currency/Interest Rate $ 0

$ 488

$ (324 ) $ (5,608 )
Total cash flow hedges 0

488

(324 ) (5,608 )
Derivatives Not Qualifying as Hedge Accounting Instruments:

Interest Rate 254

0

0
0
Currency (42 )
0

0
0
Currency/Interest Rate (963 )
0

1
0
Credit (69 )
0

0
0
Equity 5,727

0

0
0
Embedded Derivatives (12,400 )
0

0
0
Total Derivatives Not Qualifying as Hedge Accounting Instruments: (7,493 )
0

1
0
Total $ (7,493 )
$ 488

$ (323 ) $ (5,608 )


	Nine Months Ended September 30, 2020
	Realized Investment Gains (Losses)		Net Investment Income		Other Income		AOCI (1)
	(in thousands)
Derivatives Designated as Hedge Accounting Instruments:
Cash flow hedges
Currency/Interest Rate	$	(65)	$	1,436	$	(82)	$	3,441
Total cash flow hedges	(65)		1,436		(82)		3,441
Derivatives Not Qualifying as Hedge Accounting Instruments:
Interest Rate	2,063		0		0		0
Currency	(65)		0		0		0
Currency/Interest Rate	1,830		0		4		0
Credit	(71)		0		0		0
Equity	(376)		0		0		0
Embedded Derivatives	5,455		0		0		0
Total Derivatives Not Qualifying as Hedge Accounting Instruments:	8,836		0		4		0
Total	$	8,771	$	1,436	$	(78)	$	3,441

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)


	Six Months Ended June 30, 2020										Three Months Ended September 30, 2019
	Realized Investment Gains (Losses)			Net Investment Income		Other Income		AOCI (1)			Realized Investment Gains (Losses)		Net Investment Income		Other Income		AOCI(1)
	(in thousands)										(in thousands)
Derivatives Designated as Hedge Accounting Instruments:										Derivatives Designated as Hedge Accounting Instruments:
Cash flow hedges										Cash flow hedges
Currency/Interest Rate	$	26		$	966	$	681	$	10,403	Currency/Interest Rate	$	597	$	432	$	376	$	4,525
Total cash flow hedges	26			966		681		10,403		Total cash flow hedges	597		432		376		4,525
Derivatives Not Qualifying as Hedge Accounting Instruments:										Derivatives Not Qualifying as Hedge Accounting Instruments:
Interest Rate	2,093			0		0		0		Interest Rate	432		0		0		0
Currency	31			0		0		0		Currency	83		0		0		0
Currency/Interest Rate	3,564			0		20		0		Currency/Interest Rate	1,215		0		7		0
Credit	(69		)	0		0		0		Credit	0		0		0		0
Equity	(4,657		)	0		0		0		Equity	604		0		0		0
Embedded Derivatives	5,390			0		0		0		Embedded Derivatives	2,122		0		0		0
Total Derivatives Not Qualifying as Hedge Accounting Instruments:	6,352			0		20		0		Total Derivatives Not Qualifying as Hedge Accounting Instruments:	4,456		0		7		0
Total	$	6,378		$	966	$	701	$	10,403	Total	$	5,053	$	432	$	383	$	4,525


	Nine Months Ended September 30, 2019
	Realized Investment Gains (Losses)		Net Investment Income		Other Income		AOCI(1)
	(in thousands)
Derivatives Designated as Hedge Accounting Instruments:
Cash flow hedges
Currency/Interest Rate	$	587	$	1,241	$	402	$	5,851
Total cash flow hedges	587		1,241		402		5,851
Derivatives Not Qualifying as Hedge Accounting Instruments:
Interest Rate	1,791		0		0		0
Currency	97		0		0		0
Currency/Interest Rate	1,817		0		8		0
Credit	(1)		0		0		0
Equity	6,583		0		0		0
Embedded Derivatives	(13,554)		0		0		0
Total Derivatives Not Qualifying as Hedge Accounting Instruments:	(3,267)		0		8		0
Total	$	(2,680)	$	1,241	$	410	$	5,851

Three Months Ended June 30, 2019
Realized
Investment
Gains (Losses)
Net
Investment
Income
Other Income AOCI(1)
(in thousands)
Derivatives Designated as Hedge Accounting Instruments:
Cash flow hedges

Currency/Interest Rate $ 0
$ 411
$ 235
$ 1,543
Total cash flow hedges 0
411
235
1,543
Derivatives Not Qualifying as Hedge Accounting Instruments:
Interest Rate 850
0
0
0
Currency 9
0
0
0
Currency/Interest Rate 492
0
2
0
Credit 0
0
0
0
Equity 1,839
0
0
0
Embedded Derivatives (7,879 ) 0
0
0
Total Derivatives Not Qualifying as Hedge Accounting Instruments: (4,689 ) 0
2
0
Total $ (4,689 ) $ 411
$ 237
$ 1,543

(1)Net change in AOCI.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Six Months Ended June 30, 2019
Realized
Investment
Gains (Losses)
Net
Investment
Income
Other Income AOCI(1)
(in thousands)
Derivatives Designated as Hedge Accounting Instruments:
Cash flow hedges
Currency/Interest Rate $ (10 ) $ 808
$ 26
$ 1,326
Total cash flow hedges (10 ) 808
26
1,326
Derivatives Not Qualifying as Hedge Accounting Instruments:
Interest Rate 1,359
0
0
0
Currency 15
0
0
0
Currency/Interest Rate 602
0
0
0
Credit (1 ) 0
0
0
Equity 5,979
0
0
0
Embedded Derivatives (15,677 ) 0
0
0
Total Derivatives Not Qualifying as Hedge Accounting Instruments: (7,723 ) 0
0
0
Total $ (7,733 ) $ 808
$ 26
$ 1,326


~~(1)~~	~~Net change in AOCI.~~

Presented below is a rollforward of current period cash flow hedges in AOCI before taxes:


	(in thousands)
Balance, December 31, 2019	$	3,193
Amount recorded in AOCI


Currency/Interest Rate	4,730
Total amount recorded in AOCI	4,730
Amount reclassified from AOCI to income


Currency/Interest Rate	(1,289)
Total amount reclassified from AOCI to income	(1,289)
Balance, September 30, 2020	$	6,634

(in thousands)
Balance, December 31, 2019 $ 3,193
Amount recorded in AOCI
Currency/Interest Rate 12,076
Total amount recorded in AOCI 12,076
Amount reclassified from AOCI to income
Currency/Interest Rate (1,673 )
Total amount reclassified from AOCI to income (1,673 )
Balance, June 30, 2020 $ 13,596

The changes in fair value of cash flow hedges are deferred in AOCI and are included in "Net unrealized investment gains (losses)" in the Unaudited Interim Statements of Operations and Comprehensive Income (Loss); these amounts are then reclassified to earnings when the hedged item affects earnings. Using ~~June~~September 30, 2020 values, it is estimated that a pre-tax gain of ~~$1.8~~$1.6 million is expected to be reclassified from AOCI to earnings during the subsequent twelve months ending ~~June~~September 30, 2021.

The exposures the Company is hedging with these qualifying cash flow hedges include the variability of the payment or receipt of interest or foreign currency amounts on existing financial instruments.

There were no material amounts reclassified from AOCI into earnings relating to instances in which the Company discontinued cash flow hedge accounting because the forecasted transaction did not occur by the anticipated date or within the additional time period permitted by the authoritative guidance for the accounting for derivatives and hedging.

~~Table of Contents~~

~~PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY~~

~~Notes to Unaudited Interim Financial Statements—(Continued)~~

Credit Derivatives

The Company has no exposure from credit derivative positions where it has written credit protection as of ~~June~~September 30, 2020 and December 31, 2019.

The Company has purchased credit protection using credit derivatives in order to hedge specific credit exposures in the Company’s investment portfolio. The Company has outstanding notional amounts of $0.7 million and $0 million reported as of ~~June~~September 30, 2020 and December 31, 2019, respectively with a fair value of $0 million for both periods.

Credit Risk

The Company is exposed to losses in the event of non-performance by a counterparty to financial derivative transactions with a positive fair value. The Company manages credit risk by entering into derivative transactions with its affiliate, Prudential Global Funding LLC (“PGF”), related to its over-the-counter ("OTC") derivatives. PGF, in turn, manages its credit risk by: (i) entering into derivative transactions with highly rated major international financial institutions and other creditworthy counterparties governed by master netting agreement, as applicable; (ii) trading through central clearing and OTC parties; (iii) obtaining collateral, such as cash and securities, when appropriate; and (iv) setting limits on single-party credit exposures which are subject to periodic management review.

Substantially all of the Company’s derivative agreements have zero thresholds which require daily full collateralization by the party in a liability position.

5. FAIR VALUE OF ASSETS AND LIABILITIES

Fair Value Measurement – Fair value represents the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The authoritative fair value guidance establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:

Table of Contents


PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Level 1 - Fair value is based on unadjusted quoted prices in active markets that are accessible to the Company for identical assets or liabilities.

Level 2 - Fair value is based on significant inputs, other than quoted prices included in Level 1, that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability through corroboration with observable market data. Level 2 inputs include quoted market prices in active markets for similar assets and liabilities, quoted market prices in markets that are not active for identical or similar assets or liabilities, and other market observable inputs.

Level 3 - Fair value is based on at least one significant unobservable input for the asset or liability. The assets and liabilities in this category may require significant judgment or estimation in determining the fair value.

For a discussion of the Company's valuation methodologies for assets and liabilities measured at fair value and the fair value hierarchy, see Note 5 to the Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2019.

~~Table of Contents~~

~~PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY~~

~~Notes to Unaudited Interim Financial Statements—(Continued)~~

Assets and Liabilities by Hierarchy Level – The tables below present the balances of assets and liabilities reported at fair value on a recurring basis, as of the dates indicated.

As of June 30, 2020
Level 1 Level 2 Level 3 Netting(1) Total
(in thousands)
Fixed maturities, available-for-sale:
U.S. Treasury securities and obligations of U.S. government authorities and agencies $ 0
$ 16,052
$ 0
$ 0
$ 16,052
Obligations of U.S. states and their political subdivisions 0
180,090
0
0
180,090
Foreign government bonds 0
78,794
0
0
78,794
U.S. corporate public securities 0
856,451
0
0
856,451
U.S. corporate private securities 0
240,303
303
0
240,606
Foreign corporate public securities 0
59,180
0
0
59,180
Foreign corporate private securities 0
142,358
19,929
0
162,287
Asset-backed securities(2) 0
18,437
0
0
18,437
Commercial mortgage-backed securities 0
155,374
0
0
155,374
Residential mortgage-backed securities 0
4,282
0
0
4,282
Subtotal 0
1,751,321
20,232
0
1,771,553
Fixed maturities, trading 0
12,727
0
0
12,727
Equity securities 0
124
7,187
0
7,311
Cash equivalents 0
35,939
0
0
35,939
Other invested assets(3) 0
42,714
0
(8,466 ) 34,248
Reinsurance recoverables 0
0
1,741,924
0
1,741,924
Receivables from parent and affiliates 0
2,316
0
0
2,316
Subtotal excluding separate account assets 0
1,845,141
1,769,343
(8,466 ) 3,606,018
Separate account assets(4)(5) 0
13,415,971
0
0
13,415,971
Total assets $ 0
$ 15,261,112
$ 1,769,343
$ (8,466 ) $ 17,021,989
Future policy benefits(6) $ 0
$ 0
$ 1,741,924
$ 0
$ 1,741,924
Policyholders' account balances 0
0
143,242
0
143,242
Payables to parent and affiliates 0
8,457
0
(8,457 ) 0
Total liabilities $ 0
$ 8,457
$ 1,885,166
$ (8,457 ) $ 1,885,166


	As of September 30, 2020
	Level 1		Level 2		Level 3		Netting(1)		Total
	(in thousands)
Fixed maturities, available-for-sale:
U.S. Treasury securities and obligations of U.S. government authorities and agencies	$	0	$	11,838	$	0	$	0	$	11,838
Obligations of U.S. states and their political subdivisions	0		180,917		0		0		180,917
Foreign government bonds	0		86,316		0		0		86,316
U.S. corporate public securities	0		875,116		0		0		875,116
U.S. corporate private securities	0		242,181		413		0		242,594
Foreign corporate public securities	0		68,659		0		0		68,659
Foreign corporate private securities	0		143,672		20,715		0		164,387
Asset-backed securities(2)	0		18,612		0		0		18,612
Commercial mortgage-backed securities	0		156,055		0		0		156,055
Residential mortgage-backed securities	0		4,052		0		0		4,052
Subtotal	0		1,787,418		21,128		0		1,808,546
Fixed maturities, trading	0		17,857		0		0		17,857
Equity securities	0		126		8,312		0		8,438

Cash equivalents	0		61,000		0		0		61,000
Other invested assets(3)	0		42,049		0		(15,902)		26,147
Reinsurance recoverables	0		0		1,521,833		0		1,521,833
Receivables from parent and affiliates	0		808		0		0		808
Subtotal excluding separate account assets	0		1,909,258		1,551,273		(15,902)		3,444,629
Separate account assets(4)(5)	0		13,926,414		0		0		13,926,414
Total assets	$	0	$	15,835,672	$	1,551,273	$	(15,902)	$	17,371,043
Future policy benefits(6)	$	0	$	0	$	1,521,833	$	0	$	1,521,833
Policyholders' account balances	0		0		145,272		0		145,272
Payables to parent and affiliates	0		15,894		0		(15,894)		0
Total liabilities	$	0	$	15,894	$	1,667,105	$	(15,894)	$	1,667,105

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)


	As of December 31, 2019
	Level 1		Level 2		Level 3		Netting(1)		Total
	(in thousands)
Fixed maturities, available-for-sale:
U.S. Treasury securities and obligations of U.S. government authorities and agencies	$	0	$	16,015	$	0	$	0	$	16,015
Obligations of U.S. states and their political subdivisions	0		133,677		0		0		133,677
Foreign government bonds	0		77,280		0		0		77,280
U.S. corporate public securities	0		697,520		0		0		697,520
U.S. corporate private securities	0		232,903		312		0		233,215
Foreign corporate public securities	0		57,993		0		0		57,993
Foreign corporate private securities	0		163,026		866		0		163,892
Asset-backed securities(2)	0		18,542		0		0		18,542
Commercial mortgage-backed securities	0		147,389		0		0		147,389
Residential mortgage-backed securities	0		4,573		0		0		4,573
Subtotal	0		1,548,918		1,178		0		1,550,096
Fixed maturities, trading	0		13,700		0		0		13,700
Equity securities	0		207		7,305		0		7,512

Cash equivalents	0		55,896		0		0		55,896
Other invested assets(3)	0		34,413		0		(13,029)		21,384
Reinsurance recoverables	0		0		760,558		0		760,558
Receivables from parent and affiliates	0		2,433		0		0		2,433
Subtotal excluding separate account assets	0		1,655,567		769,041		(13,029)		2,411,579
Separate account assets(4)(5)	0		13,927,275		0		0		13,927,275
Total assets	$	0	$	15,582,842	$	769,041	$	(13,029)	$	16,338,854
Future policy benefits(6)	$	0	$	0	$	760,558	$	0	$	760,558
Policyholders' account balances	0		0		133,793		0		133,793
Payables to parent and affiliates	0		13,043		0		(13,043)		0
Total liabilities	$	0	$	13,043	$	894,351	$	(13,043)	$	894,351

(1)“Netting” amounts represent cash collateral of $0.0 million as of both September 30, 2020 and December 31, 2019.

(2)Includes credit-tranched securities collateralized by syndicated bank loans, sub-prime mortgages, auto loans, credit cards, education loans and other asset types.

(3)Other invested assets excluded from the fair value hierarchy include certain hedge funds, private equity funds and other funds for which fair value is measured at net asset value ("NAV") per share (or its equivalent) as a practical expedient. As of September 30, 2020 and December 31, 2019, the fair values of such investments were $3.0 million and $3.3 million, respectively.

(4)Separate account assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate, hedge funds and a corporate owned life insurance fund, for which fair value is measured at NAV per share (or its equivalent). At September 30, 2020 and December 31, 2019, the fair value of such investments was $1,961 million and $1,977 million, respectively.

(5)Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company's Unaudited Interim Statements of Financial Position.

(6)As of September 30, 2020, the net embedded derivative liability position of $1,522 million includes $31 million of embedded derivatives in an asset position and $1,553 million of embedded derivatives in a liability position. As of December 31, 2019, the net embedded derivative liability position of $761 million includes $60 million of embedded derivatives in an asset position and $821 million of embedded derivatives in a liability position.

As of December 31, 2019
Level 1 Level 2 Level 3 Netting(1) Total
(in thousands)
Fixed maturities, available-for-sale:
U.S. Treasury securities and obligations of U.S. government authorities and agencies $ 0
$ 16,015
$ 0
$ 0
$ 16,015
Obligations of U.S. states and their political subdivisions 0
133,677
0
0
133,677
Foreign government bonds 0
77,280
0
0
77,280
U.S. corporate public securities 0
697,520
0
0
697,520
U.S. corporate private securities 0
232,903
312
0
233,215
Foreign corporate public securities 0
57,993
0
0
57,993
Foreign corporate private securities 0
163,026
866
0
163,892
Asset-backed securities(2) 0
18,542
0
0
18,542
Commercial mortgage-backed securities 0
147,389
0
0
147,389
Residential mortgage-backed securities 0
4,573
0
0
4,573
Subtotal 0
1,548,918
1,178
0
1,550,096
Fixed maturities, trading 0
13,700
0
0
13,700
Equity securities 0
207
7,305
0
7,512
Cash equivalents 0
55,896
0
0
55,896
Other invested assets(3) 0
34,413
0
(13,029 ) 21,384
Reinsurance recoverables 0
0
760,558
0
760,558
Receivables from parent and affiliates 0
2,433
0
0
2,433
Subtotal excluding separate account assets 0
1,655,567
769,041
(13,029 ) 2,411,579
Separate account assets(4)(5) 0
13,927,275
0
0
13,927,275
Total assets $ 0
$ 15,582,842
$ 769,041
$ (13,029 ) $ 16,338,854
Future policy benefits(6) $ 0
$ 0
$ 760,558
$ 0
$ 760,558
Policyholders' account balances 0
0
133,793
0
133,793
Payables to parent and affiliates 0
13,043
0
(13,043 ) 0
Total liabilities $ 0
$ 13,043
$ 894,351
$ (13,043 ) $ 894,351

Table of Contents


~~(1)~~			~~“Netting” amounts represent cash collateral of $0.0 million as of both June 30, 2020 and~~ ~~December 31, 2019.~~


~~(2)~~	~~Includes credit-tranched securities collateralized by syndicated bank loans, sub-prime mortgages, auto loans, credit cards, education loans and other asset types.~~


~~(3)~~	Other invested assets excluded from the fair value hierarchy include certain hedge funds, private equity funds and other funds for which fair value is measured at net asset value ("NAV") per share (or its equivalent) as a practical expedient. At June 30, 2020 and December 31, 2019, the fair values of such investments were $2.9 million and $3.3 million, respectively.

~~(4)~~

Separate account assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate, hedge funds and a corporate owned life insurance fund, for which fair value is measured at NAV per share (or its equivalent). At June 30, 2020 and December 31, 2019, the fair value of such investments was $1,875 million and $1,977 million, respectively.

~~(5)~~

Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company's Unaudited Interim Statements of Financial Position.

~~(6)~~

As of June 30, 2020, the net embedded derivative liability position of $1,742 million includes $24 million of embedded derivatives in an asset position and $1,766 million of embedded derivatives in a liability position. As of December 31, 2019, the net embedded derivative liability position of $761 million includes $60 million of embedded derivatives in an asset position and $821 million of embedded derivatives in a liability position.

~~Table of Contents~~



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Quantitative Information Regarding Internally Priced Level 3 Assets and Liabilities – The tables below present quantitative information on significant internally-priced Level 3 assets and liabilities.


	As of September 30, 2020
	Fair Value		Valuation Techniques	Unobservable Inputs	Minimum		Maximum			Weighted Average		Impact of Increase in Input on Fair Value(1)
	(in thousands)
Assets:
Corporate securities(2)	$	21,128	Discounted cash flow	Discount rate	2.36	%	2.54	%		2.47	%	Decrease
Reinsurance recoverables	$	1,521,833	Fair values are determined using the same unobservable inputs as future policy benefits.
Liabilities:
Future policy benefits(3)	$	1,521,833	Discounted cash flow	Lapse rate(5)	1	%	20	%				Decrease
				Spread over LIBOR(6)	0.09	%	1.59	%				Decrease
				Utilization rate(7)	39	%	96	%				Increase
				Withdrawal rate					See table footnote (8) below.
				Mortality rate (9)	0	%	15	%				Decrease
				Equity volatility curve	18	%	26	%				Increase
Policyholders' account balances(4)	$	145,272	Discounted cash flow	Lapse rate(5)	1	%	6	%				Decrease
				Spread over LIBOR(6)	0.09	%	1.59	%				Decrease

				Mortality rate (9)	0	%	24	%				Decrease
				Equity volatility curve	19	%	35	%				Increase

As of June 30, 2020
Fair Value
Valuation
Techniques

Unobservable
Inputs
Minimum Maximum
Weighted
Average

Impact of Increase in Input on Fair
Value(1)
(in thousands)
Assets:
Corporate securities(2) $ 20,232
Discounted cash flow Discount rate 2.28 %
2.58 %
2.45 %
Decrease
Reinsurance recoverables $ 1,741,924
Fair values are determined using the same unobservable inputs as future policy benefits.
Liabilities:
Future policy benefits(3) $ 1,741,924
Discounted cash flow Lapse rate(5) 1 % 20 % Decrease
Spread over LIBOR(6) 0.17 % 1.69 % Decrease
Utilization rate(7) 39 % 96 % Increase
Withdrawal rate See table footnote (8) below.
Mortality rate (9) 0 % 15 % Decrease
Equity volatility curve 18 % 29 % Increase
Policyholders' account balances(4) $ 143,242
Discounted cash flow Lapse rate(5) 1 % 6 % Decrease
Spread over LIBOR(6) 0.17 % 1.69 % Decrease
Mortality rate (9) 0 % 24 % Decrease
Equity volatility curve 18 % 35 % Increase


	As of December 31, 2019
	Fair Value		Valuation Techniques	Unobservable Inputs	Minimum		Maximum		Weighted Average	Impact of Increase in Input on Fair Value(1)
	(in thousands)
Assets:

Reinsurance recoverables	$	760,558	Fair values are determined using the same unobservable inputs as future policy benefits.
Liabilities:
Future policy benefits(3)	$	760,558	Discounted cash flow	Lapse rate(5)	1	%	18	%		Decrease
				Spread over LIBOR(6)	0.10	%	1.23	%		Decrease
				Utilization rate(7)	43	%	97	%		Increase
				Withdrawal rate	See table footnote(8) below.
				Mortality rate(9)	0	%	15	%		Decrease
				Equity volatility curve	13	%	23	%		Increase
Policyholders' account balances(4)	$	133,793	Discounted cash flow	Lapse rate(5)	1	%	6	%		Decrease
				Spread over LIBOR(6)	0.10	%	1.23	%		Decrease
				Mortality rate (9)	0	%	24	%		Decrease
				Equity volatility curve	10	%	23	%		Increase

As of December 31, 2019
Fair Value Valuation
Techniques Unobservable Inputs Minimum Maximum
Weighted
Average

Impact of Increase
in Input on Fair
Value(1)
(in thousands)
Assets:
Reinsurance recoverables $ 760,558
Fair values are determined using the same unobservable inputs as future policy benefits.
Liabilities:
Future policy benefits(3) $ 760,558
Discounted cash flow Lapse rate(5) 1 % 18 % Decrease
Spread over LIBOR(6) 0.10 % 1.23 % Decrease
Utilization rate(7) 43 % 97 % Increase
Withdrawal rate See table footnote(8) below.
Mortality rate(9) 0 % 15 % Decrease
Equity volatility curve 13 % 23 % Increase
Policyholders' account balances(4) $ 133,793
Discounted cash flow Lapse rate(5) 1 % 6 % Decrease
Spread over LIBOR(6) 0.10 % 1.23 % Decrease
Mortality rate (9) 0 % 24 % Decrease
Equity volatility curve 10 % 23 % Increase

3332

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)


~~(1)~~	~~Conversely, the impact of a decrease in input would have the opposite impact on fair value as that presented in the table.~~


~~(2)~~	~~Includes assets classified as fixed maturities available-for-sale.~~

~~(3)~~

Future policy benefits primarily represent general account liabilities for the living benefit features of the Company’s variable annuity contracts which are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation.

~~(4)~~

Policyholders’ account balances primarily represent general account liabilities for the index-linked interest credited on certain of the Company’s life products that are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation.

~~(5)~~

Lapse rates for contracts with living benefit guarantees are adjusted at the contract level based on the in-the-moneyness of the living benefit and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates for contracts with index-linked crediting guarantees may be adjusted at the contract level based on the applicability of any surrender charges, product type, and market related factors such as interest rates. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For any given contract, lapse rates vary throughout the period over which cash flows are projected for the purposes of valuing these embedded derivatives.

~~(6)~~

The spread over the London Inter-Bank Offered Rate ("LIBOR") swap curve represents the premium added to the proxy for the risk-free rate (LIBOR) to reflect the Company's estimates of rates that a market participant would use to value the living benefits in both the accumulation and payout phases and index-linked interest crediting guarantees. This spread includes an estimate of NPR, which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with issuing funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because funding agreements, living benefit guarantees, and index-linked interest crediting guarantees are insurance liabilities and are therefore senior to debt.

~~(7)~~

The utilization rate assumption estimates the percentage of contracts that will utilize the benefit during the contract duration and begin lifetime withdrawals at various time intervals from contract inception. The remaining contractholders are assumed to either begin lifetime withdrawals immediately or never utilize the benefit. Utilization assumptions may vary by product type, tax status and age. The impact of changes in these assumptions is highly dependent on the product type, the age of the contractholder at the time of the sale, and the timing of the first lifetime income withdrawal. Range reflects the utilization rate for the vast majority of business with living benefits.

~~(8)~~

The withdrawal rate assumption estimates the magnitude of annual contractholder withdrawals relative to the maximum allowable amount under the contract. These assumptions vary based on the age of the contractholder, the tax status of the contract and the duration since the contractholder began lifetime withdrawals. As of June 30, 2020 and December 31, 2019, the minimum withdrawal rate assumption is 76% and 78% respectively. As of June 30, 2020 and December 31, 2019, the maximum withdrawal rate assumption may be greater than 100%. The fair value of the liability will generally increase the closer the withdrawal rate is to 100% and decrease as the withdrawal rate moves further away from 100%.

~~(9)~~

The range reflects the mortality rates for the vast majority of business with living benefits and other contracts, with policyholders ranging from 45 to 90 years old. While the majority of living benefits have a minimum age requirement, certain other contracts do not have an age restriction. This results in contractholders with mortality rates approaching 0% for certain benefits. Mortality rates may vary by product, age and duration. A mortality improvement assumption is also incorporated into the overall mortality table.

(1)Conversely, the impact of a decrease in input would have the opposite impact on fair value as that presented in the table.

(2)Includes assets classified as fixed maturities available-for-sale.

(3)Future policy benefits primarily represent general account liabilities for the living benefit features of the Company’s variable annuity contracts which are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation.

(4)Policyholders’ account balances primarily represent general account liabilities for the index-linked interest credited on certain of the Company’s life products that are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation.

(5)Lapse rates for contracts with living benefit guarantees are adjusted at the contract level based on the in-the-moneyness of the living benefit and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates for contracts with index-linked crediting guarantees may be adjusted at the contract level based on the applicability of any surrender charges, product type, and market related factors such as interest rates. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For any given contract, lapse rates vary throughout the period over which cash flows are projected for the purposes of valuing these embedded derivatives.

(6)The spread over the London Inter-Bank Offered Rate ("LIBOR") swap curve represents the premium added to the proxy for the risk-free rate (LIBOR) to reflect the Company's estimates of rates that a market participant would use to value the living benefits in both the accumulation and payout phases and index-linked interest crediting guarantees. This spread includes an estimate of NPR, which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with issuing funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because funding agreements, living benefit guarantees, and index-linked interest crediting guarantees are insurance liabilities and are therefore senior to debt.

(7)The utilization rate assumption estimates the percentage of contracts that will utilize the benefit during the contract duration and begin lifetime withdrawals at various time intervals from contract inception. The remaining contractholders are assumed to either begin lifetime withdrawals immediately or never utilize the benefit. Utilization assumptions may vary by product type, tax status and age. The impact of changes in these assumptions is highly dependent on the product type, the age of the contractholder at the time of the sale, and the timing of the first lifetime income withdrawal. Range reflects the utilization rate for the vast majority of business with living benefits.

(8)The withdrawal rate assumption estimates the magnitude of annual contractholder withdrawals relative to the maximum allowable amount under the contract. These assumptions vary based on the age of the contractholder, the tax status of the contract and the duration since the contractholder began lifetime withdrawals. As of September 30, 2020 and December 31, 2019, the minimum withdrawal rate assumption is 76% and 78% respectively. As of September 30, 2020 and December 31, 2019, the maximum withdrawal rate assumption may be greater than 100%. The fair value of the liability will generally increase the closer the withdrawal rate is to 100% and decrease as the withdrawal rate moves further away from 100%.

(9)The range reflects the mortality rates for the vast majority of business with living benefits and other contracts, with policyholders ranging from 45 to 90 years old. While the majority of living benefits have a minimum age requirement, certain other contracts do not have an age restriction. This results in contractholders with mortality rates approaching 0% for certain benefits. Mortality rates may vary by product, age and duration. A mortality improvement assumption is also incorporated into the overall mortality table.

Interrelationships Between Unobservable Inputs – In addition to the sensitivities of fair value measurements to changes in each unobservable input in isolation, as reflected in the table above, interrelationships between these inputs may also exist, such that a change in one unobservable input may give rise to a change in another, or multiple, inputs. Examples of such interrelationships for significant internally-priced Level 3 assets and liabilities are as follows:

Corporate Securities - The rate used to discount future cash flows reflects current risk-free rates plus credit and liquidity spread requirements that market participants would use to value an asset. The discount rate may be influenced by many factors, including market cycles, expectations of default, collateral, term, and asset complexity. Each of these factors can influence discount rates, either in isolation, or in response to other factors. During weaker economic cycles, as the expectations of default increases, credit spreads widen, which results in a decrease in fair value.

Future Policy Benefits – The Company expects efficient benefit utilization and withdrawal rates to generally be correlated with lapse rates. However, behavior is highly dependent on the facts and circumstances surrounding the individual contractholder, such as their liquidity needs or tax situation, which could drive lapse behavior independent of other contractholder behavior assumptions. To the extent more efficient contractholder behavior results in greater in-the-moneyness at the contract level, lapse rates may decline for those contracts. Similarly, to the extent that increases in equity volatility are correlated with overall declines in the capital markets, lapse rates may decline as contracts become more in-the-money.

Changes in Level 3 Assets and Liabilities – The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods. When a determination is made to classify assets and liabilities within Level 3, the determination is based on significance of the unobservable inputs in the overall fair value measurement. All transfers are based on changes in the observability of the valuation inputs, including the availability of pricing service information that the Company can validate. Transfers into Level 3 are generally the result of unobservable inputs utilized within valuation methodologies and the use of indicative broker quotes for assets that were previously valued using observable inputs. Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.

3433

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)


	Three Months Ended September 30, 2020
	Fair Value, beginning of period		Total realized and unrealized gains (losses)(1)		Purchases		Sales		Issuances		Settlements		Other		Transfers into Level 3		Transfers out of Level 3		Fair Value, end of period		Unrealized gains (losses) for assets still held(2)
	(in thousands)
Fixed maturities, available-for-sale:


Corporate securities(3)	$	20,232	$	895	$	0	$	1	$	0	$	0	$	0	$	0	$	0	$	21,128	$	895
Structured securities(4)	0		0		0		0		0		0		0		0		0		0		0
Other assets:

Equity securities	7,187		1,125		0		0		0		0		0		0		0		8,312		1,125



Reinsurance recoverables	1,741,924		(247,857)		27,766		0		0		0		0		0		0		1,521,833		(236,111)

Liabilities:
Future policy benefits	(1,741,924)		247,857		0		0		(27,766)		0		0		0		0		(1,521,833)		236,111
Policyholders' account balances(5)	(143,242)		(232)		0		0		(1,798)		0		0		0		0		(145,272)		1,809


	Three Months Ended September 30, 2020
	Total realized and unrealized gains (losses)								Unrealized gains (losses) for assets still held(2)
	Realized investment gains (losses), net(1)		Other income (loss)		Included in other comprehensive income (loss)		Net investment income			Realized investment gains (losses), net		Other income (loss)		Included in other comprehensive income (loss)(6)
	(in thousands)
Fixed maturities, available-for-sale	$	0	$	0	$	895	$	0		$	0	$	0	$	895
Other assets:

Equity securities	0		1,125		0		0			0		1,125		0



Reinsurance recoverables	(247,857)		0		0		0			(236,111)		0		0

Liabilities:
Future policy benefits	247,857		0		0		0			236,111		0		0
Policyholders' account balances	(232)		0		0		0			1,809		0		0

Three Months Ended June 30, 2020
Fair Value, beginning of period Total realized and unrealized gains (losses)(1) Purchases Sales Issuances Settlements Other Transfers into Level 3 Transfers out of Level 3 Fair Value, end of period Unrealized gains (losses) for assets still held(2)
(in thousands)
Fixed maturities, available-for-sale:
Corporate securities(3) $ 18,274
$ 1,959
$ 0
$ (1 ) $ 0
$ 0
$ 0
$ 0
$ 0
$ 20,232
$ 1,959
Structured securities(4) 0
0
0
0
0
0
0
0
0
0
0
Other assets:
Equity securities 6,840
347
0
0
0
0
0
0
0
7,187
348
Reinsurance recoverables 1,868,539
(153,382 ) 26,767
0
0
0
0
0
0
1,741,924
(141,848 )
Liabilities:
Future policy benefits (1,868,539 ) 153,382
0
0
(26,767 ) 0
0
0
0
(1,741,924 ) 141,848
Policyholders' account balances(5) (123,608 ) (11,691 ) 0
0
(7,943 ) 0
0
0
0
(143,242 ) (12,621 )

Three Months Ended June 30, 2020
Total realized and unrealized gains (losses) Unrealized gains (losses) for assets still held(2)
Realized investment gains (losses), net(1) Other income (loss) Included in other comprehensive income (loss) Net investment income Realized investment gains (losses), net Other income (loss) Included in other comprehensive income (loss)(6)
(in thousands)
Fixed maturities, available-for-sale $ 0
$ 0
$ 1,959
$ 0
$ 0
$ 0
$ 1,959
Other assets:
Equity securities 0
347
0
0
0
348
0
Reinsurance recoverables (153,382 ) 0
0
0
(141,848 ) 0
0
Liabilities:
Future policy benefits 153,382
0
0
0
141,848
0
0
Policyholders' account balances (11,691 ) 0
0
0
(12,621 ) 0
0

3534

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)


	Nine Months Ended September 30, 2020
	Fair Value, beginning of period		Total realized and unrealized gains (losses)(1)		Purchases		Sales		Issuances		Settlements		Other		Transfers into Level 3		Transfers out of Level 3		Fair Value, end of period		Unrealized gains (losses) for assets still held(2)
	(in thousands)
Fixed maturities, available-for-sale:


Corporate securities(3)	$	1,178	$	1,080	$	0	$	(860)	$	0	$	0	$	0	$	19,730	$	0	$	21,128	$	1,085
Structured securities(4)	0		0		0		0		0		0		0		0		0		0		0
Other assets:

Equity securities	7,305		1,007		0		0		0		0		0		0		0		8,312		1,007



Reinsurance recoverables	760,558		680,424		80,851		0		0		0		0		0		0		1,521,833		697,223

Liabilities:
Future policy benefits	(760,558)		(680,424)		0		0		(80,851)		0		0		0		0		(1,521,833)		(697,223)
Policyholders' account balances(5)	(133,793)		5,017		0		0		(16,496)		0		0		0		0		(145,272)		6,849


	Nine Months Ended September 30, 2020
	Total realized and unrealized gains (losses)								Unrealized gains (losses) for assets still held(2)
	Realized investment gains (losses), net(1)		Other income (loss)		Included in other comprehensive income (loss)		Net investment income			Realized investment gains (losses), net		Other income (loss)		Included in other comprehensive income (loss)(6)
	(in thousands)
Fixed maturities, available-for-sale	$	32	$	0	$	1,040	$	8		$	0	$	0	$	1,085
Other assets:

Equity securities	0		1,007		0		0			0		1,007		0



Reinsurance recoverables	680,424		0		0		0			697,223		0		0

Liabilities:
Future policy benefits	(680,424)		0		0		0			(697,223)		0		0
Policyholders' account balances	5,017		0		0		0			6,849		0		0

Six Months Ended June 30, 2020
Fair Value, beginning of period Total realized and unrealized gains (losses)(1) Purchases Sales Issuances Settlements Other Transfers into Level 3 Transfers out of Level 3 Fair Value, end of period Unrealized gains (losses) for assets still held(2)
(in thousands)
Fixed maturities, available-for-sale:
Corporate securities(3) $ 1,178
$ 185
$ 0
$ (861 ) $ 0
$ 0
$ 0
$ 19,730
$ 0
$ 20,232
$ 190
Structured securities(4) 0
0
0
0
0
0
0
0
0
0
0
Other assets:
Equity securities 7,305
(118 ) 0
0
0
0
0
0
0
7,187
(118 )
Reinsurance recoverables 760,558
928,281
53,085
0
0
0
0
0
0
1,741,924
940,465
Liabilities:
Future policy benefits (760,558 ) (928,281 ) 0
0
(53,085 ) 0
0
0
0
(1,741,924 ) (940,465 )
Policyholders' account balances(5) (133,793 ) 5,249
0
0
(14,698 ) 0
0
0
0
(143,242 ) 5,039

Six Months Ended June 30, 2020
Total realized and unrealized gains (losses) Unrealized gains (losses) for assets still held(2)
Realized investment gains (losses), net(1) Other income (loss) Included in other comprehensive income (loss) Net investment income Realized investment gains (losses), net Other income (loss) Included in other comprehensive income (loss)(6)
(in thousands)
Fixed maturities, available-for-sale $ 32
$ 0
$ 145
$ 8
$ 0
$ 0
$ 190
Other assets:
Equity securities 0
(118 ) 0
0
0
(118 ) 0
Reinsurance recoverables 928,281
0
0
0
940,465
0
0
Liabilities:
Future policy benefits (928,281 ) 0
0
0
(940,465 ) 0
0
Policyholders' account balances 5,249
0
0
0
5,039
0
0

3635

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)


	Three Months Ended September 30, 2019
	Fair Value, beginning of period		Total realized and unrealized gains (losses)(1)		Purchases		Sales		Issuances		Settlements		Other		Transfers into Level 3		Transfers out of Level 3		Fair Value, end of period		Unrealized gains (losses) for assets still held(2)
	(in thousands)
Fixed maturities, available-for-sale:


Corporate securities(3)	$	2,035	$	(1,017)	$	180	$	0	$	0	$	0	$	0	$	0	$	0	$	1,198	$	(1,731)
Structured securities(4)	0		0		0		0		0		0		0		0		0		0		0
Other assets:

Equity securities	7,206		(73)		0		0		0		0		0		0		0		7,133		(72)



Reinsurance recoverables	757,236		236,174		24,883		0		0		0		0		0		0		1,018,293		244,163

Liabilities:
Future policy benefits	(757,236)		(236,174)		0		0		(24,883)		0		0		0		0		(1,018,293)		(244,163)
Policyholders' account balances(5)	(112,417)		3,796		0		0		(14,467)		0		0		0		0		(123,088)		5,346


	Three Months Ended September 30, 2019
	Total realized and unrealized gains (losses)								Unrealized gains (losses) for assets still held(2)
	Realized investment gains (losses), net(1)		Other income (loss)		Included in other comprehensive income (loss)		Net investment income			Realized investment gains (losses), net		Other income (loss)
	(in thousands)
Fixed maturities, available-for-sale	$	(1,730)	$	0	$	688	$	25		$	(1,731)	$	0
Other assets:

Equity securities	0		(73)		0		0			0		(72)



Reinsurance recoverables	236,174		0		0		0			244,163		0

Liabilities:
Future policy benefits	(236,174)		0		0		0			(244,163)		0
Policyholders' account balances	3,796		0		0		0			5,346		0

Three Months Ended June 30, 2019
Fair Value, beginning of period Total realized and unrealized gains (losses)(1) Purchases Sales Issuances Settlements Other Transfers into Level 3 Transfers out of Level 3 Fair Value, end of period Unrealized gains (losses) for assets still held(2)
(in thousands)
Fixed maturities, available-for-sale:
Corporate securities(3) $ 2,344
$ (310 ) $ 0
$ 0
$ 0
$ (638 ) $ 0
$ 639
$ 0
$ 2,035
$ 0
Structured securities(4) 25,324
0
0
0
0
0
0
0
(25,324 ) 0
0
Other assets:
Equity securities 6,576
630
0
0
0
0
0
0
0
7,206
630
Reinsurance recoverables 571,117
162,593
23,526
0
0
0
0
0
0
757,236
167,330
Liabilities:
Future policy benefits (571,117 ) (162,593 ) 0
0
(23,526 ) 0
0
0
0
(757,236 ) (167,330 )
Policyholders' account balances(5) (7,529 ) (98,831 ) 0
0
(6,057 ) 0
0
0
0
(112,417 ) (98,831 )

Three Months Ended June 30, 2019
Total realized and unrealized gains (losses) Unrealized gains (losses) for assets still held(2)
Realized investment gains (losses), net(1) Other income (loss) Included in other comprehensive income (loss) Net investment income Realized investment gains (losses), net Other income (loss)
(in thousands)
Fixed maturities, available-for-sale $ 0
$ 0
$ (447 ) $ 137
$ 0
$ 0
Other assets:
Equity securities 0
630
0
0
0
630
Reinsurance recoverables 162,593
0
0
0
167,330
0
Liabilities:
Future policy benefits (162,593 ) 0
0
0
(167,330 ) 0
Policyholders' account balances (98,831 ) 0
0
0
(98,831 ) 0

3736

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)


	Nine Months Ended September 30, 2019
	Fair Value, beginning of period		Total realized and unrealized gains (losses)(1)		Purchases		Sales		Issuances		Settlements		Other		Transfers into Level 3		Transfers out of Level 3		Fair Value, end of period		Unrealized gains (losses) for assets still held(2)
	(in thousands)
Fixed maturities, available-for-sale:


Corporate securities(3)	$	2,882	$	(2,113)	$	428	$	0	$	0	$	(638)	$	0	$	639	$	0	$	1,198	$	(4,893)
Structured securities(4)	0		432		0		0		0		(68)		0		24,960		(25,324)		0		0
Other assets:

Equity securities	6,622		511		0		0		0		0		0		0		0		7,133		511



Reinsurance recoverables	488,825		458,557		70,911		0		0		0		0		0		0		1,018,293		470,731

Liabilities:
Future policy benefits	(488,825)		(458,557)		0		0		(70,911)		0		0		0		0		(1,018,293)		(470,731)
Policyholders' account balances(5)	(1,949)		(99,712)		0		0		(21,427)		0		0		0		0		(123,088)		(98,158)


	Nine Months Ended September 30, 2019
	Total realized and unrealized gains (losses)								Unrealized gains (losses) for assets still held(2)
	Realized investment gains (losses), net(1)		Other income (loss)		Included in other comprehensive income (loss)		Net investment income			Realized investment gains (losses), net		Other income (loss)
	(in thousands)
Fixed maturities, available-for-sale	$	(4,893)	$	0	$	3,041	$	171		$	(4,893)	$	0
Other assets:

Equity securities	0		511		0		0			0		511



Reinsurance recoverables	458,557		0		0		0			470,731		0

Liabilities:
Future policy benefits	(458,557)		0		0		0			(470,731)		0
Policyholders' account balances	(99,712)		0		0		0			(98,158)		0

(1)Realized investment gains (losses) on future policy benefits and reinsurance recoverables primarily represent the change in the fair value of the Company's living benefit guarantees on certain of its variable annuity contracts.

(2)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts.

(3)Includes U.S. corporate private and foreign corporate private securities.

(4)Includes asset-backed, commercial mortgage-backed and residential mortgage-backed securities.

(5)Issuances and settlements for Policyholders' account balances are presented net in the rollforward.

(6)Effective January 1, 2020, the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period were added prospectively due to adoption of ASU 2018-13. Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.

Six Months Ended June 30, 2019
Fair Value, beginning of period Total realized and unrealized gains (losses)(1) Purchases Sales Issuances Settlements Other Transfers into Level 3 Transfers out of Level 3 Fair Value, end of period Unrealized gains (losses) for assets still held(2)
(in thousands)
Fixed maturities, available-for-sale:
Corporate securities(3) $ 2,882
$ (1,096 ) $ 248
$ 0
$ 0
$ (638 ) $ 0
$ 639
$ 0
$ 2,035
$ (3,163 )
Structured securities(4) 0
432
0
0
0
(68 ) 0
24,960
(25,324 ) 0
0
Other assets:
Equity securities 6,622
584
0
0
0
0
0
0
0
7,206
584
Reinsurance recoverables 488,825
222,383
46,028
0
0
0
0
0
0
757,236
229,926
Liabilities:
Future policy benefits (488,825 ) (222,383 ) 0
0
(46,028 ) 0
0
0
0
(757,236 ) (229,926 )
Policyholders' account balances(5) (1,949 ) (103,508 ) 0
0
(6,960 ) 0
0
0
0
(112,417 ) (103,504 )

Six Months Ended June 30, 2019
Total realized and unrealized gains (losses) Unrealized gains (losses) for assets still held(2)
Realized investment gains (losses), net(1) Other income (loss) Included in other comprehensive income (loss) Net investment income Realized investment gains (losses), net Other income (loss)
(in thousands)
Fixed maturities, available-for-sale $ (3,163 ) $ 0
$ 2,353
$ 146
$ (3,163 ) $ 0
Other assets:
Equity securities 0
584
0
0
0
584
Reinsurance recoverables 222,383
0
0
0
229,926
0
Liabilities:
Future policy benefits (222,383 ) 0
0
0
(229,926 ) 0
Policyholders' account balances (103,508 ) 0
0
0
(103,504 ) 0

Table of Contents


~~(1)~~			Realized investment gains (losses) on future policy benefits and reinsurance recoverables primarily represent the change in the fair value of the Company's living benefit guarantees on certain of its variable annuity contracts.


~~(2)~~	~~Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts.~~


~~(3)~~	~~Includes U.S. corporate private and foreign corporate private securities.~~


~~(4)~~	~~Includes asset-backed, commercial mortgage-backed and residential mortgage-backed securities.~~


~~(5)~~	~~Issuances and settlements for Policyholders' account balances are presented net in the rollforward.~~


~~(6)~~	Effective January 1, 2020, the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period were added prospectively due to adoption of ASU 2018-13. ~~Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement~~.

~~Table of Contents~~



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Fair Value of Financial Instruments

The table below presents the carrying amount and fair value by fair value hierarchy level of certain financial instruments that are not reported at fair value. The financial instruments presented below are reported at carrying value on the Company’s Unaudited Interim Statements of Financial Position. In some cases, as described below, the carrying amount equals or approximates fair value.


	September 30, 2020
	Fair Value								Carrying Amount(1)
	Level 1		Level 2		Level 3		Total		Total
	(in thousands)
Assets:

Commercial mortgage and other loans	$	0	$	0	$	144,666	$	144,666	$	136,705
Policy loans	0		0		212,519		212,519		212,519


Cash and cash equivalents	7,360		0		0		7,360		7,360
Accrued investment income	0		21,027		0		21,027		21,027
Reinsurance recoverables	0		0		28,806		28,806		26,975
Receivables from parent and affiliates	0		31,967		0		31,967		31,967
Other assets	0		3,205		0		3,205		3,205
Total assets	$	7,360	$	56,199	$	385,991	$	449,550	$	439,758
Liabilities:
Policyholders’ account balances - investment contracts	$	0	$	214,695	$	41,800	$	256,495	$	254,662

Cash collateral for loaned securities	0		2,731		0		2,731		2,731
Short-term debt to affiliates	0		0		0		0		0



Payables to parent and affiliates	0		13,661		0		13,661		13,661
Other liabilities	0		44,052		0		44,052		44,052
Total liabilities	$	0	$	275,139	$	41,800	$	316,939	$	315,106

June 30, 2020
Fair Value
Carrying
Amount(1)
Level 1 Level 2 Level 3 Total Total
(in thousands)
Assets:
Commercial mortgage and other loans $ 0
$ 0
$ 145,067
$ 145,067
$ 137,914
Policy loans 0
0
213,467
213,467
213,467
Cash and cash equivalents 5,181
0
0
5,181
5,181
Accrued investment income 0
20,984
0
20,984
20,984
Reinsurance recoverables 0
0
28,020
28,020
27,465
Receivables from parent and affiliates 0
37,532
0
37,532
37,532
Other assets 0
4,725
0
4,725
4,725
Total assets $ 5,181
$ 63,241
$ 386,554
$ 454,976
$ 447,268
Liabilities:
Policyholders’ account balances - investment contracts $ 0
$ 209,012
$ 41,192
$ 250,204
$ 249,648
Cash collateral for loaned securities 0
2,700
0
2,700
2,700
Short-term debt to affiliates 0
0
0
0
0
Payables to parent and affiliates 0
26,632
0
26,632
26,632
Other liabilities 0
38,502
0
38,502
38,502
Total liabilities $ 0
$ 276,846
$ 41,192
$ 318,038
$ 317,482

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)


	December 31, 2019
	Fair Value								Carrying Amount(1)
	Level 1		Level 2		Level 3		Total		Total
	(in thousands)
Assets:

Commercial mortgage and other loans	$	0	$	0	$	148,855	$	148,855	$	143,098
Policy loans	0		0		211,986		211,986		211,986


Cash and cash equivalents	28		0		0		28		28
Accrued investment income	0		19,539		0		19,539		19,539
Reinsurance recoverables	0		0		26,400		26,400		26,286
Receivables from parent and affiliates	0		30,387		0		30,387		30,387
Other assets	0		3,071		0		3,071		3,071
Total assets	$	28	$	52,997	$	387,241	$	440,266	$	434,395
Liabilities:
Policyholders’ account balances - investment contracts	$	0	$	192,239	$	40,475	$	232,714	$	232,600

Cash collateral for loaned securities	0		2,481		0		2,481		2,481
Short-term debt to affiliates	0		89		0		89		89



Payables to parent and affiliates	0		24,958		0		24,958		24,958
Other liabilities	0		41,310		0		41,310		41,310
Total liabilities	$	0	$	261,077	$	40,475	$	301,552	$	301,438

December 31, 2019
Fair Value
Carrying
Amount(1)
Level 1 Level 2 Level 3 Total Total
(in thousands)
Assets:
Commercial mortgage and other loans $ 0
$ 0
$ 148,855
$ 148,855
$ 143,098
Policy loans 0
0
211,986
211,986
211,986
Cash and cash equivalents 28
0
0
28
28
Accrued investment income 0
19,539
0
19,539
19,539
Reinsurance recoverables 0
0
26,400
26,400
26,286
Receivables from parent and affiliates 0
30,387
0
30,387
30,387
Other assets 0
3,071
0
3,071
3,071
Total assets $ 28
$ 52,997
$ 387,241
$ 440,266
$ 434,395
Liabilities:
Policyholders’ account balances - investment contracts $ 0
$ 192,239
$ 40,475
$ 232,714
$ 232,600
Cash collateral for loaned securities 0
2,481
0
2,481
2,481
Short-term debt to affiliates 0
89
0
89
89
Payables to parent and affiliates 0
24,958
0
24,958
24,958
Other liabilities 0
41,310
0
41,310
41,310
Total liabilities $ 0
$ 261,077
$ 40,475
$ 301,552
$ 301,438


~~(1)~~	Carrying values presented herein differ from those in the Company’s Unaudited Interim Statements of Financial Position because certain items within the respective financial statement captions are not considered financial instruments or out of scope under authoritative guidance relating to disclosures of the fair value of financial instruments.

(1)Carrying values presented herein differ from those in the Company’s Unaudited Interim Statements of Financial Position because certain items within the respective financial statement captions are not considered financial instruments or out of scope under authoritative guidance relating to disclosures of the fair value of financial instruments.

6. REINSURANCE

The Company participates in reinsurance with its affiliates Prudential Arizona Reinsurance Captive Company (“PARCC”), Prudential Arizona Reinsurance Term Company (“PAR Term”), Prudential Arizona Reinsurance Universal Company (“PAR U”), Prudential Term Reinsurance Company (“Term Re”) and Dryden Arizona Reinsurance Term Company (“DART”), its parent companies, Pruco Life and Prudential Insurance, as well as third parties. The reinsurance agreements provide risk diversification and additional capacity for future growth, limit the maximum net loss potential, manage statutory capital, and facilitate the Company's capital market hedging program. Life reinsurance is accomplished through various plans of reinsurance, primarily yearly renewable term and coinsurance. Reinsurance ceded arrangements do not discharge the Company as the primary insurer. Ceded balances would represent a liability of the Company in the event the reinsurers were unable to meet their obligations to the Company under the terms of the reinsurance agreements. The Company believes a material reinsurance liability resulting from such inability of reinsurers to meet their obligations is unlikely.

Reserves related to reinsured long-duration contracts are accounted for using assumptions consistent with those used to account for the underlying contracts. Amounts recoverable from reinsurers for long-duration reinsurance arrangements are estimated in a manner consistent with the claim liabilities and policy benefits associated with the reinsured policies. Reinsurance policy charges and fee income ceded for universal life and variable annuity products are accounted for as a reduction of policy charges and fee income. Reinsurance premiums ceded for term insurance products are accounted for as a reduction of premiums.

Realized investment gains and losses include the impact of reinsurance agreements, particularly reinsurance agreements involving living benefit guarantees. The Company has entered into a reinsurance agreement to transfer the risk related to living benefit guarantees on variable annuities to Prudential Insurance. These reinsurance agreements are derivatives and have been accounted for in the same manner as embedded derivatives and the changes in the fair value of these derivatives are recognized through “Realized investment gains (losses), net”. See Note 4 for additional information related to the accounting for embedded derivatives.

4039

��

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Reinsurance amounts included in the Company’s Unaudited Interim Statements of Financial Position as of ~~June~~September 30, 2020 and December 31, 2019 were as follows:


	September 30, 2020		December 31, 2019
	(in thousands)
Reinsurance recoverables(1)	$	4,116,435	$	3,200,642
Policy loans	(21,317)		(18,627)
Deferred policy acquisition costs	(665,414)		(736,575)
Deferred sales inducements	(40,283)		(47,423)
Other assets	15,195		16,540
Other liabilities	112,754		93,557

June 30, 2020 December 31, 2019
(in thousands)
Reinsurance recoverables(1) $ 4,310,574
$ 3,200,642
Policy loans (21,366 ) (18,627 )
Deferred policy acquisition costs (692,414 ) (736,575 )
Deferred sales inducements (42,906 ) (47,423 )
Other assets 16,629
16,540
Other liabilities 110,493
93,557
(1)Includes $4 million of unaffiliated activity for both September 30, 2020 and December 31, 2019.


~~(1)~~	~~Includes $1 million~~ ~~and~~ ~~$4 million of unaffiliated activity as of June 30, 2020 and December 31, 2019, respectively.~~

Reinsurance recoverables by counterparty are broken out below:



	September 30, 2020		December 31, 2019
	(in thousands)
Prudential Insurance	$	2,044,812	$	1,245,450
PAR U	1,100,831		1,027,304
PARCC	438,289		458,441
PAR Term	235,103		219,757
Term Re	214,421		190,633
DART	59,500		38,651
Pruco Life	19,523		16,428
Unaffiliated	3,956		3,978
Total reinsurance recoverables	$	4,116,435	$	3,200,642

June 30, 2020 December 31, 2019
(in thousands)
Prudential Insurance $ 2,265,669
$ 1,245,450
PAR U 1,073,143
1,027,304
PARCC 461,524
458,441
PAR Term 232,857
219,757
Term Re 212,540
190,633
DART 49,662
38,651
Pruco Life 14,196
16,428
Unaffiliated 983
3,978
Total reinsurance recoverables $ 4,310,574
$ 3,200,642

4140

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Reinsurance amounts, included in the Company’s Unaudited Interim Statements of Operations and Comprehensive Income (Loss) for the three and ~~six~~nine months ended ~~June~~September 30, were as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
	(in thousands)
Premiums:
Direct	$	59,724	$	62,203	$	187,332	$	187,147

Ceded	(54,138)		(59,104)		(171,423)		(177,429)
Net premiums	5,586		3,099		15,909		9,718
Policy charges and fee income:
Direct	101,644		96,550		305,653		309,054

Ceded(1)	(87,021)		(86,206)		(248,818)		(256,256)
Net policy charges and fee income	14,623		10,344		56,835		52,798
Net investment income:
Direct	23,433		18,232		61,499		56,775

Ceded	(173)		(173)		(591)		(503)
Net investment income	23,260		18,059		60,908		56,272
Asset administration fees:
Direct	10,196		9,761		29,211		28,034

Ceded	(8,440)		(8,261)		(24,344)		(23,742)
Net asset administration fees	1,756		1,500		4,867		4,292






Realized investment gains (losses), net:
Direct	250,085		(231,963)		(672,787)		(459,863)

Ceded	(247,550)		234,682		680,875		451,416
Realized investment gains (losses), net	2,535		2,719		8,088		(8,447)
Policyholders’ benefits (including change in reserves):
Direct	91,346		157,537		348,921		360,844

Ceded(2)	(90,119)		(155,140)		(317,565)		(338,119)
Net policyholders’ benefits (including change in reserves)	1,227		2,397		31,356		22,725
Interest credited to policyholders’ account balances:
Direct	20,388		22,351		58,707		54,839

Ceded	(9,552)		(8,592)		(25,693)		(22,022)
Net interest credited to policyholders’ account balances	10,836		13,759		33,014		32,817
Reinsurance expense allowances and general and administrative expenses, net of capitalization and amortization	(50,216)		(48,298)		(149,912)		(145,971)

Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
(in thousands)
Premiums:
Direct $ 62,975
$ 61,930
$ 127,608
$ 124,944
Ceded (57,846 ) (58,649 ) (117,285 ) (118,325 )
Net premiums 5,129
3,281
10,323
6,619
Policy charges and fee income:
Direct 94,937
118,884
204,009
212,504
Ceded(1) (76,694 ) (96,279 ) (161,797 ) (170,050 )
Net policy charges and fee income 18,243
22,605
42,212
42,454
Net investment income:
Direct 20,874
19,634
38,066
38,543
Ceded (191 ) (162 ) (418 ) (330 )
Net investment income 20,683
19,472
37,648
38,213
Asset administration fees:
Direct 9,290
9,394
19,015
18,273
Ceded (7,744 ) (7,945 ) (15,904 ) (15,481 )
Net asset administration fees 1,546
1,449
3,111
2,792
Realized investment gains (losses), net:
Direct 146,576
(165,057 ) (922,872 ) (227,900 )
Ceded (154,088 ) 160,001
928,425
216,734
Realized investment gains (losses), net (7,512 ) (5,056 ) 5,553
(11,166 )
Policyholders’ benefits (including change in reserves):
Direct 126,289
131,279
257,575
203,307
Ceded(2) (112,846 ) (120,928 ) (227,446 ) (182,979 )
Net policyholders’ benefits (including change in reserves) 13,443
10,351
30,129
20,328
Interest credited to policyholders’ account balances:
Direct 16,061
17,271
38,319
32,488
Ceded (4,074 ) (7,266 ) (16,141 ) (13,430 )
Net interest credited to policyholders’ account balances 11,987
10,005
22,178
19,058
Reinsurance expense allowances and general and administrative expenses, net of capitalization and amortization (24,163 ) (58,171 ) (99,696 ) (97,673 )
(1)Includes $(4.0) million and $0 millionof unaffiliated activity for the three months ended September 30, 2020 and 2019, respectively, and $(4.0) million and $(4) million for the nine months ended September 30, 2020 and 2019, respectively.

(2)Includes $(3.4) million and $(3.0) million of unaffiliated activity for the three months ended September 30, 2020 and 2019, respectively, and $(1.9) million and $(1.0) million for the nine months ended September 30, 2020 and 2019, respectively.


~~(1)~~	~~Includes $0.0 million~~ ~~and~~ ~~$(4.0) millionof unaffiliated activity for the three months ended June 30, 2020 and 2019, respectively, and $0.0 million and $(4.0) million for the six months ended June 30, 2020 and 2019, respectively.~~


~~(2)~~	~~Includes $0.5 million~~ ~~and~~ ~~$1.0 million of unaffiliated activity for the three months ended June 30, 2020 and 2019, respectively, and $1.5 million and $2.0 million for the six months ended June 30, 2020 and 2019, respectively.~~

~~Table of Contents~~

~~PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY~~

~~Notes to Unaudited Interim Financial Statements—(Continued)~~

The gross and net amounts of life insurance face amount in force as of ~~June~~September 30, 2020 and 2019 were as follows:


	2020		2019
	(in thousands)
Direct gross life insurance face amount in force	$	152,707,454	$	146,659,725
Reinsurance ceded	(138,917,401)		(133,731,588)
Net life insurance face amount in force	$	13,790,053	$	12,928,137

2020 2019
(in thousands)
Direct gross life insurance face amount in force $ 151,576,594
$ 145,001,035
Reinsurance ceded (138,189,156 ) (132,123,416 )
Net life insurance face amount in force $ 13,387,438
$ 12,877,619

Table of Contents


PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Information regarding significant affiliated reinsurance agreements is described below.

Prudential Insurance

The Company has a yearly renewable term reinsurance agreement with Prudential Insurance and reinsures the majority of all mortality risks not otherwise reinsured. Effective July 1, 2017, this agreement was terminated for certain new business, primarily Universal Life business, and such business was reinsured to Pruco Life under a yearly renewable term reinsurance agreement. As of January 1, 2020, the remaining portions of new business (specifically Term policies) ceased being reinsured by the Company to Prudential Insurance, and a separate yearly renewable term reinsurance agreement was established with Pruco Life for Term policies. Effective April 1, 2016, the Company entered into a reinsurance agreement with Prudential Insurance to reinsure its variable annuity base contracts, along with the living benefit guarantees.

PAR U

Effective July 1, 2012, the Company reinsures an amount equal to 95% of all risks associated with Universal Protector policies having no-lapse guarantees as well as certain of its universal policies, excluding those policies that are subject to principle-based reserving.

PARCC

The Company reinsures 90% of the risks under its term life insurance policies with effective dates prior to January 1, 2010 through an automatic coinsurance agreement with PARCC.

PAR Term

The Company reinsures 95% of the risks under its term life insurance policies, with effective dates January 1, 2010 through December 31, 2013, through an automatic coinsurance agreement with PAR Term.

Term Re

The Company reinsures 95% of the risks under its term life insurance policies with effective dates on or after January 1, 2014 through December 31, 2017, through an automatic coinsurance agreement with Term Re.

Pruco Life

Effective July 1, 2017, the Company entered into a yearly renewable term reinsurance agreement with Pruco Life for new business, primarily covering Universal Life policies. Effective January 1, 2020, the Company entered in a similar yearly renewable term reinsurance agreement with Pruco Life for new business relating to Term policies. Under these agreements the majority of all mortality risk is ceded to Pruco Life. The Company also reinsures certain Corporate Owned Life Insurance (“COLI”) policies with Pruco Life. Through March 31, 2016, the Company reinsured Prudential Defined Income ("PDI") living benefit guarantees with Pruco Life. Effective April 1, 2016, the Company recaptured PDI living benefit guarantees from Pruco Life and reinsured them, together with the related variable annuity base contracts, with Prudential Insurance.

~~Table of Contents~~

~~PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY~~

~~Notes to Unaudited Interim Financial Statements—(Continued)~~

DART

Effective January 1, 2018, the Company entered into an automatic coinsurance agreement with DART to reinsure an amount equal to 95% of the risks associated with its term life insurance policies with effective dates on or after January 1, 2018 through December 31, 2019, excluding those policies that are subject to principle-based reserving.

Table of Contents


PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

7. INCOME TAXES

The Company uses a ~~full year~~full-year projected effective tax rate approach to calculate year-to-date taxes. In addition, certain items impacting total income tax expense are recorded in the periods in which they occur. The projected effective tax rate is the ratio of projected “Income tax expense (benefit)” divided by projected “Income (loss) from operations before income taxes". The interim period tax expense (or benefit) is the difference between the year-to-date income tax provision and the amounts reported for the previous interim periods of the fiscal year.

The Company's income tax provision amounted to an income tax benefit of ~~$(6.7)~~$(5.4) million, or ~~(36.98)~~(14.15)% of income (loss) from operations before income taxes in the first ~~six~~nine months of 2020, compared to ~~$(0.2)~~an income tax expense of $0.0 million, or ~~(1.10)%~~0.06%, in the first ~~six~~nine months of 2019. The Company’s current and prior effective tax rates differed from the U.S. statutory tax rate of 21% primarily due to non-taxable investment income, tax credits, and ~~tax credits.~~the item discussed below.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was enacted into law. One provision of the CARES Act amends the Tax Cuts and Jobs Act (“TCJA”) and allows companies with net operating losses (“NOLs”) originating in 2018, 2019 or 2020 to carry back those losses for five years. The Company has incorporated into the full year projected effective tax rate an income tax benefit of $7$5 million that would result from carrying the estimated 2020 NOL back to tax years that have a 35% tax rate. This amount is an estimate and will change if the amount of, and sources of, 2020 net taxable income are different from forecast.

4443

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

8. EQUITY

Accumulated Other Comprehensive Income (Loss)

AOCI represents the cumulative OCI items that are reported separate from net income and detailed on the Unaudited Interim Statements of Comprehensive Income. The balance of and changes in each component of AOCI as of and for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, are as follows:


	Accumulated Other Comprehensive Income (Loss)
	Foreign Currency Translation Adjustment		Net Unrealized Investment Gains (Losses)(1)		Total Accumulated Other Comprehensive Income (Loss)
	(in thousands)
Balance, December 31, 2019	$	(981)	$	86,616	$	85,635
Change in OCI before reclassifications	133		91,833		91,966
Amounts reclassified from AOCI	0		(783)		(783)
Income tax benefit (expense)	(28)		(19,121)		(19,149)
Balance, September 30, 2020	$	(876)	$	158,545	$	157,669


	Accumulated Other Comprehensive Income (Loss)
	Foreign Currency Translation Adjustment		Net Unrealized Investment Gains (Losses)(1)		Total Accumulated Other Comprehensive Income (Loss)
	(in thousands)
Balance, December 31, 2018	$	(989)	$	(13,378)	$	(14,367)
Change in OCI before reclassifications	(60)		125,543		125,483
Amounts reclassified from AOCI	0		7,999		7,999
Income tax benefit (expense)	13		(28,044)		(28,031)
Balance, September 30, 2019	$	(1,036)	$	92,120	$	91,084

Accumulated Other Comprehensive Income (Loss)
Foreign Currency Translation Adjustment
Net Unrealized
Investment Gains
(Losses)(1)
Total Accumulated Other Comprehensive Income (Loss)
(in thousands)
Balance, December 31, 2018 $ (989 ) $ (13,378 ) $ (14,367 )
Change in OCI before reclassifications 4
88,557
88,561
Amounts reclassified from AOCI 0
4,304
4,304
Income tax benefit (expense) (1 ) (19,500 ) (19,501 )
Balance, June 30, 2019 $ (986 ) $ 59,983
$ 58,997
(1)Includes cash flow hedges of $7 million and $3 million as of September 30, 2020 and December 31, 2019, respectively, and $8 million and $2 million as of September 30, 2019 and December 31, 2018, respectively.


~~(1)~~	Includes cash flow hedges of $14 million and $3 million as of June 30, 2020 and December 31, 2019, respectively, and $3 million and $2 million as of June 30, 2019 and December 31, 2018, respectively.

Reclassifications out of Accumulated Other Comprehensive Income (Loss)


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
	(in thousands)
Amounts reclassified from AOCI (1)(2):
Net unrealized investment gains (losses):
Cash flow hedges - Currency/ Interest rate(3)	$	(384)	$	(1,405)	$	1,289	$	(2,230)
Net unrealized investment gains (losses) on available-for-sale securities	137		(2,290)		(506)		(5,769)
Total net unrealized investment gains (losses)(4)	(247)		(3,695)		783		(7,999)
Total reclassifications for the period	$	(247)	$	(3,695)	$	783	$	(7,999)

(1)All amounts are shown before tax.

(2)Positive amounts indicate gains/benefits reclassified out of AOCI. Negative amounts indicate losses/costs reclassified out of AOCI.

(3)See Note 4 for additional information on cash flow hedges.

(4)See table below for additional information on unrealized investment gains (losses), including the impact on DAC and other costs, future policy benefits, policyholders’ account balances and other liabilities.

Three Months Ended
June 30, Six Months Ended
June 30,
2020 2019 2020 2019
(in thousands)
Amounts reclassified from AOCI (1)(2):
Net unrealized investment gains (losses):
Cash flow hedges - Currency/ Interest rate(3) $ 164
$ (646 ) $ 1,673
$ (825 )
Net unrealized investment gains (losses) on available-for-sale securities (41 ) (384 ) (643 ) (3,479 )
Total net unrealized investment gains (losses)(4) 123
(1,030 ) 1,030
(4,304 )
Total reclassifications for the period $ 123
$ (1,030 ) $ 1,030
$ (4,304 )

Table of Contents


~~(1)~~			~~All amounts are shown before tax.~~


~~(2)~~	~~Positive amounts indicate gains/ benefits reclassified out of AOCI. Negative amounts indicate losses/ costs reclassified out of AOCI.~~


~~(3)~~	~~See Note 4 for additional information on cash flow hedges.~~


~~(4)~~	See table below for additional information on unrealized investment gains (losses), including the impact on DAC and other costs, future policy benefits, policyholders’ account balances and other liabilities.

~~Table of Contents~~



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Net Unrealized Investment Gains (Losses)

Net unrealized investment gains (losses) on available-for-sale fixed maturity securities and certain other invested assets and other assets are included in the Company’s Unaudited Interim Statements of Financial Position as a component of AOCI. Changes in these amounts include reclassification adjustments to exclude from OCI those items that are included as part of “Net income” for a period that had been part of OCI in earlier periods. ~~The amounts for the periods indicated below, split between~~There are no amounts related to available-for-sale fixed maturity securities on which an allowance for credit losses has been recognized ~~and~~as of September 30, 2020. The amounts for the periods indicated below represent all other net unrealized investment gains (losses)~~, are as follows:~~:

~~Net Unrealized Investment Gains (Losses) on Available-for-Sale Fixed Maturity Securities on which an allowance for credit losses has been recognized~~

Net Unrealized Gains (Losses) on
Investments DAC and Other Costs(2) Future Policy Benefits, Policyholders' Account Balances and Other Liabilities(3)
Deferred
Income Tax
(Liability)
Benefit

Accumulated Other Comprehensive
Income (Loss) Related To Net Unrealized Investment Gains (Losses)
(in thousands)
Balance, December 31, 2019(1) $ 0
$ 0
$ 0
$ 0
$ 0
Net investment gains (losses) on investments arising during the period 0
0
0
0
0
Reclassification adjustment for (gains) losses included in net income 0
0
0
0
0
Increase (decrease) due to non-credit related losses recognized in AOCI during the period 0
0
0
0
0
Impact of net unrealized investment (gains) losses on DAC and other costs 0
4
0
(1 ) 3
Impact of net unrealized investment (gains) losses on future policy benefits, policyholders' account balances and other liabilities 0
0
50
(10 ) 40
Balance, June 30, 2020 $ 0
$ 4
$ 50
$ (11 ) $ 43


~~(1)~~	~~Allowance for credit losses on available-for-sale fixed maturity securities effective January 1, 2020.~~


~~(2)~~	~~"Other costs" primarily includes reinsurance recoverables and deferred reinsurance losses.~~


~~(3)~~	~~"Other liabilities" primarily includes reinsurance payables.~~

~~Table of Contents~~

~~PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY~~

~~Notes to Unaudited Interim Financial Statements—(Continued)~~

All Other Net Unrealized Investment Gains (Losses) in AOCI


	Net Unrealized Gains (Losses) on Investments(1)		DAC and Other Costs(3)		Future Policy Benefits, Policyholders' Account Balances and Other Liabilities(4)		Deferred Income Tax (Liability) Benefit		Accumulated Other Comprehensive Income (Loss) Related To Net Unrealized Investment Gains (Losses)
	(in thousands)
Balance, December 31, 2019(2)	$	116,039	$	8,973	$	(15,373)	$	(23,023)	$	86,616
Net investment gains (losses) on investments arising during the period	100,965		0		0		(21,203)		79,762
Reclassification adjustment for (gains) losses included in net income	(783)		0		0		164		(619)

Impact of net unrealized investment (gains) losses on DAC and other costs	0		18,403		0		(3,865)		14,538
Impact of net unrealized investment (gains) losses on future policy benefits, policyholders' account balances and other liabilities	0		0		(27,535)		5,783		(21,752)
Balance, September 30, 2020	$	216,221	$	27,376	$	(42,908)	$	(42,144)	$	158,545

Net Unrealized Gains (Losses) on
Investments(1)
DAC and Other Costs(3) Future Policy Benefits, Policyholders' Account Balances and Other Liabilities(4)
Deferred
Income Tax
(Liability)
Benefit
Accumulated Other Comprehensive
Income (Loss) Related To Net Unrealized Investment Gains (Losses)
(in thousands)
Balance, December 31, 2019(2) $ 116,039
$ 8,973
$ (15,373 ) $ (23,023 ) $ 86,616
Net investment gains (losses) on investments arising during the period 83,683
0
0
(17,574 ) 66,109
Reclassification adjustment for (gains) losses included in net income (1,030 ) 0
0
216
(814 )
Reclassification due to allowance for credit losses recorded during the period 0
0
0
0
0
Impact of net unrealized investment (gains) losses on DAC and other costs 0
15,723
0
(3,302 ) 12,421
Impact of net unrealized investment (gains) losses on future policy benefits, policyholders' account balances and other liabilities 0
0
(21,971 ) 4,614
(17,357 )
Balance, June 30, 2020 $ 198,692
$ 24,696
$ (37,344 ) $ (39,069 ) $ 146,975


~~(1)~~	~~Includes cash flow hedges. See Note 4 for information on cash flow hedges.~~


~~(2)~~	~~Includes net unrealized gains (losses) for which an OTTI loss had been previously recognized.~~


~~(3)~~	~~"Other costs" primarily includes reinsurance recoverables and deferred reinsurance losses.~~


~~(4)~~	~~"Other liabilities" primarily includes reinsurance payables.~~

(1)Includes cash flow hedges. See Note 4 for information on cash flow hedges.

(2)Includes net unrealized gains (losses) for which an OTTI loss had been previously recognized.

(3)"Other costs" primarily includes reinsurance recoverables and deferred reinsurance losses.

(4)"Other liabilities" primarily includes reinsurance payables.

9. RELATED PARTY TRANSACTIONS

The Company has extensive transactions and relationships with Prudential Insurance and other affiliates. Although we seek to ensure that these transactions and relationships are fair and reasonable, it is possible that the terms of these transactions are not the same as those that would result from transactions among unrelated parties.

Expense Charges and Allocations

The majority of the Company’s expenses are allocations or charges from Prudential Insurance or other affiliates. These expenses can be grouped into general and administrative expenses and agency distribution expenses.

Table of Contents


PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

The Company’s general and administrative expenses are charged to the Company using allocation methodologies based on business production processes. Management believes that the methodology is reasonable and reflects costs incurred by Prudential Insurance to process transactions on behalf of the Company. The Company operates under service and lease agreements whereby services of officers and employees, supplies, use of equipment and office space are provided by Prudential Insurance. The Company reviews its allocation methodology periodically which it may adjust accordingly. General and administrative expenses include allocations of stock compensation expenses related to a stock-based awards program and a deferred compensation program issued by Prudential Financial. The expense charged to the Company for the stock-based awards program was $0.0 million ~~and $0.1 million~~ for both the three months ended ~~June~~September 30, 2020 and 2019, ~~respectively,~~ and $0.1 million for both the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019. The expense charged to the Company for the deferred compensation program was ~~$0.0~~$0.2 million and $0.1 million for the three months ended ~~June~~September 30, 2020 and 2019, respectively, and ~~$0.3 million and $0.4~~$0.5 million for both the ~~six~~nine months ended ~~June~~September 30, 2020 and ~~2019, respectively.~~2019.

The Company is charged for its share of employee benefit expenses. These expenses include costs for funded and non-funded, non-contributory defined benefit pension plans. Some of these benefits are based on final earnings and length of service while others are based on an account balance, which takes into consideration age, service and earnings during a career. The Company’s share of net expense for the pension plans was ~~$0.4~~$0.5 million and $0.6 million for the three months ended ~~June~~September 30, 2020 and 2019, respectively, and ~~$1.0~~$1.5 million and ~~$1.1~~$1.7 million for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively.

~~Table of Contents~~

~~PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY~~

~~Notes to Unaudited Interim Financial Statements—(Continued)~~

The Company is also charged for its share of the costs associated with welfare plans issued by Prudential Insurance. These expenses include costs related to medical, dental, life insurance and disability. The Company's share of net expense for the welfare plans was ~~$0.4~~$0.5 million and $0.7 million for the three months ended ~~June~~September 30, 2020 and 2019, respectively, and ~~$1.1~~$1.6 million and ~~$1.4~~$2.1 million for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively.

Prudential Insurance sponsors voluntary savings plans for its employee 401(k) plans. The plans provide for salary reduction contributions by employees and matching contributions by the Company of up to 4% of annual salary. The Company’s expense for its share of the voluntary savings plan was $0.2 million and $0.3 million for the three months ended ~~June~~September 30, 2020 and 2019, respectively, and ~~$0.4~~$0.6 million and ~~$0.5~~$0.8 million for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively.

The Company is charged distribution expenses from Prudential Insurance’s agency network for both its domestic life and annuity products through a transfer pricing agreement, which is intended to reflect a market-based pricing arrangement.

The Company pays commissions and certain other fees to Prudential Annuities Distributors, Inc. (“PAD”) in consideration for PAD’s marketing and underwriting of the Company’s annuity products. Commissions and fees are paid by PAD to broker-dealers who sell the Company’s annuity products. Commissions and fees paid by the Company to PAD were $12 million and ~~$20~~$21 million for the three months ended ~~June~~September 30, 2020 and 2019, respectively, and ~~$29~~$41 million and ~~$39~~$60 million for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively.

The Company is charged for its share of corporate expenses incurred by Prudential Financial to benefit its businesses, such as advertising, executive oversight, external affairs and philanthropic activity. The Company’s share of corporate expenses was ~~$1 million and~~ $2 million for both the three months ended ~~June~~September 30, 2020 and 2019, ~~respectively,~~ and $3$5 million and $4$6 million for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively.

Corporate-Owned Life Insurance

The Company has sold 3 Corporate-Owned Life Insurance ("COLI") policies to Prudential Insurance and 1 to Prudential Financial. The cash surrender value included in separate accounts for these COLI policies was ~~$2,694~~$2,852 million at ~~June~~September 30, 2020 and $2,743 million at December 31, 2019. Fees related to these COLI policies were $7 million and $6 million for ~~both~~ the three months ended ~~June~~September 30, 2020 and 2019, respectively, and ~~$14~~$21 million and ~~$13~~$20 million for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively. The Company retains 10% of the mortality risk associated with these COLI policies up to $0.1 million per individual policy.

Table of Contents


PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Affiliated Investment Management Expenses

In accordance with an agreement with PGIM, Inc. (“PGIM”), the Company pays investment management expenses to PGIM who acts as investment manager to certain Company general account and separate account assets. Investment management expenses paid to PGIM related to this agreement were ~~$0.7~~$0.8 million and $0.6 million for the three months ended ~~June~~September 30, 2020 and 2019, respectively, and ~~$1.3~~$2.1 million and ~~$1.1~~$1.7 million for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively. These expenses are recorded as “Net investment income” in the Company's Unaudited Interim Statements of Operations and Comprehensive Income (Loss).

Derivative Trades

In its ordinary course of business, the Company enters into OTC derivative contracts with an affiliate, PGF. For these OTC derivative contracts, PGF has a substantially equal and offsetting position with an external counterparty. See Note 4 for additional information.

Joint Ventures

The Company has made investments in joint ventures with certain subsidiaries of Prudential Financial. "Other invested assets" includes $39 million and $37 million as of ~~June~~September 30, 2020 and December 31, ~~2019.~~2019, respectively. "Net investment income" related to these ventures includes a gain of ~~$2.0~~$2.1 million and ~~$0.8~~$0.0 million for the three months ended ~~June~~September 30, 2020 and 2019, respectively, and a gain of ~~$0.3~~$2.4 million and ~~$2.1~~$2.2 million for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively.

~~Table of Contents~~

~~PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY~~

~~Notes to Unaudited Interim Financial Statements—(Continued)~~

Affiliated Asset Administration Fee Income

The Company has a revenue sharing agreement with AST Investment Services, Inc. ("ASTISI") and PGIM Investments LLC ("PGIM Investments") whereby the Company receives fee income based on policyholders' separate account balances invested in the Advanced Series Trust. Income received from ASTISI and PGIM Investments related to this agreement was $8 million for both the three months ended ~~June~~September 30, 2020 and 2019, and ~~$16 million and $15~~$24 million for both the ~~six~~nine months ended ~~June~~September 30, 2020 and ~~2019, respectively.~~2019. These revenues are recorded as “Asset administration fees” in the Company's Unaudited Interim Statements of Operations and Comprehensive Income (Loss).

The Company has a revenue sharing agreement with PGIM Investments, whereby the Company receives fee income based on policyholders' separate account balances invested in The Prudential Series Fund. Income received from PGIM Investments related to this agreement was $2 million and $1 million for ~~both~~ the three months ended ~~June~~September 30, 2020 and 2019, respectively, and $3$5 million and $4 million for ~~both~~ the ~~six~~nine months ended ~~June~~September 30, 2020 and ~~2019.~~2019, respectively. These revenues are recorded as “Asset administration fees” in the Company’s Unaudited Interim Statements of Operations and Comprehensive Income (Loss).

Affiliated Notes Receivable

Affiliated notes receivable included in “Receivables from parent and affiliates” at ~~June~~September 30, 2020 and December 31, 2019 were as follows:


	Maturity Date		Interest Rates				September 30, 2020		December 31, 2019
							(in thousands)

U.S. dollar fixed rate notes		2027	0.00%	-	14.85	%	$	808	$	2,433
Total notes receivable - affiliated(1)							$	808	$	2,433

Maturity Dates Interest Rates June 30, 2020 December 31, 2019
(in thousands)
U.S. dollar fixed rate notes 2026 - 2027 0.00% - 14.85 % $ 2,316
$ 2,433
Total notes receivable - affiliated(1) $ 2,316
$ 2,433

(1) All notes receivable may be called for prepayment prior to the respective maturity dates under specified circumstances.


~~(1)~~	~~All notes receivable may be called for prepayment prior to the respective maturity dates under specified circumstances.~~

The affiliated notes receivable shown above are classified as available-for-sale securities and other trading assets carried at fair value. The Company monitors the internal and external credit ratings of these loans and loan performance. The Company also considers any guarantees made by Prudential Insurance for loans due from affiliates.

Table of Contents


PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Accrued interest receivable related to these loans was $0.0 million at both ~~June~~September 30, 2020 and December 31, 2019 and is included in “Other assets”. Revenues related to these assets were $0.0 million and $0.1 million for the three months ended ~~June~~September 30, 2020 and 2019, respectively, and $0.1 million for both the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, and are included in “Other income”.

Affiliated Asset Transfers

The Company participates in affiliated asset trades with parent and sister companies. Book and market value differences for trades with a parent and sister are recognized within "Additional paid-in capital" (“APIC”) and "Realized investment gains (losses), net", respectively. The table below shows affiliated asset trades for the ~~six~~nine months ended ~~June~~September 30, 2020 and for the year ended December 31, 2019.


Affiliate	Date	Transaction	Security Type	Fair Value		Book Value		APIC, Net of Tax Increase/(Decrease)		Realized Investment Gain (Loss)
				(in thousands)
Prudential Annuities Life Assurance Corporation	April 2019	Sale	Equity Securities	$	3,293	$	2,995	$	0	$	298
Prudential Insurance	April 2020	Purchase	Fixed Maturities	$	3,485	$	3,320	$	(130)	$	0

Affiliate Date Transaction Security Type Fair Value Book Value APIC, Net of Tax Increase/(Decrease)
Realized
Investment
Gain (Loss)
(in thousands)
Prudential Annuities Life Assurance Corporation April 2019 Sale Equity Securities $ 3,293
$ 2,995
$ 0
$ 298
Prudential Insurance April 2020 Purchase Fixed Maturities $ 3,485
$ 3,320
$ (130 ) $ 0

Debt Agreements

The Company is authorized to borrow funds up to $200 million from affiliates to meet its capital and other funding needs. As of ~~June~~September 30, 2020 there was 0 debt outstanding. The short-term debt was $0.1 million as of December 31, 2019.

~~Table of Contents~~

~~PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY~~

~~Notes to Unaudited Interim Financial Statements—(Continued)~~

The total interest expense to the Company related to loans payable to affiliates was $0.0 million and $0.1 million for ~~both~~ the three months ended ~~June~~September 30, 2020 and 2019, respectively, and $0.0 million and $0.1 million for ~~both~~ the ~~six~~nine months ended ~~June~~September 30, 2020 and ~~2019.~~2019, respectively.

Contributed Capital and Dividends

In March 2020, the Company received a capital contribution in the amount of $85 million from Pruco Life. In December 2019, the Company received a capital contribution in the amount of $60 million from Pruco Life.

Through ~~June~~September 2020, the Company did 0t pay any dividends. In 2019, the Company did 0t pay any dividends to Pruco Life.

Reinsurance with Affiliates

As discussed in Note 6, the Company participates in reinsurance transactions with certain affiliates.

Table of Contents


PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

10. COMMITMENTS AND CONTINGENT LIABILITIES

Commitments

The Company has made commitments to fund commercial mortgage loans. As of ~~June~~September 30, 2020 and December 31, 2019, the outstanding balances on these commitments were $1$0.4 million and $4 million, respectively. The above amount includes unfunded commitments that are not unconditionally cancellable. For related credit exposure, there was an allowance for credit losses of ~~$0.0~~$0.0 million as of ~~June~~September 30, 2020, which is a ~~change~~change of $0.0 million for the three and ~~six~~nine months ended ~~June~~September 30, 2020. The Company has made commitments to purchase or fund investments, mostly private fixed maturities. As of ~~June~~September 30, 2020 and December 31, 2019, ~~$63~~$70 million and $48 million, respectively, of these commitments were outstanding. The above amount includes unfunded commitments that are not unconditionally cancellable. There were 0 related charges for credit losses for both the three and ~~six~~nine months ended ~~June~~September 30, 2020.

Contingent Liabilities

On an ongoing basis, the Company and its regulators review its operations including, but not limited to, sales and other customer interface procedures and practices, and procedures for meeting obligations to its customers and other parties. These reviews may result in the modification or enhancement of processes or the imposition of other action plans, including concerning management oversight, sales and other customer interface procedures and practices, and the timing or computation of payments to customers and other parties. In certain cases, if appropriate, the Company may offer customers or other parties remediation and may incur charges, including the cost of such remediation, administrative costs and regulatory fines.

The Company is subject to the laws and regulations of states and other jurisdictions concerning the identification, reporting and escheatment of unclaimed or abandoned funds, and is subject to audit and examination for compliance with these requirements.

For additional discussion of these matters, see “Litigation and Regulatory Matters” below.

It is possible that the results of operations or the cash flows of the Company in a particular quarterly or annual period could be materially affected as a result of payments in connection with the matters discussed above or other matters depending, in part, upon the results of operations or cash flows for such period. Management believes, however, that ultimate payments in connection with these matters, after consideration of applicable reserves and rights to indemnification, should not have a material adverse effect on the Company’s financial position.

~~Table of Contents~~

~~PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY~~

~~Notes to Unaudited Interim Financial Statements—(Continued)~~

Litigation and Regulatory Matters

The Company is subject to legal and regulatory actions in the ordinary course of its business. Pending legal and regulatory actions include proceedings specific to the Company and proceedings generally applicable to business practices in the industry in which it operates. The Company is subject to class action lawsuits and other litigation involving a variety of issues and allegations involving sales practices, claims payments and procedures, premium charges, policy servicing and breach of fiduciary duty to customers. The Company is also subject to litigation arising out of its general business activities, such as its investments, contracts, leases and labor and employment relationships, including claims of discrimination and harassment, and could be exposed to claims or litigation concerning certain business or process patents. In addition, the Company, along with other participants in the businesses in which it engages, may be subject from time to time to investigations, examinations and inquiries, in some cases industry-wide, concerning issues or matters upon which such regulators have determined to focus. In some of the Company’s pending legal and regulatory actions, parties are seeking large and/or indeterminate amounts, including punitive or exemplary damages. The outcome of litigation or a regulatory matter, and the amount or range of potential loss at any particular time, is often inherently uncertain.

The Company establishes accruals for litigation and regulatory matters when it is probable that a loss has been incurred and the amount of that loss can be reasonably estimated. For litigation and regulatory matters where a loss may be reasonably possible, but not probable, or is probable but not reasonably estimable, no accrual is established, but the matter, if material, is disclosed. The Company estimates that as of ~~June~~September 30, 2020, the aggregate range of reasonably possible losses in excess of accruals established for those litigation and regulatory matters for which such an estimate currently can be made is less ~~than~~than $10 million. This estimate is not an indication of expected loss, if any, or the Company's maximum possible loss exposure on such matters. The Company reviews relevant information with respect to its litigation and regulatory matters on a quarterly and annual basis and updates its accruals, disclosures and estimates of reasonably possible loss based on such reviews.

Table of Contents


PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

The following discussion of litigation and regulatory matters provides an update of those matters discussed in Note 14 to the Company's Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2019, and should be read in conjunction with the complete descriptions provided in the Form 10-K.

Behfarin v. Pruco Life

In June 2020, the court issued an order: (i) granting plaintiffs’ motion for certification of the settlement class; (ii) approving the proposed nationwide class settlement agreement; (iii) approving the class notice; (iv) awarding attorneys’ fees and costs to plaintiffs and a reduced incentive award to Behfarin; and (v) dismissing the action with prejudice, but maintaining jurisdiction over the settlement.

Summary

The Company’s litigation and regulatory matters are subject to many uncertainties, and given their complexity and scope, their outcome cannot be predicted. It is possible that the Company’s results of operations or cash flows in a particular quarterly or annual period could be materially affected by an ultimate unfavorable resolution of pending litigation and regulatory matters depending, in part, upon the results of operations or cash flows for such period. In light of the unpredictability of the Company’s litigation and regulatory matters, it is also possible that in certain cases an ultimate unfavorable resolution of one or more pending litigation or regulatory matters could have a material adverse effect on the Company’s financial position. Management believes, however, that, based on information currently known to it, the ultimate outcome of all pending litigation and regulatory matters, after consideration of applicable reserves and rights to indemnification, is not likely to have a material adverse effect on the Company’s financial position.

Table of Contents


PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

11. REVISION TO PRIOR YEAR INFORMATION

Revision to 2019 Financial Statements

The Company identified an error in the presentation of certain cash flow activity related to policyholders' account balances that impacted several line items within previously issued Statements of Cash Flows. While these items affect the cash flows from operating and financing activities, they had no impact on the net increase (decrease) in cash and cash equivalents for the previously reported periods. Prior period amounts have been revised in the financial statements to correct this error as shown below.

~~Table of Contents~~

~~PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY~~

~~Notes to Unaudited Interim Financial Statements—(Continued)~~

Management assessed the materiality of the misstatement described above on prior period financial statements in accordance with SEC Staff Accounting Bulletin ("SAB") No. 99, Materiality, codified in ASC 250-10, Accounting Changes and Error Corrections ("ASC 250"), and concluded that these misstatements were not material to any prior annual or interim periods. Accordingly, in accordance with ASC 250 (SAB No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements), the financial statements for the ~~six~~nine months ended ~~June~~September 30, 2019, which are presented herein, have been revised. Similarly, impacted prior periods presented within the ~~Quarterly Report on Form 10-Q for the period ended September 30, 2020 and~~ Annual Report on Form 10-K for the year ended December 31, 2020 will be revised.

The following are selected line items from the financial statements illustrating the effects of these revisions:

Statements of Cash Flows


	Nine Months Ended September 30, 2019
	As Previously Reported		Revision		As Revised
	(in thousands)
CASH FLOWS FROM OPERATING ACTIVITIES:
Policy charges and fee income	$	(37,295)	$	23,421	$	(13,874)
Cash flows from (used in) operating activities	(6,247)		23,421		17,174
CASH FLOWS FROM FINANCING ACTIVITIES:
Policyholders' account withdrawals	(248,126)		(15,815)		(263,941)
Other, net	0		(7,606)		(7,606)
Cash flows from (used in) financing activities	80,929		(23,421)		57,508

Six Months Ended June 30, 2019

As Previously Reported
Revision
As Revised

(in thousands)
CASH FLOWS FROM OPERATING ACTIVITIES:

Policy charges and fee income $ (25,026 )
$ 15,958

$ (9,068 )
Cash flows from (used in) operating activities (2,993 )
15,958

12,965
CASH FLOWS FROM FINANCING ACTIVITIES:

Policyholders' account withdrawals (162,051 )
(11,023 )
(173,074 )
Other, net 0

(4,935 )
(4,935 )
Cash flows from (used in) financing activities 61,354

(15,958 )
45,396

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) addresses the financial condition of Pruco Life Insurance Company of New Jersey, or the “Company,” as of ~~June~~September 30, 2020, compared with December 31, 2019, and its results of operations for the three and ~~six~~nine months ended ~~June~~September 30, 2020 and 2019. You should read the following analysis of our financial condition and results of operations in conjunction with the MD&A, the “Risk Factors” section, and the audited Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, as well as the statements under “Forward-Looking Statements”, the "Risk Factors" section and the Unaudited Interim Financial Statements included elsewhere in this Quarterly Report on Form 10-Q.

Overview

The Company sells variable annuities, universal life insurance, variable life insurance and term life insurance in New Jersey and New York only and sells such products primarily through affiliated and unaffiliated distributors.

COVID-19

Beginning in the first quarter of 2020, the outbreak of the 2019 novel coronavirus (“COVID-19”) created extreme stress and disruption in the global economy and financial markets and elevated mortality and morbidity experience for the global population. These events impacted our results of operations in the current period and are expected to drive future impacts to our results of operations. The Company has taken several measures to manage the impacts of this crisis. The actual and expected impacts of these events and other items are included in the following update:

•

•Outlook. We expect COVID-19 to continue to contribute to elevated levels of mortality, resulting in increased life insurance claims in the near-term. We have taken pricing and product actions to ensure we realize appropriate returns for the current economic environment, and to diversify our product mix to further limit our sensitivity to interest rates, while maintaining a solid value proposition for our customers. These actions included the suspension in July 2020 of our single life guaranteed universal life product, and a pivot to less rate-sensitive annuities products with the decision to discontinue sales of traditional variable annuities with guaranteed living benefits effective December 31, 2020. In addition, while our distribution platforms include a suite of digital, hybrid, and in-person options, mandated social distancing has limited in-person engagement between customers and financial professionals. Collectively, we expect the product actions we have taken and the constrained distribution environment to adversely impact our sales prospects in the near-term.

•Results of Operations. For the three months and nine months ended September 30, 2020 we reported a net gain of $19 million and $44 million, respectively, inclusive of the unfavorable financial market conditions that impacted our reported results. See “Results of Operations” for a discussion of results for the third quarter and the first nine months of 2020.

•Liquidity. The impact of COVID-19 and related market dislocations could strain our existing liquidity and cause us to increase the use of our alternative sources of liquidity, which could result in increased financial leverage on our balance sheet and negatively impact our credit and financial strength ratings or ratings outlooks. See “Liquidity and Capital Resources-Liquidity” for a discussion of our liquidity.

•Capital Resources. As of September 30, 2020, we maintained capital levels consistent with our ratings targets. However, market conditions could negatively impact our statutory capital and constrain our overall capital flexibility. Adverse market conditions could require us to take additional management actions to maintain capital consistent with our ratings objectives, which may include redeploying financial resources from internal sources, or using available affiliate sources of capital or seeking additional sources. See “Liquidity and Capital Resources-Capital” for a discussion of our capital resources.

•Risk Factors. The COVID-19 pandemic has adversely impacted our results of operations, financial position, investment portfolio, new business opportunities and operations, and these impacts are expected to continue. For additional information on the risks to our business posed by the COVID-19 pandemic, see “Risk Factors.”

Table of Contents

•Business Continuity. One of the main impacts of the COVID-19 pandemic has been executing our business continuity protocols to ensure our employees are safe and able to serve our customers. This included effectively transitioning the vast majority of our employees to remote work arrangements.

We expect COVID-19 to drive elevated levels of mortality, resulting in increased life insurance claims in the near-term. We have taken pricing and product actions, including the suspension of our life guaranteed universal life product in July 2020, to ensure we realize appropriate returns for the current economic environment, and to diversify our product mix to further limit our sensitivity to interest rates, while maintaining a solid value proposition for our customers. In addition, while our distribution platforms include a suite of digital, hybrid advisory, and in-person advisory options, mandated social distancing has limited in-person engagement between customers and advisors. Collectively, we expect the product actions we have taken and the constrained distribution environment to adversely impact our sales prospects in the near-term.


•	~~Results of Operations~~. For the three months and six months ended June 30, 2020 we reported a net gain of $10 million and $25 million, respectively, inclusive of the unfavorable financial market conditions that impacted our reported results. See “Results of Operations” for a discussion of results for second quarter and first half of the year.

•

~~Liquidity~~. The impact of COVID-19 and related market dislocations could strain our existing liquidity and cause us to increase the use of our alternative sources of liquidity, which could result in increased financial leverage on our balance sheet and negatively impact our credit and financial strength ratings or ratings outlooks. See “Liquidity and Capital Resources-Liquidity” for a discussion of our liquidity.

•

~~Capital Resources~~. Market conditions could negatively impact our statutory capital and constrain our overall capital flexibility. Market conditions could require us to take additional management actions to maintain capital consistent with our ratings objectives, which may include redeploying financial resources from internal sources, or using available affiliate sources of capital or seeking additional sources. See “Liquidity and Capital Resources-Capital” for a discussion of our capital resources.


•	~~Risk Factors~~. The COVID-19 pandemic has adversely impacted our results of operations, financial position, investment portfolio, new business opportunities and operations, and these impacts are expected to continue. For additional information on the risks to our business posed by the COVID-19 pandemic, see “Risk Factors.”


•	~~Business Continuity~~. One of the main impacts of the COVID-19 pandemic has been executing our business continuity protocols to ensure our employees are safe and able to serve our customers. This included effectively transitioning the vast majority of our employees to remote work arrangements.

We believe we can sustain remote work and social distancing for an indefinite period while ensuring that critical business operations are sustained. In addition, we are managing COVID-19-related impacts on third-party provided services, and do not anticipate significant interruption in critical operations.

~~Table of Contents~~

•CARES Act and Other Regulatory Developments. In March 2020 Congress enacted the Coronavirus Aid, Relief, and Economic Security Act ("the CARES Act"), which provides $2 trillion in economic stimulus to taxpayers, small businesses, and corporations through various grant and loan programs, tax provisions and regulatory relief. One provision of the CARES Act amends the Tax Cuts and Jobs Act ("TCJA") and allows companies with net operating losses (“NOLs”) originating in 2018, 2019 or 2020 to carry back those losses for five years. See Note 7 to the Unaudited Interim Financial Statements for more information.

•

~~CARES Act and Other Regulatory Developments~~. In March 2020 Congress enacted the Coronavirus Aid, Relief, and Economic Security Act ("the CARES Act"), which provides $2 trillion in economic stimulus to taxpayers, small businesses, and corporations through various grant and loan programs, tax provisions and regulatory relief. One provision of the CARES Act amends the Tax Cuts and Jobs Act (“TCJA”) and allows companies with net operating losses (“NOLs”) originating in 2018, 2019 or 2020 to carry back those losses for five years. See Note 7 to the Unaudited Interim Financial Statements for more information. We are continuing to analyze the CARES Act and its potential impact on the Company, and implementing operational changes necessary to accommodate the CARES Act.

Other governments and regulators, including the NAIC and state insurance regulators, have implemented, or are considering, a number of actions in response to the crisis, including delaying implementation of certain regulatory changes, temporarily waiving certain regulatory requirements and requiring or requesting insurers to waive premium payments and policy provisions and exclusions for certain periods of time.

The Company is not aware of any new or proposed government mandates that could materially impact the Company’s solvency or liquidity position.

Regulatory Developments

DOL Fiduciary Rules

In June 2020, the Department of Labor ("DOL") announced that it is proposing a new exemption to replace the previously vacated “best interest contract exemption." This proposed exemption would allow fiduciaries meeting the requirements of the exemption to receive compensation, including as a result of advice to roll over assets from a qualified plan to an Individual Retirement Account (“IRA”), and to purchase from or sell certain investments to qualified plans and IRAs. The DOL also reinstated the prior investment advice regulation and other existing exemptions and provided its current interpretation of the pre-2016 fiduciary investment advice regulation. We cannot predict what impact the newly proposed exemption or interpretative guidance will have on the Company.

Impact of a Low Interest Rate Environment

As a financial services company, market interest rates are a key driver of our results of operations and financial condition. Changes in interest rates can affect our results of operations and/or our financial condition in several ways, including favorable or adverse impacts to:

• investment-related activity, including: investment income returns, net interest margins, net investment spread results, new money rates, mortgage loan prepayments and bond redemptions;

• insurance reserve levels, amortization of deferred policy acquisition costs (“DAC”) and market experience true-ups;

• customer account values, including their impact on fee income;

• product offerings, design features, crediting rates and sales mix; and

• policyholder behavior, including surrender or withdrawal activity.

For more information on interest rate risks, see "Risk Factors" in this Quarterly Report on Form 10-Q and “Risk Factors—Market Risk” included in our Annual Report on Form 10-K for the year ended December 31, 2019.

Table of Contents

Revenues and Expenses

The Company earns revenues principally from insurance premiums, mortality and expense fees, asset administration fees from insurance and investment products, and from net investment income on the investment of general account and other funds. The Company receives premiums primarily from the sale of individual life insurance and annuity products. The Company earns mortality and expense fees, and asset administration fees, primarily from the sale and servicing of universal life insurance and separate account products including variable life insurance and variable annuities. The Company’s operating expenses principally consist of insurance benefits provided and reserves established for anticipated future insurance benefits, general business expenses, reinsurance premiums, commissions and other costs of selling and servicing the various products sold and interest credited on general account liabilities.

~~Table of Contents~~

Accounting Policies & Pronouncements

Application of Critical Accounting Estimates

The preparation of financial statements in conformity with U.S. GAAP requires the application of accounting policies that often involve a significant degree of judgment. Management, on an ongoing basis, reviews estimates and assumptions used in the preparation of financial statements. If management determines that modifications in assumptions and estimates are appropriate given current facts and circumstances, the Company’s results of operations and financial position as reported in the Unaudited Interim Financial Statements could change significantly.

Management believes the accounting policies relating to the following areas are most dependent on the application of estimates and assumptions and require management’s most difficult, subjective, or complex judgments:

•DAC and other costs, including deferred sales inducements (“DSI”);

•Policyholder liabilities;

•Valuation of investments, including derivatives, measurement of allowance for credit losses, and recognition of other-than-temporary impairments ("OTTI");

•Reinsurance recoverables;

•Taxes on income; and

•Reserves for contingencies, including reserves for losses in connection with unresolved legal matters.

Market Performance - Equity and Interest Assumptions

DAC and other costs associated with the variable and universal life policies and the variable and fixed annuity contracts are generally amortized over the expected lives of these policies in proportion to total gross profits. Total gross profits include both actual gross profits and estimates of gross profits for future periods. The quarterly adjustments for market performance reflect the impact of changes to our estimate of total gross profits to reflect actual fund performance and market conditions. A significant portion of gross profits for our variable annuity contracts and, to a lesser degree, our variable life contracts are dependent upon the total rate of return on assets held in separate account investment options. This rate of return influences the fees we earn on variable annuity and variable life contracts, costs we incur associated with the guaranteed minimum death and guaranteed minimum income benefit features related to our variable annuity contracts and expected claims to be paid on variable life contracts, as well as other sources of profit. Returns that are higher than our expectations for a given period produce higher than expected account balances, which increase the future fees we expect to earn on variable annuity and variable life contracts and decrease the future costs we expect to incur associated with the guaranteed minimum death and guaranteed minimum income benefit features related to our variable annuity contracts and expected claims to be paid on variable life contracts. The opposite occurs when returns are lower than our expectations. The changes in future expected gross profits are used to recognize a cumulative adjustment to all prior periods’ amortization.

Furthermore, the calculation of the estimated liability for future policy benefits related to certain insurance products includes an estimate of associated revenues and expenses that are dependent on both historical market performance as well as estimates of market performance in the future. Similar to DAC and other costs described above, these liabilities are subject to quarterly adjustments for experience including market performance, in addition to annual adjustments resulting from our annual reviews of assumptions.

Table of Contents

The weighted average rate of return assumptions used in developing estimated market returns consider many factors specific to each product type, including asset durations, asset allocations and other factors. With regard to equity market assumptions, the near-term future rate of return assumption used in evaluating DAC, other costs and liabilities for future policy benefits for certain of our products, primarily our domestic variable annuity and variable life insurance products, is generally updated each quarter and is derived using a reversion to the mean approach, a common industry practice. Under this approach, we consider historical equity returns and adjust projected equity returns over an initial future period of five years (the “near-term”) so that equity returns converge to the long-term expected rate of return. If the near-term projected future rate of return is greater than our near-term maximum future rate of return of 15.0%, we use our maximum future rate of return. As of ~~June~~September 30, 2020, our variable annuities and variable life insurance businesses assume an 8.0% long-term equity expected rate of return and a ~~9.7%~~3.5% near-term mean reversion equity expected rate of return.

~~Table of Contents~~

With regard to interest rate assumptions used in evaluating DAC, DSI and liabilities for future policy benefits for certain of our products, we generally update the long-term and near-term future rates used to project fixed income returns annually and quarterly, respectively. As a result of our 2020 annual reviews and update of assumptions and other refinements, we reduced our long-term expectation of the 10-year U.S. Treasury rate by 50 basis points and grade to a rate of 3.25% over ten years. As part of our quarterly market experience updates, we update our near-term projections of interest rates to reflect changes in current rates.

For a discussion of the impact that could result from changes in certain key assumptions, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Accounting Policies and Pronouncements—Sensitivities for Insurance Assets and Liabilities” in our Annual Report on Form 10-K for the year ended December 31, 2019

Future Adoption of New Accounting Pronouncements

ASU 2018-12, Financial Services - Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts, was issued by the Financial Accounting Standards Board (“FASB”) on August 15, 2018 and is expected to have a significant impact on the Consolidated Financial Statements and Notes to the Consolidated Financial Statements. In October 2019, the FASB issued ASU 2019-09, Financial Services - Insurance (Topic 944): Effective Date to affirm its decision to defer the effective date of ASU 2018-12 to January 1, 2022 (with early adoption permitted), representing a one year extension from the original effective date of January 1, 2021. As a result of the COVID-19 pandemic, in November 2020 the FASB ~~voted in June 2020~~issued ASU 2020-11, Financial Services - Insurance (Topic 944): Effective Date and Early Application to ~~tentatively~~ defer for an additional one year the ~~current~~ effective date of ASU 2018-12 from January 1, 2022 to January 1, 2023, and to provide transition relief to facilitate the early adoption of the ASU. Subsequently in July 2020, the FASB issued a proposed ASU with comment deadline of August 24, 2020 to obtain additional feedback on the tentative decisions, which are expected to be finalized during the third quarter of 2020. The transition relief would allow large calendar-year public companies that early adopt ASU 2018-12 to apply the guidance either as of January 1, 2020 or January 1, 2021 (and record transition adjustments as of January 1, 2020 or January 1, 2021) in the 2022 financial statements. Companies that do not early adopt ASU 2018-12 would ~~also~~ apply the guidance as of January 1, 2021 (and record transition adjustments as of January 1, 2021) in the 2023 financial statements. ASU 2018-12 will impact, at least to some extent, the accounting and disclosure requirements for all long-duration insurance and investment contracts issued by the Company. In addition to the impacts to the balance sheet upon adoption, the Company also expects an impact to how earnings emerge thereafter. See Note 2 to our Unaudited Interim Financial Statements for a more detailed discussion of ASU 2018-12, as well as other accounting pronouncements issued but not yet adopted and newly adopted accounting pronouncements.

Changes in Financial Position

Total assets increased ~~$0.8~~$1.2 billion from $21.4 billion at December 31, 2019 to ~~$22.2~~$22.6 billion at ~~June~~September 30, 2020. Significant ~~components were:~~component was:

•Reinsurance recoverables increased ~~$1.1~~$0.9 billion primarily related to the variable annuity reinsured living benefit liabilities resulting from an increase in reserves related to our variable annuity living benefit guarantees driven by declining interest rates and the widening of credit spreads, partially offset by a favorable non-performance risk ~~("NPR") adjustment;~~adjustment.

~~Partially offset by:~~

~~Separate account assets decreased $0.6 billion primarily driven by net unfavorable market conditions, policy charges and net outflows.~~

Total liabilities increased ~~$0.6~~$1.0 billion from $20.8 billion at December 31, 2019 to ~~$21.4~~$21.8 billion at ~~June~~ September 30, 2020. Significant ~~components were:~~ component was:

•Future policy benefits increased ~~$1.1~~$0.9 billion primarily driven by an increase in ~~the~~reserves related to our variable annuity living benefit guarantees, as discussed above, as well as growth in universal and term ~~life;~~life.

~~Partially offset by:~~

~~Separate account liabilities decreased $0.6 billion, corresponding to the decrease in Separate account assets, as discussed above.~~

Table of Contents

Total equity increased $0.2 billion from $0.6 billion at December 31, 2019 to $0.8 billion at ~~June~~September 30, 2020, primarily driven by a capital contribution from Pruco Life to fund additional reserve requirements.

~~Table of Contents~~

Results of Operations

Income (loss) from Operations before Income Taxes

Three Months Comparison

Income (loss) from operations before income taxes ~~decreased $8~~increased $11.7 million from ~~$10~~$8.6 million for the three months ended ~~June~~September 30, 2019 to $2$20.3 million for the three months ended ~~June~~September 30, 2020 primarily driven by:

•Higher Policy charges and fee income due to higher revenue from sales of principle-based reserving (“PBR”) products;

•Higher Net investment income due to higher non-coupon investment results from favorable market conditions; and

•Higher Premiums from continued growth in PBR term policies retained within the Company;

Partially offset by:

•Higher Policyholders' benefits from an increase in guaranteed minimum death benefit ("GMDB") reserves due to business growth from sales of PBR products and projected low interest rates; and

•Higher General, administrative and other expenses driven by an unfavorable comparative impact from commission and expense allowance ceded due to lower annuity sales.

Nine Months Comparison

Income (loss) from operations before income taxes increased $9.1 million from $29.4 million for the nine months ended September 30, 2019 to $38.5 million for the nine months ended September 30, 2020. Excluding the impact of our annual reviews and update of assumptions and other refinements, income (loss) ~~decreased $12~~increased $6 million primarily driven by:

~~Lower Realized~~•Higher Policyholders' benefits from an increase in benefit reserves from continued growth in retained PBR term products and higher GMDB reserves due to business growth from sales of PBR products and unfavorable interest rate environment; and

•Higher General, administrative and other expenses driven by an unfavorable comparative impact from commission and expense allowance ceded due to lower annuity sales;

Partially offset by:

•Higher Premiums from continued growth in PBR term policies; and

•Higher Policy charges and fee income due to higher revenue from sales of PBR products.

Revenues, Benefits and Expenses

Three Months Comparison

Revenues increased $14.9 million from a gain of $36.2 million for the three months ended September 30, 2019 to a gain of $51.1 million for the three months ended September 30, 2020 primarily driven by:

•Higher Net investment ~~gains/(losses), net~~income due to an increase in revenue from non-coupon investments;

•Higher Policy charges and fee income due to higher revenue from sales of PBR products that are fully retained in the Company; and

•Higher Premiums from continued growth in PBR term policies.

Table of Contents

Benefits and expenses increased $3.3 million from an expense of $27.6 million for the three months ended September 30, 2019 to an expense of $30.9 million for the three months ended September 30, 2020 primarily driven by:

•Higher General, administrative and other expenses driven by an unfavorable comparative impact from commission and expense allowance ceded due to lower annuity sales; and

•Higher Amortization of deferred policy acquisitions costs primarily driven by ~~losses on~~higher retained business growth in the Company;

Partially offset by:

•Lower Interest credited to policyholders' account balances primarily driven by an offsetting Index Universal Life ~~product's embedded derivative as a result of more favorable equity market performance in the second quarter of 2020; and~~refinement impact to Realized investment gains (losses), net.

Higher Policyholders' benefits primarily driven by lower term reserves ceded on principle-based reserving ("PBR") products that are retained in the Company and not reinsured to our affiliated captive entities and unfavorable mortality.

~~Six~~Nine Months Comparison

~~Income (loss) from operations before income taxes decreased $3~~Revenues increased $32 million from ~~$21~~a gain of $117.7 million for the ~~six~~nine months ended ~~June~~September 30, 2019 to ~~$18~~a gain of $149.7 million for the ~~six~~nine months ended ~~June~~September 30, 2020. Excluding the impact of our annual reviews and update of assumptions and other refinements, ~~income (loss) decreased $7~~Revenues increased $32 million primarily driven by:

~~Higher Policyholders' benefits primarily driven by lower term reserves ceded on PBR products and unfavorable mortality, as discussed above;~~

~~Partially offset by:~~

•Higher Policy charges and fee income ~~primarily driven by business growth in the life business.~~

~~Revenues, Benefits and Expenses~~

~~Three Months Comparison~~

Revenues decreased $3 million from $43 million for the three months ended June 30, 2019 to $40 million for the three months ended June 30, 2020. Excluding the impact of our annual reviews and update of assumptions and other refinements, which was relatively flat, Revenues decreased by $3 million primarily driven by:

~~Lower Realized investment gains/(losses), net primarily driven by losses on the Index Universal Life product's embedded derivative, as discussed above;~~

~~Partially offset by:~~

~~Higher Net investment income~~ due to ~~lower non-coupon investments and lower investment yields; and~~

~~Higher Premiums driven by growth~~higher revenue from sales of PBR products that are fully retained in the ~~Company~~Company;

•Higher Realized Investment gains (losses), net driven by an increase in living benefit fees ceded as reserves on the living benefit guarantees increased relatively more than prior year with an offsetting impact in Policy charges and ~~not reinsured to our affiliated captive entities.~~fee income; and

•Higher Premiums from continued growth in PBR term policies.

Benefits and expenses increased $5$22.9 million from ~~$33~~an expense of $88.3 million for the ~~three~~nine months ended ~~June~~September 30, 2019 to ~~$38~~an expense of $111.2 million for the ~~three~~nine months ended ~~June~~September 30, 2020. Excluding the impact of our annual reviews and update of assumptions and other refinements, Benefits and expenses increased $9$26 million primarily driven by:

•Higher General, administrative and other expenses driven by ~~higher operating expenses allocated~~an unfavorable comparative impact from commission and expense allowance ceded due to ~~the Company~~lower annuity sales; and ~~higher premium taxes; and~~

•Higher Policyholders' benefits ~~as discussed above.~~

~~Six Months Comparison~~

~~Table of Contents~~

~~Revenues increased $17 million~~ from $82 million for the six months ended June 30, 2019 to $99 million for the six months ended June 30, 2020. Excluding the impact of our annual reviews and update of assumptions and other refinements which was relatively flat, Revenues decreased primarily driven by:

~~Higher Realized investment gains/(losses), net primarily~~an increase in benefit reserves from ~~gains on the Index Universal Life product’s embedded derivative as a result of unfavorable market conditions; and~~

~~Higher Policy charges and fee income, as discussed above.~~

Benefits and expenses increased $19 million from $61 million for the six months ended June 30, 2019 to $80 million for the six months ended June 30, 2020. Excluding the impact of our annual reviews and update of assumptions and other refinements, Benefits and expenses increased $23 million primarily driven by:

~~Higher Policyholders’ benefits, as discussed above; and~~

~~Higher General, administrative and other expenses driven by higher operating expenses allocated to the Company~~continued growth in retained PBR term products and higher ~~premium taxes.~~GMDB reserves due to business growth from sales of PBR products and unfavorable interest rate environment.

Variable Annuity Risks and Risk Mitigants

The following is a summary of certain risks associated with Individual Annuities' products, certain strategies in mitigating those risks, including any updates to those strategies since the previous year-end, and the related financial results. For a more detailed description of these items and their related accounting treatment, refer to the complete descriptions provided in our Annual Report on Form 10-K for the year ended December 31, 2019.

The primary risk exposures of our variable annuity contracts relate to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including capital markets assumptions such as equity market returns, interest rates and market volatility, along with actuarial assumptions such as contractholder mortality, the timing and amount of annuitization and withdrawals, and contract lapses. For these risk exposures, achievement of our expected earnings is subject to the risk that actual experience will differ from the assumptions used in the original pricing of these products. Prudential Financial manages our exposure to certain risks driven by capital markets fluctuations primarily through a combination of Product Design Features and an Asset Liability Management Strategy ("ALM"), as discussed below.

Table of Contents

Product Design Features

A portion of the variable annuity contracts that we offer include an asset transfer feature. This feature is implemented at the contract level, and transfers assets between certain variable investment sub-accounts selected by the annuity contractholder and, depending on the benefit feature, a fixed-rate account in the general account or a bond fund sub-account within the separate account. The objective of the asset transfer feature is to reduce our exposure to equity market risk and market volatility. Other product design features we utilize include, among others, asset allocation restrictions, minimum issuance age requirements and certain limitations on the amount of contractholder purchase payments, as well as a required minimum allocation to our general account for certain of our products. We have also introduced products that diversify our risk profile and have incorporated provisions in product design allowing frequent revisions of key pricing elements for certain products. In addition, there is diversity in our fee arrangements, as certain fees are primarily based on the benefit guarantee amount, the contractholder account value and/or premiums, which helps preserve certain revenue streams when market fluctuations cause account values to decline.

Asset Liability Management Strategy (including fixed income instruments and derivatives)

Prudential Insurance employs an ALM strategy that utilizes a combination of both traditional fixed income instruments and derivatives to help defray potential claims associated with our variable annuity living benefit guarantees. The economic liability we manage with this ALM strategy consists of expected living benefit claims under less severe market conditions, which are managed using an ALM strategy through the accumulation of fixed income and derivative instruments, and potential living benefit claims resulting from more severe market conditions, which are hedged using derivative instruments. For our Prudential Defined Income (“PDI”) variable annuity, we utilize fixed income instruments to help defray potential claims. For the portion of our ALM strategy executed with derivatives, Prudential Insurance enter into a range of exchange-traded and over-the-counter equity and interest rate derivatives, including, but not limited to: equity and treasury futures; total return and interest rate swaps; and options including equity options, swaptions, and floors and caps. The intent of this strategy is to more efficiently manage the capital and liquidity associated with these products while continuing to mitigate fluctuations in net income due to movements in capital markets. Since the ALM strategy is conducted in Prudential Insurance, the results of the strategy do not directly impact the Company's results of operations or financial condition.

~~Table of Contents~~

Income Taxes

For information regarding income taxes, see Note 7 to the Unaudited Interim Financial Statements.

Liquidity and Capital Resources

This section supplements and should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources” included in our Annual Report on Form 10-K for the year ended December 31, 2019.

Overview

Liquidity refers to the ability to generate sufficient cash resources to meet the payment obligations of the Company. Capital refers to the long-term financial resources available to support the operations of our business, fund business growth, and provide a cushion to withstand adverse circumstances. Our ability to generate and maintain sufficient liquidity and capital depends on the profitability of our business, general economic conditions, our ability to borrow from affiliates and our access to the capital markets through affiliates as described herein.

The Company is subject to comprehensive regulation and supervision by domestic and international regulators. These regulations currently ~~include, or may~~ include, requirements (many of which are the subject of ongoing rule-making) relating to capital, leverage, liquidity, stress-testing, overall risk management, credit exposure reporting and credit concentration. For information on these regulatory initiatives and their potential impact on us, see “Business—Regulation” and “Risk Factors” included in our Annual Report on Form 10-K for the year ended December 31, 2019.

Table of Contents

COVID-19 and Related Market Disruptions

Beginning in the first quarter of 2020, broad market concerns over the impact of COVID-19 have led to significant volatility and disruptions in the global economy and financial markets. Given this macro environment and the global pandemic, as examined through our stress testing, in the first ~~half~~nine months of the year we accelerated our product diversification strategy and repriced certain products, which are expected to support the capital position over time.

Liquidity. The Company continues to operate with significant liquid resources. Nevertheless, adverse developments related to COVID-19 and associated market dislocations could strain our existing liquidity. Any need to increase the use of our alternative sources of liquidity may result in increased financial leverage on our balance sheet and negatively impact our credit and financial strength ratings or ratings outlooks.

Capital. As of ~~June~~September 30, 2020, the Company maintained capital levels consistent with its ratings targets. However, market conditions could negatively impact the statutory capital and constrain our overall capital flexibility. For example, adverse market conditions may lead to increased defaults and/or further deterioration in the credit quality or fair values of our investment portfolio, which would negatively impact our statutory capital. Adverse market conditions could require us to take additional management actions to maintain capital consistent with our ratings objectives, which may include redeploying financial resources from internal sources or using available external sources of capital or seeking additional sources.

Liquidity and Capital Risk Management. Effective and prudent liquidity and capital management is a priority across the organization. Management monitors the liquidity of the Company on a daily basis and projects borrowing and capital needs over a multi-year time horizon. We use a Risk Appetite Framework (“RAF”) to ensure that all risks taken by the Company aligns with our capacity and willingness to take those risks. The RAF provides a dynamic assessment of capital and liquidity stress impacts, including scenarios similar to, and more severe than, those occurring due to COVID-19, and is intended to ensure that sufficient resources are available to absorb those impacts. We believe that our capital and liquidity resources are sufficient to satisfy the capital and liquidity requirements of the Company.

Capital

We manage the Company to regulatory capital levels consistent with our "AA" ratings targets. We utilized the risk-based capital ("RBC") ratio as a primary measure of capital adequacy. RBC is calculated based on statutory financial statements and risk formulas consistent with the practices of the National Association of Insurance Commissioners ("NAIC"). RBC considers, among other things, risks related to the type and quality of the invested assets, insurance-related risks associated with an insurer’s products and liabilities, interest rate risks and general business risks. RBC ratio calculations are intended to assist insurance regulators in measuring an insurer’s solvency and ability to pay future claims. The reporting of RBC measures is not intended for the purpose

~~Table of Contents~~

of ranking any insurance company or for use in connection with any marketing, advertising or promotional activities, but is available to the public. The Company’s capital levels substantially exceed the minimum level required by applicable insurance regulations.

Our regulatory capital levels may be affected in the future by changes to the applicable regulations, proposals for which are currently under consideration by both domestic and international insurance regulators.

The regulatory capital level of the Company can be materially impacted by interest rate and equity market fluctuations, changes in the values of derivatives, the level of impairments recorded, and credit quality migration of the investment portfolio, among other items. In addition, the reinsurance of business or the recapture of business subject to reinsurance arrangements due to defaults by, or credit quality migration affecting, the reinsurers or for other reasons could negatively impact regulatory capital levels. The Company’s regulatory capital level is also affected by statutory accounting rules, which are subject to change by each applicable insurance regulator.

Affiliated Captive Reinsurance Companies

See “Management’s Discussion and Analysis of Financial Condition and Results of Operations-Liquidity and Capital Resources-Capital-Affiliated Captive Reinsurance Companies” included in our Annual Report on Form 10-K for the year ended December 31, 2019, for a discussion of our use of captive reinsurance companies.

Table of Contents

Liquidity

Our liquidity is managed to ensure stable, reliable and cost-effective sources of cash flows to meet all of our obligations. Liquidity is provided by a variety of sources, as described more fully below, including portfolios of liquid assets. Our investment portfolios are integral to the overall liquidity of the Company. We use a projection process for cash flows from operations to ensure sufficient liquidity to meet projected cash outflows, including claims. The impact of Prudential Funding, LLC's ("Prudential Funding"), a wholly-owned subsidiary of Prudential Insurance, financing capacity on liquidity is considered in the internal liquidity measures of the Company.

Liquidity is measured against internally-developed benchmarks that take into account the characteristics of both the asset portfolio and the liabilities that they support. We consider attributes of the various categories of liquid assets (e.g., type of asset and credit quality) in calculating internal liquidity measures to evaluate our liquidity under various stress scenarios, including company-specific and market-wide events. We continue to believe that cash generated by ongoing operations and the liquidity profile of our assets provide sufficient liquidity under reasonably foreseeable stress scenarios.

The principal sources of the Company’s liquidity are premiums and certain annuity considerations, investment and fee income, investment maturities, sales of investments and internal borrowings. The principal uses of that liquidity include benefits, claims, and payments to policyholders and contractholders in connection with surrenders, withdrawals and net policy loan activity. Other uses of liquidity include commissions, general and administrative expenses, purchases of investments, the payment of dividends and returns of capital to the parent company, hedging and reinsurance activity and payments in connection with financing activities.

In managing liquidity, we consider the risk of policyholder and contractholder withdrawals of funds earlier than our assumptions when selecting assets to support these contractual obligations. We use surrender charges and other contract provisions to mitigate the extent, timing and profitability impact of withdrawals of funds by customers.

Liquid Assets

Liquid assets include cash and cash equivalents, short-term investments, U.S. Treasury fixed maturities, and fixed maturities that are not designated as held-to-maturity and public equity securities. As of ~~June~~September 30, 2020 and December 31, 2019, the Company had liquid assets of ~~$1,833~~$1,903 million and $1,627 million, respectively. The portion of liquid assets comprised of cash and cash equivalents was ~~$41~~$68 million and $56 million as of ~~June~~September 30, 2020 and December 31, 2019, respectively. As of ~~June~~September 30, 2020, ~~$1,696~~$1,734 million, or 96%, of the fixed maturity investments in the Company's general account portfolios, were rated high or highest quality based on NAIC or equivalent rating.

Term and Universal Life Reserve Financing

The Company uses affiliated captive reinsurance subsidiaries to finance the portion of the statutory reserves required to be held under Regulation XXX and Guideline AXXX that is considered to be non-economic. The financing arrangements involve the reinsurance of term and universal life business to our affiliated captive reinsurers and the issuance of surplus notes by those

~~Table of Contents~~

affiliated captives that are treated as capital for statutory purposes. These surplus notes are subordinated to policyholder obligations, and the payment of principal and interest on the surplus notes can only be made with prior insurance regulatory approval.

As of ~~June~~September 30, 2020, the affiliated captive reinsurance companies have entered into agreements with external counterparties providing for the issuance of up to an aggregate of ~~$14.8 billion~~$14,825 million of surplus notes by our affiliated captive reinsurers in return for the receipt of credit-linked notes (“Credit-Linked Note Structures”), of which ~~$12.8 billion~~$12,849 million of surplus notes was outstanding, compared to an aggregate insurance capacity of ~~$13.7 billion,~~$13,700 million, of which ~~$12 billion~~$12,009 million was outstanding as of December 31, 2019. The amounts reflect a ~~$1.2 billion~~$1,200 million Credit-Linked Note Structure entered into in June 2020 for Guideline AXXX reserves, of which ~~$0.7 billion~~$700 million was outstanding as of ~~June~~September 30, 2020. Under the agreements, the affiliated captive receives in exchange for the surplus notes one or more credit-linked notes issued by a special-purpose affiliate of the Company with an aggregate principal amount equal to the surplus notes outstanding. The affiliated captive holds the credit-linked notes as assets supporting Regulation XXX or Guideline AXXX non-economic reserves, as applicable. For more information on our Credit-Linked Note Structures, see “Management’s Discussion and Analysis of Financial Condition and Results of ~~Operations-Liquidity~~Operations—Liquidity and Capital ~~Resources-Financing~~Resources—Financing Activities” in our Annual Report on Form 10-K for the year ended December 31, 2019.

Table of Contents

As of ~~June~~September 30, 2020, our affiliated captive reinsurance companies had outstanding an aggregate of $2.3 billion of debt issued for the purpose of financing Regulation XXX and Guideline AXXX non-economic reserves, of which approximately $0.7 billion relates to Regulation XXX reserves and approximately $1.6 billion relates to Guideline AXXX reserves. In addition, as of ~~June~~September 30, 2020, for purposes of financing Guideline AXXX reserves, one of our affiliated captives had approximately $4$4.0 billion of surplus notes outstanding that were issued to affiliates.

The Company has introduced updated versions of its individual life products in conjunction with the requirement to adopt principle-based reserving by January 1, 2020. These updated products are currently priced to support the principle-based statutory reserve level without the need for reserve financing. Certain elements of the implementation of principle-based reserving are yet to be finalized by the NAIC and may have a material impact on statutory reserves. The Company continues to assess the impact of the implementation of principle-based reserving on projected statutory reserve levels, product pricing and the use of financing.

Table of Contents



PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Notes to Unaudited Interim Financial Statements—(Continued)

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Market risk is the risk of fluctuations in the value of financial instruments as a result of absolute or relative changes in interest rates, foreign currency exchange rates, equity prices or commodity prices. To varying degrees, our products and services, and the investment activities supporting them, generate exposure to market risk. The market risk incurred, and our strategies for managing this risk, vary by product. As of ~~June~~September 30, 2020, there have been no material changes in our economic exposure to market risk from December 31, 2019,, a description of which may be found in our Annual Report on Form 10-K, for the year ended December 31, 2019, Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” filed with the Securities and Exchange Commission. See “Risk Factors” in this Quarterly Report on Form 10-Q and Item 1A, “Risk Factors” included in the Annual Report on Form 10-K for the year ended December 31, 2019, for a discussion of how difficult conditions in the financial markets and the economy generally may materially adversely affect our business and results of our operations.

Table of Contents

Item 4. Controls and Procedures

In order to ensure that the information we must disclose in our filings with the SEC is recorded, processed, summarized, and reported on a timely basis, the Company’s management, including our Chief Executive Officer and Chief Financial Officer, have reviewed and evaluated the effectiveness of our disclosure controls and procedures, as defined in Securities Exchange Act of 1934, as amended (“Exchange Act”) Rule 13a-15(e), as of ~~June~~September 30, 2020. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of ~~June~~September 30, 2020, our disclosure controls and procedures were effective. No change in our internal control over financial reporting, as defined in Exchange Act Rule 13a-15(f), occurred during the quarter ended ~~June~~September 30, 2020, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

See Note 10 to the Unaudited Interim Financial Statements under “—Litigation and Regulatory Matters” for a description of certain pending litigation and regulatory matters affecting us, and certain risks to our business presented by such matters, which is incorporated herein by reference.

Item 1A. Risk Factors

You should carefully consider the risks described under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019. These risks could materially affect our business, results of operations or financial condition or cause our actual results to differ materially from those expected or those expressed in any forward-looking statements made by or on behalf of the Company. These risks are not exclusive, and additional risks to which we are subject include, but are not limited to, the factors mentioned under “Forward-Looking Statements” above and the risks of our business described elsewhere in this Quarterly Report on Form 10-Q. The following should be read in conjunction with and supplements and amends the section titled “Risk Factors” in our Annual Report on Form 10-K.

The COVID-19 pandemic has resulted in extreme stress and disruption in the global economy and financial markets, and has adversely impacted, and may continue to adversely impact, our results of operations, financial condition and prospects.

During the first ~~half~~nine months of 2020, the COVID-19 crisis (i) caused unfavorable financial market conditions which had a substantial negative effect on reported results ~~and market values in~~of our ~~investment portfolio,~~business, (ii) negatively impacted our statutory capital and constrained our overall capital flexibility primarily due to asset value declines and the need to strengthen reserves, and (iii) caused us to lower our outlook for the future, as described further under “Management’s Discussion and Analysis of Financial Condition and Results of Operations-Overview-COVID-19.”

We cannot predict what impact the COVID-19 pandemic will ultimately have on the global economy, markets or our business. The pandemic could exacerbate existing areas of concern, such as the pace of economic growth, equity market performance, and continued low interest rates, among others. Changes in consumer spending, business investment, and government debt and spending as a result of the crisis may negatively impact our business.

These risks may have manifested, and may continue to manifest, in our business in the following areas, among others:

Investment Risk. The COVID-19 pandemic and its impact on the global economy has increased the risk of loss on our investments due to default or deterioration in credit quality or value.

Insurance Risk. We expect COVID-19 to drive elevated levels of mortality in the near-term. The COVID-19 pandemic may ultimately result in a mortality calamity, which is the risk that short-term mortality rates deviate adversely from what is expected as a result of pandemics or other disasters. Elevated losses will reduce our earnings and capital, and we may be forced to liquidate assets before maturity in order to pay the excess claims. The pandemic situation may worsen depending on the evolution of the virus’s transmissibility and virulence, effectiveness of public health measures and availability of potential vaccines and treatments. Ultimate losses would depend on several factors, including the rates of mortality and morbidity among various segments of the insured population, age distribution of associated deaths, collectability of reinsurance, performance of our investment portfolio, effect on lapses and surrenders of existing policies, as well as sales of new policies and other variables.

The pandemic may also result in a change in policyholder behavior, such as policyholders choosing to defer or stop paying insurance premiums. It may also result in a lapse calamity, which is the risk that lapse rates over the short-term deviate adversely from what is expected. For example, surrenders of cash surrender value products by customers in need of liquidity can impact our liquidity, and it may be necessary in certain market conditions to sell assets to meet surrender demands. Lapse calamity can also impact our earnings through its impact on estimated future profits.

Finally, we cannot predict whether COVID-19 will ultimately lead to longer-term deviations from the mortality or policyholder behavior ~~or morbidity~~ assumptions we used to price our products.

Market Risk. Continued market disruptions and volatility may further negatively impact the profitability of many of our insurance and annuity products, which depends in part on the value of the separate accounts supporting these products which can fluctuate substantially depending on market conditions. Market volatility and reduced liquidity may reduce our ability to implement asset-liability management and hedging strategies. The decline in interest rates, in particular, may result in lower investment income, higher reserve levels and other consequences.

6364

Table of Contents

Liquidity Risk. The impact of the COVID-19 crisis and related market dislocations could strain our existing liquidity and cause us to increase the use of our alternative sources of liquidity, which could result in increased financial leverage on our balance sheet and negatively impact our credit and financial strength ratings. Furthermore, certain sources of liquidity might not be available during times of stress, or may only be available on unfavorable terms, which can result in a decrease in our profitability and a significant reduction in our financial flexibility.

In particular, abrupt changes to interest rate, equity, and/or currency markets could lead to increased collateral requirements to counterparties, and cash demands due to severe mortality calamity, customer withdrawals or lapse events.

Operational Risk. One of the main impacts of the COVID-19 crisis has been executing our business continuity protocols to ensure our employees are safe and able to serve our customers. This included transitioning the vast majority of our employees to remote work arrangements. We have also made a number of operational changes to accommodate our customers.

In this environment, there is an elevated risk that weaknesses or failures in our business continuation plans could lead to disruption of our operations, liability to clients, exposure to disciplinary action or harm to our reputation. Furthermore, weaknesses or failures within a vendor’s business continuation plan can materially disrupt our business operations. Our information systems and those of our vendors and service providers may be more vulnerable to cyber-attacks, computer viruses or other computer related attacks, programming errors and similar disruptive problems during a business continuation event.

Strategic Risk. The COVID-19 pandemic could ultimately generate an economic downturn; higher unemployment, lower family income, lower corporate earnings, lower business investment and lower consumer spending. In such an environment, the demand for our products and our investment returns could be materially adversely affected. In addition, we expect near-term sales to be slowed by the impact of social distancing and financial hardship on our customers.

Finally, we cannot predict what actions governments will take in response to the COVID-19 pandemic, and how any new laws, regulations, or state-sponsored programs may impact our business.

Table of Contents

Item 6. Exhibits


EXHIBIT INDEX

~~EXHIBIT INDEX~~

31.1 Section 302 Certification of the Chief Executive Officer

31.2 Section 302 Certification of the Chief Financial Officer

32.1 Section 906 Certification of the Chief Executive Officer

32.2 Section 906 Certification of the Chief Financial Officer

101.INS - XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH - XBRL Taxonomy Extension Schema Document.

101.CAL - XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB - XBRL Taxonomy Extension Label Linkbase Document

101.PRE - XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF - XBRL Taxonomy Extension Definition Linkbase Document

104.Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



			Pruco Life Insurance Company of New Jersey

			By:						/s/ Susan M. Mann
			Name:						Susan M. Mann
									Vice President and Chief Financial Officer
									(Authorized Signatory and Principal Financial Officer)

Date: ~~August~~November 12, 2020

6667



	June 30, 2020		December 31, 2019
ASSETS
Fixed maturities available for sale, at fair value (amortized cost: 2020 - $1,587,004; 2019–$1,437,796)	$	1,771,553	$	1,550,096
Fixed maturities, trading, at fair value (amortized cost: 2020 - $14,221; 2019–$14,221)	12,727		13,700
Equity securities, at fair value (cost: 2020 - $5,065; 2019–$5,139)	7,311		7,512
Policy loans	213,467		211,986
Commercial mortgage and other loans (net of $457 and $165 allowance for credit losses at June 30, 2020 and December 31, 2019, respectively)(1)	137,914		143,098
Other invested assets (includes $37,189 and $24,726 of assets measured at fair value at June 30, 2020 and December 31, 2019, respectively)	107,524		89,536
Total investments	2,250,496		2,015,928
Cash and cash equivalents	41,120		55,924
Deferred policy acquisition costs	203,125		178,813
Accrued investment income	20,984		19,539
Reinsurance recoverables	4,310,574		3,200,642
Receivables from parent and affiliates	39,848		32,820
Income taxes receivable(1)	1,827		6,268
Other assets	22,948		21,203
Separate account assets	15,290,949		15,904,208
TOTAL ASSETS	$	22,181,871	$	21,435,345
LIABILITIES AND EQUITY
LIABILITIES
Future policy benefits	$	3,425,560	$	2,302,959
Policyholders’ account balances	2,477,893		2,424,120
Cash collateral for loaned securities	2,700		2,481
Short-term debt to affiliates	0		89
Payables to parent and affiliates	26,632		24,958
Other liabilities(1)	156,347		140,628
Separate account liabilities	15,290,949		15,904,208
Total liabilities	21,380,081		20,799,443
COMMITMENTS AND CONTINGENT LIABILITIES (See Note 10)
EQUITY
Common stock ($5 par value; 400,000 shares authorized, issued and outstanding)	2,000		2,000
Additional paid-in capital	348,735		268,021
Retained earnings	304,986		280,246
Accumulated other comprehensive income (loss)	146,069		85,635
Total equity	801,790		635,902
TOTAL LIABILITIES AND EQUITY	$	22,181,871	$	21,435,345



	Three Months Ended June 30,						Six Months Ended June 30,
	2020			2019			2020			2019
REVENUES
Premiums	$	5,129		$	3,281		$	10,323		$	6,619
Policy charges and fee income	18,243			22,605			42,212			42,454
Net investment income	20,683			19,472			37,648			38,213
Asset administration fees	1,546			1,449			3,111			2,792
Other income	1,640			1,329			(309		)	2,643
Realized investment gains (losses), net	(7,512		)	(5,056		)	5,553			(11,166		)
TOTAL REVENUES	39,729			43,080			98,538			81,555
BENEFITS AND EXPENSES
Policyholders’ benefits	13,443			10,351			30,129			20,328
Interest credited to policyholders’ account balances	11,987			10,005			22,178			19,058
Amortization of deferred policy acquisition costs	1,967			6,174			7,279			7,399
General, administrative and other expenses	10,395			6,858			20,769			13,956
TOTAL BENEFITS AND EXPENSES	37,792			33,388			80,355			60,741
INCOME (LOSS) FROM OPERATIONS BEFORE INCOME TAXES	1,937			9,692			18,183			20,814
Income tax expense (benefit)	(8,425		)	(805		)	(6,724		)	(228		)
NET INCOME (LOSS)	$	10,362		$	10,497		$	24,907		$	21,042
Other comprehensive income (loss), before tax:
Foreign currency translation adjustments	42			4			41			4
Net unrealized investment gains (losses)	97,427			46,263			76,459			92,861
Total	97,469			46,267			76,500			92,865
Less: Income tax expense (benefit) related to other comprehensive income (loss)	20,470			9,715			16,066			19,501
Other comprehensive income (loss), net of taxes	76,999			36,552			60,434			73,364
Comprehensive income (loss)	$	87,361		$	47,049		$	85,341		$	94,406



	Three Months Ended June 30,						Six Months Ended June 30,
	2020			2019			2020			2019
	(in thousands)
Fixed maturities, available-for-sale:
Proceeds from sales(1)	$	885		$	8,383		$	2,295		$	11,639
Proceeds from maturities/prepayments	5,361			19,043			17,615			22,206
Gross investment gains from sales and maturities	2			40			26			143
Gross investment losses from sales and maturities	(44		)	(424		)	(44		)	(459		)
OTTI recognized in earnings(2)	N/A			0			N/A			(3,163		)
Write-downs recognized in earnings(3)	0			N/A			(625		)	N/A
(Addition to) release of allowance for credit losses(4)	0			N/A			0			N/A



	Three Months Ended June 30, 2020
	Realized Investment Gains (Losses)			Net Investment Income		Other Income			AOCI (1)
	(in thousands)
Derivatives Designated as Hedge Accounting Instruments:
Cash flow hedges
Currency/Interest Rate	$	0		$	488	$	(324	)	$	(5,608	)
Total cash flow hedges	0			488		(324		)	(5,608		)
Derivatives Not Qualifying as Hedge Accounting Instruments:
Interest Rate	254			0		0			0
Currency	(42		)	0		0			0
Currency/Interest Rate	(963		)	0		1			0
Credit	(69		)	0		0			0
Equity	5,727			0		0			0
Embedded Derivatives	(12,400		)	0		0			0
Total Derivatives Not Qualifying as Hedge Accounting Instruments:	(7,493		)	0		1			0
Total	$	(7,493	)	$	488	$	(323	)	$	(5,608	)



	Three Months Ended June 30, 2019
	Realized Investment Gains (Losses)			Net Investment Income		Other Income		AOCI(1)
	(in thousands)
Derivatives Designated as Hedge Accounting Instruments:
Cash flow hedges
Currency/Interest Rate	$	0		$	411	$	235	$	1,543
Total cash flow hedges	0			411		235		1,543
Derivatives Not Qualifying as Hedge Accounting Instruments:
Interest Rate	850			0		0		0
Currency	9			0		0		0
Currency/Interest Rate	492			0		2		0
Credit	0			0		0		0
Equity	1,839			0		0		0
Embedded Derivatives	(7,879		)	0		0		0
Total Derivatives Not Qualifying as Hedge Accounting Instruments:	(4,689		)	0		2		0
Total	$	(4,689	)	$	411	$	237	$	1,543



	Six Months Ended June 30, 2019
	Realized Investment Gains (Losses)			Net Investment Income		Other Income		AOCI(1)
	(in thousands)
Derivatives Designated as Hedge Accounting Instruments:
Cash flow hedges
Currency/Interest Rate	$	(10	)	$	808	$	26	$	1,326
Total cash flow hedges	(10		)	808		26		1,326
Derivatives Not Qualifying as Hedge Accounting Instruments:
Interest Rate	1,359			0		0		0
Currency	15			0		0		0
Currency/Interest Rate	602			0		0		0
Credit	(1		)	0		0		0
Equity	5,979			0		0		0
Embedded Derivatives	(15,677		)	0		0		0
Total Derivatives Not Qualifying as Hedge Accounting Instruments:	(7,723		)	0		0		0
Total	$	(7,733	)	$	808	$	26	$	1,326



	As of June 30, 2020
	Level 1		Level 2		Level 3		Netting(1)			Total
	(in thousands)
Fixed maturities, available-for-sale:
U.S. Treasury securities and obligations of U.S. government authorities and agencies	$	0	$	16,052	$	0	$	0		$	16,052
Obligations of U.S. states and their political subdivisions	0		180,090		0		0			180,090
Foreign government bonds	0		78,794		0		0			78,794
U.S. corporate public securities	0		856,451		0		0			856,451
U.S. corporate private securities	0		240,303		303		0			240,606
Foreign corporate public securities	0		59,180		0		0			59,180
Foreign corporate private securities	0		142,358		19,929		0			162,287
Asset-backed securities(2)	0		18,437		0		0			18,437
Commercial mortgage-backed securities	0		155,374		0		0			155,374
Residential mortgage-backed securities	0		4,282		0		0			4,282
Subtotal	0		1,751,321		20,232		0			1,771,553
Fixed maturities, trading	0		12,727		0		0			12,727
Equity securities	0		124		7,187		0			7,311
Cash equivalents	0		35,939		0		0			35,939
Other invested assets(3)	0		42,714		0		(8,466		)	34,248
Reinsurance recoverables	0		0		1,741,924		0			1,741,924
Receivables from parent and affiliates	0		2,316		0		0			2,316
Subtotal excluding separate account assets	0		1,845,141		1,769,343		(8,466		)	3,606,018
Separate account assets(4)(5)	0		13,415,971		0		0			13,415,971
Total assets	$	0	$	15,261,112	$	1,769,343	$	(8,466	)	$	17,021,989
Future policy benefits(6)	$	0	$	0	$	1,741,924	$	0		$	1,741,924
Policyholders' account balances	0		0		143,242		0			143,242
Payables to parent and affiliates	0		8,457		0		(8,457		)	0
Total liabilities	$	0	$	8,457	$	1,885,166	$	(8,457	)	$	1,885,166



	Three Months Ended June 30,						Six Months Ended June 30,
	2020			2019			2020			2019
	(in thousands)
Amounts reclassified from AOCI (1)(2):
Net unrealized investment gains (losses):
Cash flow hedges - Currency/ Interest rate(3)	$	164		$	(646	)	$	1,673		$	(825	)
Net unrealized investment gains (losses) on available-for-sale securities	(41		)	(384		)	(643		)	(3,479		)
Total net unrealized investment gains (losses)(4)	123			(1,030		)	1,030			(4,304		)
Total reclassifications for the period	$	123		$	(1,030	)	$	1,030		$	(4,304	)



	Net Unrealized Gains (Losses) on Investments		DAC and Other Costs(2)		Future Policy Benefits, Policyholders' Account Balances and Other Liabilities(3)		Deferred Income Tax (Liability) Benefit			Accumulated Other Comprehensive Income (Loss) Related To Net Unrealized Investment Gains (Losses)
	(in thousands)
Balance, December 31, 2019(1)	$	0	$	0	$	0	$	0		$	0
Net investment gains (losses) on investments arising during the period	0		0		0		0			0
Reclassification adjustment for (gains) losses included in net income	0		0		0		0			0
Increase (decrease) due to non-credit related losses recognized in AOCI during the period	0		0		0		0			0
Impact of net unrealized investment (gains) losses on DAC and other costs	0		4		0		(1		)	3
Impact of net unrealized investment (gains) losses on future policy benefits, policyholders' account balances and other liabilities	0		0		50		(10		)	40
Balance, June 30, 2020	$	0	$	4	$	50	$	(11	)	$	43



	Maturity Dates			Interest Rates				June 30, 2020		December 31, 2019
								(in thousands)
U.S. dollar fixed rate notes	2026	-	2027	0.00%	-	14.85	%	$	2,316	$	2,433
Total notes receivable - affiliated(1)								$	2,316	$	2,433